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Summary 
The asymmetric distribution of RNA, lipids and proteins is the basis of cell polarity. Polarized cells are 
vital for the organization of multicellular organism. Malfunctions in the processes generating cell 
polarity are linked with cancer and developmental defects. For cell polarization, the PAR complex, 
consisting of atypical protein kinase C, Par3 and Par6, is essential. Par3 is the central scaffold of the 
PAR complex. Par3 comprises of an N-terminal oligomerization domain, three Postsynaptic density 
protein-95, Disk large, Zonula occludens 1 (PDZ) domains, a kinase binding domain and an 
unstructured C-terminus. Its PDZ domains are the major protein-protein interaction domains. 
However, a detailed analysis of their specificities towards PDZ binding motifs (PBMs) occurring in 
Par3 interaction partners in the environment of cell polarity is missing. 
Here, I present the structural basis of the interaction of Par3 with Par6. I identified a PBM in Par6 
that is essential for Par3 interaction and interacts with the PDZ1 and PDZ3, but not the PDZ2 
domains in vitro. Together with my coauthors, I showed that the Par6 PBM  interacts with Par3 via a 
canonical PDZ:PBM interaction and functions together with the Par6 PDZ domain in Par6 localization 
in vivo. 
In addition, I investigated the specificities of the individual Par3 PDZ domains for cell polarity 
proteins. My analysis revealed a unique binding profile for the dmPar3 PDZ1 and PDZ2 domains, 
while the binding profile of the dmPar3 PDZ3 domain is very promiscuous and overlaps with the 
specificities of the other two Par3 PDZ domains. These overlapping specificities enable Par3 to 
mediate multivalent interactions and thereby enable Par3 to form large protein networks with many 
different cell polarity proteins. 
In a third project, I discovered a hitherto unknown short motif N-terminal of the third PDZ domain of 
dmPar3, denoted FID-motif. I was able to show that the FID-motif folds back onto the dmPar3 PDZ3 
domain in close vicinity of the PBM binding groove thereby reducing the affinities of the PDZ3 
domain towards various PBMs in polarity proteins. These reductions in affinity prevent a subset of 
the previous identified PDZ3 ligands to interact with the PDZ3 domain. Hence, the FID-motif seems 
to fine-tune the recruitment of PBM-carrying polarity proteins via the dmPar3 PDZ3 domain.  
The detailed analyses presented in this thesis provide important insights into the individual roles of 
the Par3 PDZ domains in the assembly of polarity protein complexes. I present new clues in regard of 
functional redundancies within the Par3 PDZ module and provide the further evidence for Par3 
acting as a central scaffold of polarity protein networks. Therefore, the function of the Par3 protein 
during establishment, maintenance and disruption of cell polarity during development and the 
related process of cancer metastasis can be understood in greater detail.  
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Zusammenfassung 
Die asymmetrische Verteilung von RNS, Lipiden und Proteinen ist die Grundlage für die Polarität von 
Zellen. Die Zellpolarität ist essentiell für die Organisation multizellulärer Organismen. Fehler in den 
Vorgängen, die der Polarisation von Zellen zugrunde liegen, stehen in Verbindung mit Krebs und 
Entwicklungsstörungen. Für die Zellpolarität ist der PAR-Komplex, bestehend aus der atypischen 
Proteinkinase C, Par3 und Par6, essentiell. Hierbei ist Par3 das zentrale Gerüstprotein des PAR-
Komplexes und besteht aus einer Oligomerisierungsdomäne am Aminoende, drei Postsynaptic 
density protein-95, Disk large, Zonula occludens 1 (PDZ) Domänen, einer Kinasebindedomäne und 
einem unstrukturiertem Carboxylende. Die drei PDZ-Domänen sind die wichtigsten 
Proteininteraktionsdomänen von Par3. Es fehlt jedoch eine detaillierte Analyse ihrer Spezifitäten in 
Bezug auf PDZ-Bindungsmotiven (PBM) von Par3 Interaktionspartner, die im Kontext der 
Zellpolarisation vorkommen. 
Ich stelle hier die strukturelle Grundlage der Interaktion von Par3 und Par6 vor. Ich habe ein PBM, 
das essentiell für die Interaktion mit Par3 ist, in Par6 identifiziert. Das Par6 PBM interagiert mit der 
ersten und dritten Par3 PDZ-Domäne in vitro, wohingegen es nicht mit der PDZ2-Domäne interagiert. 
Zusammen mit meinen Koautoren konnte ich zeigen, dass das Par6 PBM mit Par3 mittels einer 
kanonischen PDZ:PBM-Bindung interagiert und dass das Par6 PBM zusammen mit der Par6 PDZ-
Domäne in vivo eine Rolle bei der Par6-Lokalisation spielt.  
Des Weiteren führte ich Untersuchungen über die Spezifitäten der einzelnen Par3 PDZ-Domänen im 
Hinblick auf die PBM von Zellpolaritätsproteinen durch. Meine Analyse ergab eindeutige Bindeprofile 
für die dmPar3 PDZ2- und PDZ3-Domänen, wohingegen das Bindeprofil der dmPar3 PDZ3-Domäne 
sehr promisk war und sich mit den Spezifitäten der anderen beiden Par3 PDZ-Domänen überschnitt. 
Diese Überschneidungen ermöglichen es Par3 multivalente Interaktionen mit vielen verschiedenen 
Zellpolaritätsproteinen ein zu gehen. Dadurch wird es Par3 gestattet weitreichende 
Proteinnetzwerke mit vielen unterschiedlichen Zellpolaritätsproteinen zu formen. 
Während eines dritten Forschungsprojektes habe ich ein bis dahin unbekanntes, kurzes Motiv, als 
FID-Motiv benannt, am Aminoende der dritten Par3 PDZ-Domäne entdeckt. Ich konnte zeigen, dass 
sich das FID-Motiv auf die dmPar3 PDZ3-Domäne zurück faltet und dadurch die Affinitäten der PDZ3-
Domäne für die PBM einiger Zellpolaritätsproteine reduziert. Diese Verringerung der Affinitäten 
hindert einige der zuvor identifizierten PDZ3-Liganden an der Interaktion mit der PDZ3-Domäne. 
Daher scheint das FID-Motiv ein Feinregler der PBM-vermittelten Rekrutierung von 
Zellpolaritätsproteinen durch die dmPar3 PDZ3-Domäne zu sein. 
Die detaillierte Studie der Bindeeigenschaften der dmPar3 PDZ-Domänen, die in dieser Dissertation 
vorgestellt werden, liefert wichtige Einblicke in die Rollen der einzelnen Par3 PDZ-Domänen beim 
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Aufbau von Polaritätsproteinkomplexen. Ich stelle neue Hinweise in Bezug auf die funktionale 
Redundanz innerhalb des Par3 PDZ-Moduls vor und bringe weitere Beweise für die These, dass Par3 
das zentrale Gerüstprotein von Polaritätsproteinkomplexen ist, dar. Infolgedessen kann die Funktion 
des Par3-Proteins bei der Etablierung, dem Aufrechterhalten und der Auflösung der Zellpolarität 
während der Embryonalentwicklung und der damit verwandten Metastasenbildung bei 
Krebserkrankungen besser verstanden werden. 
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1. Introduction 
1.1 Cell polarity 
Multicellular organisms contain many different cell types that display an asymmetric distribution of 
their components that is crucial for their cellular function. These asymmetric distributions of 
proteins, RNAs and lipids give rise to cell polarity. These asymmetries inside cells are important in a 
huge variety of biological processes. For instance, during development, asymmetric cell division can 
give rise to distinct daughter and mother cells, each with unique cell fates (Figure 1A). Moreover, 
migratory cells, neurons as well as epithelia cells also display asymmetries (Figure 1A). Not 
surprisingly, the proper asymmetric distribution of the involved factors has to be established and 
maintained and under certain circumstances be reverted in a tightly controlled fashion to avoid 
detrimental outcomes such as cancer (Figure 1B) (Nelson 2003; Tepass 2012). 
All these examples of polarized cells are the basis of tissues and organs with highly specialized 
functions in multicellular organisms. However, to fulfill these specific functions properly, the 
organization of the polarized cells must be maintained. Moreover, this tissues organization relies on 
tissue compartments which are physically separated and allow at the same time communication as 
well as transport between neighboring compartments. Usually, epithelia are found at tissue borders 
which satisfy all these needs. In addition, epithelia are also present at the boundaries of the body 
lining the skin and body cavities. Epithelia are sheets of polarized cells and separate different 
compartments of an organism such as organs, body cavities or the outside. Hence, epithelia face two 
sides, one inner side and one outer side. The apical membrane of epithelia cells face the outside 
whereas the basolateral membrane faces the inside which is defined by the extracellular matrix 
(Figure 1A). In addition, epithelia cells are connected with each other by cell junctions. Hence, the 
cell-cell contacts define a third domain of the membrane called the lateral membrane. Each 
membrane domain is defined by the presence of characteristic proteins and lipids. 
Yet, epithelia are no static assemblies but are dynamic. They are able to adapt to changes in their 
environment and to change their environment. For example, during development and wound 
healing, the transition from stationary epithelia cells to mobile mesenchymal cells (epithelial-
mesenchymal transition, EMT) and vice versa (mesenchymal-epithelial transition, MET) are crucial 
events (Figure 1B). The first hallmark event of EMT is the loss of tight junctions (TJ) followed by the 
dissolution of adherens junctions (AJ) (Figure 1B). Of note, MET begins with the assembly of spot AJ 
followed by maturation of those cell contacts as well as assembly of TJ. Noteworthy, the same 
processes as in EMT and MET are involved in cancer metastasis (Muthuswamy & Xue 2012). 
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Figure 1: Different examples of polarized cells and remodeling of cell polarity during development and cancer 
metastasis. (A) Asymmetries of cellular components are crucial for the function of various cell types and cellular functions. 
As an example, the distribution of the cell polarity proteins Par3, Par3 and aPKC as well as cytoskeletal elements such as 
actin fibrils and microtubules are shown in red, blue and green, respectively, to highlight the asymmetric distributions of 
cellular components during asymmetric cell division, in migratory cells, neurons and epithelial cells. (B) Cell polarity is not a 
static but a dynamic process. Epithelial-mesenchymal transition is initiated by tight junction dissolution followed by 
adherens junction dissolution (top). Mesenchymal-epithelial transition occurs in reverse that is assembly of adherens 
junctions followed by tight junction assembly. 
It is thus of utmost importance to understand the molecular mechanisms underlying the 
establishment and maintenance of cell polarity. 
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1.2 Invertebrate epithelia as a model system to study cell polarity 
1.2.1 Establishment and maintenance of cell polarity in Drosophila epithelia 
The first genes connected with cell polarity were identified in screens for mutants with affected 
asymmetric cell division in the zygote of C. elegans. These genes as well as their expressed proteins 
were named after the observed PARtition-defective phenotype (Kemphues et al. 1988; Watts et al. 
1996; Tabuse et al. 1998). Noteworthy, all eight proteins identified in C. elegans are conserved in 
eukaryotes with the exception of Par2 (Macara 2004). Additionally, the pathways by which epithelial 
polarity is established and maintained is conserved from worm to humans (Macara 2004; Elsum et 
al. 2012). However, the organization of cell-cell junctions differs between invertebrates and 
vertebrates. In vertebrates, the tight junctions localize apically to the adherens junctions whereas in 
flies, the adherens junctions localize apical to the septate junctions (Figure 2) which fulfill similar 
roles as the vertebrate tight junctions (Macara 2004). 
During the formation of epithelia, Par3 localization to the apical part of the cell is the landmark of 
the initial stages of epitheliogenesis. First, Par3 localizes to early spot-like cell-cell contacts were it 
serves as transient recruitment hub for Par6 and atypical protein kinase C (aPKC), to assemble the 
PAR complex. Additionally, Par3 serves as an assembly hub of the Crumbs complex, interacting with 
Crumbs (Crb) and Stardust (Sdt) (Figure 2A and Figure 3) (Tepass 2012; Lang & Munro 2017). 
After the formation of epithelia and maturation of the cell-cell contacts, Par3 is excluded from the 
apical domain by aPKC dependent phosphorylation and localizes to the adherens junction belt 
whereas the Par6/aPKC module associates with the Crumbs complex (Tepass 2012; Lang & Munro 
2017). The Crumbs complex defines the apical domain of mature epithelia cell and consists of the 
transmembrane protein Crb, the scaffold protein disc-lost (Dlt) and the Guanylate kinase Std (Figure 
2A and Figure 3) (Tepass 2012). However, a fraction of Par6/aPKC still interacts with Par3 but aPKC is 
inactivated by the Par3 KBD (Lang & Munro 2017). Of note, in vertebrate epithelia Par3 is not 
associated with the adherens junctions but localizes to the more apical tight junctions (Macara 
2004). 
In mature epithelia, the basolateral sides are enriched with the kinase Par1 as well as members of 
the Scribble complex comprising of the scaffold proteins Scribble (Scrib), Lethal giant larvae (Lgl) and 
the guanylate kinase Disc large (Dlg) (Figure 2 and Figure 3). The Scribble complex is localized with 
the septate junctions in flies (Figure 2) and basal to adherens junctions in vertebrates (Macara 2004; 
Elsum et al. 2012). Par1 phosphorylates apical polarity proteins such as Par3. Next, Par5, a 14-3-3 
protein, binds those phosphorylated proteins and facilitates their exclusion from the basolateral 
domain (Macara 2004; McCaffrey & Macara 2009) thereby maintaining their asymmetric 
distribution. Moreover, the Scribble complex, acts antagonistic to the Par complex via a Lgl mediated 
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inhibition of aPKC thereby inactivating aPKC at the basolateral domain (Elsum et al. 2012). Of note, 
aPKC is able to phosphorylate Par1, thereby priming Par1 for exclusion from the apical domain via a 
Par5 mediated mechanism (Goldstein & Macara 2007) thereby generating a mutual exclusion 
mechanisms between aPKC and Par1. 
 
Figure 2: The PAR complex in Drosophila epithelia cells. The PAR complex localizes subapically in mature invertebrate 
epithelia cells. Std, Stardust; Dlt, Discs-lost; Cdc42, Cell division control protein 42; Par3, Partitioning defective 3; aPKC, 
atypical protein kinase C; α-cat, α-catenin; Arm, Armadillo; Pyd, Polychaetoid; Scrib, Scribble; Lgl, Lethal giant larvae; Dlg, 
Disc-large; Par1, Partitioning defective 1. 
Interestingly, flies can maintain cell polarity in mature epithelia by the presence of either the Crumbs 
complex or Par3 (Tanentzapf & Tepass 2003; Fletcher et al. 2012), indicating a high degree of 
complementary in the functions of the PAR and Crumbs complexes. Thereby this functional 
redundancy convolutes the analysis of the individual functions of those complexes in mature 
epithelia. Nevertheless, the Drosophila embryo and its epithelia offer partial solutions for this 
problem. Since Std is expresses at earlier stages of Drosophila embryogenesis compared to Crb 
(Krahn, Bückers, et al. 2010; Sen et al. 2015; Renschler et al. 2018) whereas there is a strong 
maternal expression of Par3 (Wieschaus & Noell 1986; Müller & Wieschaus 1996; Kuchinke et al. 
1998), it is feasible to partially dissect the individual contributions. 
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1.2.2 Polarity proteins and the PAR complex 
As in all biological processes, protein complexes play a vital role in the organization of cell polarity. 
The PAR complex serves as central scaffold involved in cell polarity and consists of Par3, Par6 and 
aPKC (Macara 2004; McCaffrey & Macara 2009; Lang & Munro 2017). While a single set of genes 
encodes each of the proteins associated with the PAR complex in invertebrates, the number of 
genes has been expanded in vertebrates. Hence, two Par3 proteins (Par3 and Par3L), three Par6 
proteins (Par6α, Par6β and Par6γ) as well as two aPKC proteins (aPKCλ/ι and aPKCζ) are present in 
higher eukaryotes (Noda et al. 2001; Gao et al. 2002; Suzuki et al. 2003).  
 
Figure 3: Domain organization of polarity proteins. Known Par3 PDZ domain ligands used in this study are highlighted in 
bold. OD, oligomerization domain; PDZ, Postsynaptic density protein-95, Disk large, Zonula occludens 1; KBD, kinase 
binding domain; PB1, Phox and Bem1 domain; CRIB, Cdc42/Rac interactive binding domain; PBM, PDZ binding motif; LamG, 
Laminin G; EGF, epidermal growth factor; TM, transmembrane domain; FBD, Ferm binding domain; L27, LIN2/7 binding 
domain; SH3, Src-homology-3 domain; Gu-Kinase, Guanylate kinase; LRR, Leucine-rich repeats; CC, coiled coil; LIM, Zinc-
binding domain present in Lin-11, Isl-1, Mec-3; CA repeats, Cadherin repeats; Ig, Immunoglobulin domain; RA, Ras 
association (RalGDS/AF-6) domain; FHA, Forkhead associated domain; VH, Vinculin homology domain; ABR, actin binding 
region; ZU5, Domain present in ZO-1 and Unc5-like netrin receptors 
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Par3 or Bazooka (Baz) in Drosophila is the main scaffold protein inside the PAR complex. It consists of 
an N-terminal oligomerization domain (OD), followed by three Postsynaptic density protein-95, Disk 
large, Zonula occludens 1 (PDZ) domains. Additionally, a kinase binding domain (KBD) interacting 
with aPKC is present in its large unstructured C-terminus (Figure 3 and Figure 4) (Tepass 2012; Lang 
& Munro 2017). Of note, a region in C-terminal vicinity of the KBD was reported to interact with 
phosphatidylinositol phosphate (PIP) (Krahn, Klopfenstein, et al. 2010). 
 
Figure 4: The interactions inside the PAR complex. The Par complex consists of Par3, Par6 and aPKC. Par3 oligomerizes 
with its N-terminal oligomerization domain (Zhang et al. 2013). It is suggested that the Par3 PDZ1 domain and the Par6 PDZ 
domain interact with each other (Joberty et al. 2000; Lin et al. 2000; Li et al. 2010). Par6 and aPKC dimerize via their N-
terminal PB1 domains (Hirano et al. 2005). The S/T-kinase domain of aPKC is inhibited by the Par3 KBD. At the same time, 
the Par3 KBD can be phosphorylated by aPKC releasing aPKC inhibition (Wang et al. 2012; Soriano et al. 2016). The small 
Ras-like GTPase Cdc42 can bind in its GTP-bound state to the Par6 CRIB motif which results in an affinity increase of the 
Par6 PDZ domain for some of its ligands (Garrard et al. 2003; Peterson et al. 2004; Whitney et al. 2011; Whitney et al. 
2016). Domain abbreviations according to Figure 3. 
Currently, three functions are associated with Par3 (Harris 2017). First, Par3 is involved in adherens 
junction assembly during epithelialization (Figure 2). Next, Par3 sequesters the Par6/aPKC module in 
an inhibited state at the apical-basolateral border (Figure 2). Last, in asymmetric cell division, Par3 
acts as assembly site at the cell cortex for the Pins (Partner of Inscutable) complex (Figure 5) 
(Culurgioni & Mapelli 2013). For example, in asymmetric cell division of Drosophila neuroblasts, Pins 
associates with G protein α i subunits (Gαi) at the apical site. The Gαi subunits are membrane 
anchored by myristoyl groups and thus recruit Pins to the membrane. In addition, Pins interacts with 
Inscutable (Insc) via the Insc asymmetry domain (Figure 3) (Culurgioni & Mapelli 2013). With this 
interaction, Insc links Pins to Par3. However, the details of the Par3:Insc interaction are not well 
understood (Culurgioni & Mapelli 2013). Finally, Pins orients the mitotic spindle via Discs large (Dlg) 
mediated interaction with the Kinesin heavy chain 73 motor protein (Khc-73) (Figure 5) (Lu & 
Johnston 2013; Culurgioni & Mapelli 2013). 
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Figure 5: The PAR complex localizes the Pins complex to the apical site during asymmetric cell division of Drosophila 
neuroblast cells. Cdc42, Cell division control protein 42; Par3, Partitioning defective 3; aPKC, atypical protein kinase C; Dlg, 
Disc-large; Insc, Inscutable; Pins, Partner of Inscutable; Dlg, Discs large; Gαi, G protein αi subunit; Khc-73, Kinesin heavy 
chain 73. 
In recent publications, it was shown that all these roles rely on the oligomerization of Par3 into large 
clusters (Harris 2017; Rodriguez et al. 2017; Dickinson et al. 2017; Wang et al. 2017). This clustering 
is mediated by the N-terminal OD domain which is able to form large fibrillar structures in vitro 
(Zhang et al. 2013). Yet, inhibition of Par3 clustering severely inhibits proper Par3 function (Harris 
2017). In addition, deletion of other domains also impairs specific Par3 functions. For instance, the 
inhibition of aPKC is mediated by regions in direct vicinity of the Par3 KBD (Wang et al. 2012; Soriano 
et al. 2016). Whereas the three PDZ domains have been shown to have specialized functions 
(McKinley et al. 2012). In short, this study addressed the effects of deletions of single dmPar3 
domains or multiple domain combinations on the Par3 function and analyzed the resulting 
phenotype with fluorescence microscopy. With this analysis, the authors concluded that PDZ1 and 
PDZ3 are important for dmPar3 recruitment to the apical domain whereas downstream effects on 
epithelial structure are mediated by PDZ2. In addition, PDZ1 increases dmPar3 turnover thereby 
decreasing Par3 levels. However, Par3 oligomerization is important for all those functions. 
Therefore, Par3 clustering has to act together with additional Par3 domains to fulfill all Par3 
functions. Of note, the most interaction partners of Par3 are recruited via its PDZ domains. A 
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detailed description of PDZ domains and especially the ligands of the Par3 PDZ domains can be 
found in the following paragraphs. 
Par6 acts as an adapter between Par3 and aPKC. Par6 heterodimerizes with its N-terminal Phox and 
Bem1 domain (PB1) domain (Figure 4) with the N-terminal PB1 domain of aPKC (Hirano et al. 2005), 
generating the Par6/aPKC module. Besides the PB1 domain, Par6 comprises a PDZ domain with a 
Cdc42/Rac interactive binding domain (CRIB) domain directly N-terminal to its PDZ domain (Figure 3 
and Figure 4). Interestingly, the Par6 PDZ domain partially unfolds to adopt high affinity state 
(Whitney et al. 2013). This high affinity state is induced by the interaction of the small GTPase Cell 
division control protein 42 (Cdc42) in its GTP bound state with the CRIB domain directly N-terminal 
of the Par6 PDZ domain (Garrard et al. 2003; Peterson et al. 2004). Thereby, Cdc42 enhances the 
affinity of the Par6 PDZ domain for the Crb PBM (Whitney et al. 2016) as well as for synthetic ligands 
(Whitney et al. 2011) (Figure 4). The Cdc42 induced affinity switch probably results in the localization 
of the Par6/aPKC module with the Crumbs complex (Figure 2 and Figure 4). Previous studies 
reported the Par3:Par6 interaction to be dependent on the PDZ1 domain of Par3 and the PDZ 
domain of Par6 (Joberty et al. 2000; Lin et al. 2000; Li et al. 2010) (Figure 4). Conversely, all these 
reports disputed whether or not the interaction relies additionally on the Par6 Crib-motif in front its 
PDZ domain. Besides, the in vivo relevance was not established without doubt (Li et al. 2010) and 
aPKC has been reported as linker, proposing an indirect Par3:Par6 interaction (Suzuki et al. 2001; 
Nagai-Tamai et al. 2002). 
The key enzyme of the PAR complex is the serine/threonine atypical protein kinase C (aPKC). It is an 
atypical member of the protein kinase C family since its N-terminal regulatory domain is truncated 
and a PB1 domain is present at its N-terminus (Figure 3 and Figure 4) (Drummond & Prehoda 2016). 
In addition, the kinase domain of aPKC has only two out of three conserved phosphorylation 
activation sites. Of note, a PDZ binding motif (PBM) is present at its C-terminus (Drummond & 
Prehoda 2016). Besides the Par3 KBD, aPKC substrates are involved in a variety of signaling pathways 
such as cell cycle control, cell fate decision via the Hedgehog pathway, tissue homeostasis via Wnt 
signaling or depolarization via JAK/Stat signaling (Drummond & Prehoda 2016). Of note, several 
aPKC substrates are phosphorylated in motifs associated with phospholipid interactions, such as the 
Par3 KBD, and are impaired from membrane binding upon phosphorylation (Drummond & Prehoda 
2016; Soriano et al. 2016). 
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1.3 PDZ domains and PDZ binding motifs 
1.3.1 PDZ domains interact with short peptide motifs 
Many polarity proteins contain so-called Postsynaptic density protein-95, Disk large, Zonula 
occludens 1 (PDZ) domains (Figure 3). PDZ domains can be found in various signaling complexes in 
the animal kingdom (Ivarsson 2012) where they usually act as protein-protein interaction scaffolds. 
PDZ domains contain about 90 amino acids and fold into an antiparallel β-barrel with 5-6 β-strands 
and 1-2 α-helices (Luck et al. 2012; Ivarsson 2012; Ye & Zhang 2013) (Figure 6). 
 
Figure 6: PDZ domain ligand recognition. (A) Cartoon representation of a canonical PDZ:PBM interaction based on the 
dmPar3 PDZ2:Insc PBM structure solved in this study (for details see Figure 29 and Table 32). The PBM augments the β-
sheet consisting of the β2- and β3-strand. Together the α2-helix and the β2-strand form the PBM binding groove. The PDZ 
domain is depicted in grey and the PBM in green, respectively. (B) Representation of a canonical PDZ:PBM interaction. The 
PBM is depicted as green sticks to highlight the PBM classification based on the -2 residue (Lee & Zheng 2010; Ivarsson 
2012). The PDZ domain is displayed as grey tube, otherwise as in (A). 
The two α-helices cap the open sites of the β-sheets. Canonical PDZ:ligand interaction are based on 
short motifs, called PDZ binding motifs (PBMs), at the C-terminus of the ligand protein. In a PDZ:PBM 
interaction, the PBM augments the PDZ β-sheet at the β2-strand (Figure 6). The carboxy terminus of 
the PBM interacts extensively with a highly conserved GXGL motif inside the loop between the β1- 
and β2-strands. This loop is therefore called the carboxy-binding loop. Since the last and third last 
residue of the PBM directly face towards the PDZ domain, the identity of those residues can be used 
to assign classes to the PBMs (Table 2) (Lee & Zheng 2010; Ivarsson 2012). Moreover, the residues of 
a PBM are numbered starting at the most C-terminal residue as position 0, the second most C-
terminal as position -1, the third most C-terminal as position -2 and so on. Hence, class I PBMs have 
serine or threonine residues at their -2 position, class II PBMs have hydrophobic residues at position 
-2, whereas the -2 position of class III PBMs is acidic. Nonetheless, this classification scheme seems 
to suggest a strict selectivity of PDZ domains towards certain PBMs or ligand classes. Yet, it has been 
shown in mice, that the PDZ domain selectivity is not restricted to discrete classes, but evenly 
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distributed through the sequence space (Stiffler et al. 2007). Despite this fact, I will use this 
classification of PBMs into those three classes for clarity. 
Table 2: PDZ ligand classes  
PBM class Consensus sequence 
I X-T/S-X-φ-COO
-
 
II X- φ -X-φ-COO
-
 
III X-D/E-X-φ-COO
-
 
X depicts any amino acid, φ depicts hydrophobic amino acids, (Lee & Zheng 2010; Ivarsson 2012) 
Besides the canonical PDZ:PBM interaction, various other PDZ domain binding modes have been 
revealed (Luck et al. 2012; Ivarsson 2012; Ye & Zhang 2013). The most similar to the conventional 
PDZ:PBM β-sheet augmentation, are internal PBMs (Figure 7).  
 
Figure 7: Interaction of internal PBMs with PDZ domains. (A) Cartoon representation of the interaction of the internal 
PBM of Stardust (Std) with the dmPar6 PDZ domain (Penkert et al. 2004) (PDB ID: 1x8s). The internal PBM augments the β-
sheet consisting of the β2- and β3-strand. Together the α2-helix and the β2-strand form the PBM binding groove. The PDZ 
domain is depicted in dark grey and the internal PBM in orange, respectively. (B) Cartoon representation of the interaction 
of the internal PBM of Stardust (Std) with the dmPar6 PDZ domain. The PBM is depicted as orange sticks to highlight the 
mimic of the C-terminus by the aspartic acid side chain (“COO
-
“). PBM positions in parenthesis indicate equivalent positions 
of C-terminal PBMs (Figure 6B) The PDZ domain is displayed as dark grey tube, otherwise as in (A). 
As suggested by their name, internal PBMs are not at the very C-terminal position of a protein. 
Nevertheless, they also interact with PDZ domains via a β-sheet augmentation. Here, internal PBMs 
mimic the C-terminal carboxyl group with an aspartic acid side chain (Ivarsson 2012). Additionally, 
they usually mitigate steric clashes with the carboxy-binding loop by formation of a β-hairpin of the 
internal PBM (Ivarsson 2012). Interestingly, some PDZ domains can interact with both canonical and 
internal PBMs. For example, a recent study (Merino-Gracia et al. 2016) has shown that the PDZ 
domain of neuronal Nitric Oxide Synthase can interact with classI, II and II ligands as well as internal 
ligands. Moreover, the Par6 PDZ is known to interact with canonical and internal PBMs of Crumbs 
(Whitney et al. 2016; Lemmers et al. 2004) and Stardust (Figure 7) (Penkert et al. 2004; Kempkens et 
al. 2006; Wang et al. 2004), respectively. 
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Besides the importance of the core PBM consisting of the four last amino acids, upstream residues 
have been shown to influence PDZ:PBM interactions. These interactions are occasionally found 
outside the PBM binding groove and are located in the β2-β3-loop or within extensions of the PDZ 
domain (Luck et al. 2012). Interestingly, the majority of the extended PBM:PDZ interactions are 
observed within PBM positions -7 and -4 (Luck et al. 2012). In rare cases such as the Par3 PDZ3 
domain of rats and mice, the interaction between the PDZ domain and the PBM can extend to 
position -10. Most strikingly, these distal interactions observed in the rat Par3 PDZ3 domain with the 
class I PBM of VE-cadherin (Feng et al. 2008) as well as in the mouse Par3 PDZ3 domain with the 
class II PBM of the phosphatase PTEN (Tyler et al. 2010) seem to be important for the dual specificity 
of the rodent Par3 PDZ3 domain. Of note, phosphorylation sites are found in these upstream 
sequences and various examples exist where phosphorylation inside the extended PBM contributes 
to an increase or decrease in affinity (Luck et al. 2012). In addition, an elegant study by Amacher et 
al. could show that both, the presence of residues in the PBM which interact with the PDZ domain as 
well as the absence of negative modulators, that is residues lowering the PDZ:PBM affinity by 
repulsive interactions (e.g. electrostatic repulsion), are necessary for high affinity PDZ:PBM 
interactions (Amacher et al. 2014). 
Beyond the recognition of short motifs, PDZ domains can form homo- and heterodimers (Ivarsson 
2012; Ye & Zhang 2013). PDZ dimerization can occur in different modes, ranging from elaborated β-
strand swap interactions (Figure 8A) to simple back to back dimerization (Figure 8B) (Ivarsson 2012). 
In general, PDZ dimers can have various functions such as providing addition interaction sites for 
ligands, stabilization of the PDZ domains or protein dimerization (Ivarsson 2012; Ye & Zhang 2013). 
 
 
Figure 8: Examples of PDZ dimerization. (A) Cartoon representation of ZO-1 PDZ dimer (Fanning et al. 2007) (PDB ID: 2rcz) 
illustrating β-strand swap dimers. The individual PDZ domains are colored white and dark grey, respectively. (B) Cartoon 
representation of the Shank1 PDZ dimer in complex with the guanylate kinase associated protein (GKAP1a) PBM (Im et al. 
2003) (pdb ID: 1q3p) illustrating back-to-back dimerization. The individual PDZ domains are colored white and dark grey, 
respectively. The bound ligands are colored in dark blue and green, respectively. 
In addition to protein-protein interactions, PDZ domains also mediate protein-lipid interactions. 
Several different interaction modes between PDZ domains and phospholipids have been published 
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(Gallardo et al. 2010; Ivarsson 2012). These interactions are based on electrostatic membrane 
interactions, membrane penetration or specific binding to phosphoinositide head groups (Figure 9). 
In contrast to the conserved PBM binding groove, the lipid interaction surfaces are more diverse 
(Gallardo et al. 2010; Chen et al. 2012) and seem to be acquired convergent in the evolution of PDZ 
domains (Chen et al. 2012). For example, studies investigating the lipid-interactions of the second 
Par3 PDZ domain in rat revealed three distinct interaction surfaces interacting with lipids (Figure 9). 
A binding site for phosphoinositide head groups is present in close proximity of the carboxy-binding 
loop. In addition, residues next to the α1-helix can be inserted into the cell membrane. Moreover, 
the authors also proposed the presence of positively charged clusters responsible for membrane 
association (Wu et al. 2007). Of note, all residues reported are conserved between rat and fly (Wu et 
al. 2007). Worth mentioning, initial, systematic studies addressing the lipid binding properties of PDZ 
domains revealed that approximately 30-40% of PDZ domains are able to bind to various lipids 
including phosphoinositides (Chen et al. 2012). Yet, for the majority of those PDZ domains it is 
unclear if and how those PDZ-lipid interactions are involved in biological processes. 
 
Figure 9: Phospholipid interaction surfaces of the rat Par3 PDZ2 domain. Cartoon representation of the rat Par3 PDZ2 
domain (Wu et al. 2007) (PDB ID: 2ogp). Residues interacting with phosphoinositide head groups are shown as light blue 
sticks. Residues inserting into the membrane are shown as green sticks. Residues forming positively charged clusters are 
shown as dark blue sticks. 
In sum, PDZ domains can mediate protein-protein interactions between short linear motifs such as 
C-terminal PBMs (Figure 6) and internal PBMs (Figure 7). In addition, dimerization is a well-known 
interaction mechanism between PDZ domains (Figure 8). Moreover, some PDZ domains possess the 
ability to interact with certain lipids (Figure 9). All those interaction possibilities highlight the 
versatility of PDZ domains as organizers of signaling complexes. 
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1.3.2 Extensions at the termini of PDZ domains and regulation of PDZ:PBM interactions 
N- and C-terminal extensions can influence the dynamics, stability and solubility of PDZ domains as 
well as provide additional ligand interaction sites or regulate the PDZ domain function (Wang et al. 
2010; Luck et al. 2012; Ivarsson 2012; Ye & Zhang 2013). Similar to their broad functions, the 
structures of PDZ extensions can vary and include additional α-helices and β-strands at both termini. 
Besides, secondary structure based predictions assessed that approximately 40% of all PDZ domains 
contain extensions on at least one of their termini (Wang et al. 2010).  
A well-studied example of a PDZ extension in the context of cell polarity is the CRIB domain N-
terminal of the Par6 PDZ domain (Figure 3). The unstructured CRIB domain forms two additional β-
strands upon interaction of the Par6 PDZ domain with GTP-bound Cdc42 (Garrard et al. 2003; 
Peterson et al. 2004; Whitney et al. 2011; Whitney et al. 2013). This structural rearrangement allows 
the PDZ to transit via partial unfolding into a high affinity state with enhanced affinity for the Crb 
PBM (Whitney et al. 2011; Whitney et al. 2016). 
In addition to extensions at the termini, PDZ domains can also form supramodules. There are two 
types of supramodules (Luck et al. 2012; Ye & Zhang 2013). Homotypic PDZ domain supramodules 
only consist of PDZ domains which form larger complexes. Those larger PDZ domain assemblies form 
tandems and usually a short, conserved linker sequence can be found between the two PDZ 
domains. Of note, PDZ tandems may not be confused with PDZ dimers as the later occur between 
PDZ domains of different protein chains whereas PDZ tandems occur in one protein chain. The 
functions of those PDZ tandems are similar to the short extensions as they can stabilize the fold of 
one of the involved PDZ domains and provide additional ligand binding sites such as in the 
PDZ1:PDZ2 and PDZ4:PDZ5 tandem of the multiple PDZ domain protein Glutamate receptor-
interacting protein 1 (Luck et al. 2012; Ye & Zhang 2013). 
Another kind of PDZ supramodules are heterotypic PDZ domain supramodules. As the name 
suggests, heterotypic supramodules contain other domains besides PDZ domains. Herein, the 
additional domains serve similar purposes as in homotypic PDZ domain supramodules. For example, 
they can stabilize the PDZ domain and generate additional ligand binding interfaces, as in the 
Harmonin N domain and PDZ domain supramodule (Ye & Zhang 2013). One more example in the 
contex of cell polarity are the PDZ-SH3-GK supramodules found in members of the membrane-
associated guanylate kinase (MAGUK) family such as ZO-1 or Std/Pals1 (Figure 3) (Ye & Zhang 2013; 
Li et al. 2014). In PDZ-SH3-GK supramodules, a PDZ domain forms with C-terminal SH3- and GK-
domains an elaborate binding surface which include canonical PDZ:PBM interactions as well as 
additional binding surfaces provided by the SH3- and GK domains. 
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There are various examples present in which regulation of PDZ:PBM interactions occur. Non-
surprising, phosphorylation of residues inside the PBM or inside the PBM binding groove of a PDZ 
domain as well as inside PDZ extensions is reported to weaken or disrupt PDZ:PBM interactions (Luck 
et al. 2012; Ivarsson 2012; Ye & Zhang 2013). In addition, allosteric changes as induced by the 
binding of Cdc42 to the Par6 CRIB domain N-terminal of its PDZ domain (Figure 4) also influence the 
binding properties of PDZ domains (Luck et al. 2012; Ivarsson 2012; Ye & Zhang 2013). 
 
1.3.3 Investigating PDZ specificity 
Much effort has been taken to investigate the specificity of PDZ domains. Over the years, several 
high through-put studies have been published investigating selected PDZ domains or investigating 
the PDZ specificity on a proteome-wide scale with large efforts on predicting PDZ specificity. 
The first study quantifying PDZ domain specificities on a larger scale used peptide arrays to screen  
the interactions of three PDZ domain with 6223 human C-terminal peptide sequences. Subsequently, 
the authors used surface plasmon resonance and NMR spectroscopy to investigate the basis of the 
ligand affinities of the PDZ domains (Wiedemann et al. 2004) and to identify areas of the PDZ 
domain influencing PBM recognition. These areas included the carboxy-binding loop, the α2-helix as 
well as residues from β2- and β3-strand (Figure 6). Afterwards, systematic mutational studies were 
applied to separate the relative affinity contributions of each PBM side chain. Thereby the authors 
identified regions on the PDZ domains which are responsible for the interactions with the individual 
PBM position. This knowledge was finally used to design high affinity ligands. 
In order to address the specificities of PDZ domains on a larger scale, proteome-wide studies 
investigating the PDZ specificity in mice were performed (Stiffler et al. 2007). To this end, 157 PDZ of 
the 270 human PDZ domains (Luck et al. 2012) were screened against 217 PBMs in a protein 
microarray. The authors used their protein microarray data together with fluorescence polarization 
data to train and refine a prediction model. At the end, their prediction model suggested an even 
distribution of PDZ specificity across the proteome. This even distribution suggests that PDZ:PBM 
interaction do not fall into discrete classes but rather have evolved to use as much sequence 
diversity as possible to ensure non-overlapping specificities between PDZ:PBM interactions. In 
addition, a further study from the same lab provided an improved sequence based prediction of 
PDZ:PBM pairs (Chen et al. 2008). However, the suggested prediction methods are based on a highly 
underdetermined training data set. Although, the authors tried to bypass the effects of the 
underdetermined training data set, the prediction method seems to be limited to prediction 
interactions of PDZ domains sharing high sequence identity with the training data (Chen et al. 2008). 
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A similar approach investigating the specificities of 82 human and worm PDZ domains used phage 
display selected ligands to correlate the sequence of the PDZ domain, especially the residues 
surrounding the PBM binding pocket, with the sequence of the PBM (Tonikian et al. 2008). Since the 
authors used optimal ligands selected by phage display, the predicted ligand sequence is a 
prediction of the optimal ligand. However, due to the fact that natural PDZ ligands are usually not 
optimal, the predicted ligand is just a suggestion (Tonikian et al. 2008). Later studies using structural 
information to predict PDZ:PBM interactions suggested that the sequence and structure based 
approaches are complementary and largely depend on the sequence identity between the test and 
training PDZ domains (Hui et al. 2013). Another approach to predict PDZ specificities was developed 
combining clustering of PDZ domains into families according to their sequence as well as a machine 
learning for predication and generation of negative training data derived (Kundu & Backofen 2014). 
The negative training data derived from machine learning was used to balance the positive 
interaction data present in the literature (Kundu & Backofen 2014). However, the authors published 
predictions for the PDZ domains present in the training data set and therefore do not cover all PDZ 
domains. 
Yet, the structure based as well as the sequence based prediction methods are unable to detect the 
established interaction between the dmPar6 PDZ domain and the Crb PBM (Whitney et al. 2016; 
Lemmers et al. 2004). Of note, the Par6 PDZ domain shares only low identity with the PDZ domains 
used to generate the prediction algorithms. Therefore, prediction of PDZ:PBM interactions is still an 
unsolved problem and thorough analysis of PDZ:PBM interactions are inevitable. 
Most strikingly, all prediction methods only investigated the core PBM as well as PDZ domain 
without N- or C-terminal extensions (Wiedemann et al. 2004; Stiffler et al. 2007; Chen et al. 2008; 
Tonikian et al. 2008; Hui et al. 2013; Kundu & Backofen 2014). Not surprisingly, this limits the 
predication capabilities since it is estimated for 40% of all PDZ domains to have extensions at one of 
their termini (Wang et al. 2010). Moreover, residues upstream of the core PBM can influence 
PDZ:PBM interactions quite dramatically (Luck et al. 2012; Ivarsson 2012; Ye & Zhang 2013). 
A comprehensive structural study was performed investigating high affinity PDZ:PBM interactions 
(Ernst et al. 2014). The aim of this study was to provide structural information on non-class I PBMs 
bound to PDZ domains since the available structural information was previously dominated by class I 
PBMs. Noteworthy, this study was based on phage display derived PDZ:PBM pairs reported 
previously (Tonikian et al. 2008) and therefore selects artificially tight interaction partners. 
Nevertheless, the authors provide detailed information about specificity generating mechanisms 
concerning PBM positions 0 to -3. 
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Interestingly, a phage display screen to identify the ligand specificities of the dmPar3 PDZ domains 
was performed (Yu et al. 2014). However, the data presented seems to be biased towards 
tryptophan residues. It is known that phage display data can be enriched in hydrophobic residues 
and therefore comprise prediction algorithms based on phage display data (Luck & Travé 2011). 
Moreover, the first screen of a library containing all unique C-termini in the human proteome as well 
as all unique C-termini of selected viruses was published recently (Ivarsson et al. 2014). However, 
only nine human PDZ domains were tested. Nevertheless, this screening method renders predictions 
obsolete since it includes all possible ligands. However, only a very small subset of the 270 PDZ 
domains present in humans (Luck et al. 2012) have been tested so far. 
Taken together, much progress has been made over the past years in understanding PDZ:PBM 
interactions. It became obvious that PDZ:PBM interactions are fine-tuned between specificity and 
optimal affinity in their biological context. Furthermore, it turned out to be close to impossible to 
predict all PDZ:PBM interactions present in nature. In addition, studies addressing the interactions of 
PDZ domains with several ligands to overcome the limitations of prediction are still sparse. 
 
1.4 The role of the Par3 PDZ domains in cell polarity 
Par3 is the central scaffold of the PAR complex and contains three PDZ domains as central 
interaction modules (Figure 4). Since PDZ domains are known to be promiscuous in regard of ligand 
recognition, it is not surprising that several ligands for the Par3 PDZ domains were suggested in the 
literature. Still, the question arises how the Par3 PDZ domains and other PDZ domains present in cell 
polarity associated proteins can discriminate between their ligands in an environment enriched with 
PBMs (Figure 3). 
Of note, some interactions of the Par3 PDZ domains are already well studied. For example, structural 
studies investigating the interactions of the rodent Par3 PDZ3 domain revealed its ability to interact 
with the class I ligand VE-cadherin in rats (Feng et al. 2008) as well as with the class II ligand PTEN in 
mice (Tyler et al. 2010). Both interactions rely on an additional binding site in the β2-β3-loop besides 
the PBM binding groove. Of note, the β2-β3-loop is only conserved in vertebrate Par3 PDZ3 domains. 
In contrast, invertebrate Par3 PDZ3 domains do not contain this conserved loop (Figure 27). In the 
Drosophila Par3 protein, this loop has a unique sequence consisting of glycine and serine residues. 
Furthermore, previous studies in the lab of Silke Wiesner showed that the β2-β3-loop does not 
influence the fold of the dmPar3 PDZ3 domain (Renschler 2013; Brückner 2014). This suggests that 
the extended β2-β3-loop is probably dispensable for dmPar3 PDZ3 function.  
Additionally, the rat Par3 PDZ2 domain can interact with phosphatidylinositol lipids (Figure 9) and 
the residues mediating this interaction are conserved in the Drosophila protein (Wu et al. 2007). In 
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addition, the PDZ domains and the PIP binding region in the vicinity of the KBD (Krahn, Klopfenstein, 
et al. 2010) seem to be involved in Par3 oligomerization dependent membrane association in the 
Drosophila embryo ectoderm (McKinley et al. 2012). However, the phospholipid interactions of the 
second Par3 PDZ domain alone are not sufficient for membrane recruitment (McKinley et al. 2012).  
In this study, I investigated the interactions of the dmPar3 PDZ domains with different PBMs in 
greater detail to dissect their specificities. To this end, I searched the literature for ligands reported 
to interact with at least one of the Par3 PDZ domains. These interactions should be at least proven 
by biochemical data such as pulldown assays. In order to test also PBMs not listed as Par3 PDZ 
ligands but present in the cellular environment of Par3, I included several PBMs found in members 
of the PAR and Crumbs complexes. Therefore, I choose to investigate the interactions of the dmPar3 
PDZ domains with the class I PBMs of Smallish (Smash), Inscutable (Insc), Crumbs (Crb) and Starry 
night (Stan) as well as the class II PBMs of Echinoid (Ed), Shotgun (Shg) and dmPar6 (Table 5). 
Furthermore, the class III PBMs of α-catenin (α-cat) and aPKC as well as the internal PBM of Stardust 
(Std) have been included in my analysis (Figure 10). 
 
Figure 10: The Par3 PDZ domains in cell polarity. Known interaction partners of the dmPar3 PDZ domains are indicated 
with solid lines whereas possible interaction partners are indicated with dashed lines. Approximate subcellular localizations 
of the interaction partners are indicated. Abbreviations according to Figure 2 and Figure 3. 
The PBM of the LIM domain containing protein Smash was recently identified as an interaction 
partner of the dmPar3 PDZ2 and PDZ3 domains as well as of the Canoe PDZ domain (Beati et al. 
2018). This initial study suggested Smash as a mediator between dmPar3, the Src family kinase 
Src42A, Canoe, the Drosophila afadin, and the apical actomyosin network (Figure 10) regulating cell 
shape as well as cortical tension during epitheliogenesis. 
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Inscutable (Insc) is the link of the PAR complex to asymmetric cell division (Lu & Johnston 2013; Lang 
& Munro 2017). Insc is an adaptor protein which directly associates with Par3 (Figure 5 and Figure 
10) (Wodarz et al. 1999; Schober et al. 1999; Culurgioni & Mapelli 2013; Lu & Johnston 2013) and the 
Partner of Inscutable (Pins) which is the major scaffolding protein of the Pins complex (Figure 5). 
Additionally, the Pins complex comprises of the heterotrimeric G-protein Gαi, Disk large (Dlg) and 
the kinesin motor protein KHC-73 (Lu & Johnston 2013). In short, the Pins complex facilitates the 
localization of one centromere of the mitotic spindle at a distinct cell cortex thereby aligning the 
division plane of the asymmetric cell division (Culurgioni & Mapelli 2013). 
The Crb PBM is a known interaction partner of the Par6 PDZ domain (Whitney et al. 2016; Lemmers 
et al. 2004). Moreover, this interaction is enhanced by the interaction of Cdc42 with the Par6 CRIB 
domain (Whitney et al. 2016). However, since Par3 recruits members of the Crumbs complex during 
epitheliogenesis (Tepass 2012; Lang & Munro 2017), I tested whether the Crb PBM is able to interact 
with the Par3 PDZ domains. Additionally, determining the affinities of the interactions of the Crb 
PBM with the Par3 PDZ domains might shed light on the molecular basis for the later displacement 
of Crb from initial adherens junctions and establishment of the Crumbs complex. Of note, the 
interaction of Crb and Std (or its vertebrate homolog Pals1) is a high affinity interaction between the 
PBM and upstream sequences of Crb C-terminus with the PDZ-SH3-GK module of Std/Pals1 (Li et al. 
2014; Ivanova et al. 2015). 
Starry night (Stan) is the splice isoform of the flamingo gene in Drosophila containing a class I PBM at 
its C-terminus (Wasserscheid et al. 2007). The flamingo gene encodes a cadherin that promotes 
hemophilic cell adhesion and is required for planar cell polarity. The C-terminus of Stan has been 
shown to interact with the first and second dmPar3 PDZ domain (Figure 10) (Wasserscheid et al. 
2007). 
The C-termini of nectins bind to all Par3 PDZ domains in mouse (Takekuni et al. 2003; Ooshio et al. 
2007). Although, no nectin orthologs are present in Drosophila, the transmembrane protein Echinoid 
(Ed) fulfills similar functions in flies (Harris & Tepass 2010). Furthermore, it was shown, that the Ed 
PBM indeed interacts with the dmPar3 PDZ domains (Figure 10) (Wei et al. 2005). 
The Drosophila DE-Cadherin Shotgun (Shg) was reported to interact with the dmPar3 PDZ domains 
(Figure 10) (Wei et al. 2005; Bulgakova et al. 2013). Besides, a similar interaction between the 
human VE-Cadherin and the third PDZ of human Par3 was shown to be dependent not only on a 
classic PBM but also involves interactions upstream of the C-terminal PBM (Iden et al. 2006; Tyler et 
al. 2010). 
A PDZ-PDZ heterodimerization between Par3 with Par6 has been controversially discussed in 
literature (Joberty et al. 2000; Lin et al. 2000; Suzuki et al. 2001; Nagai-Tamai et al. 2002; Li et al. 
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2010). However, the presence of a conserved class II PBM at the C-terminus of Par6 proposes an 
alternative worth investigating (Figure 10). 
α-catenin, a member of the catenin family, a protein family defined by the association of its 
members with cadherins, have been shown to interact with all three Par3 PDZ domains (Figure 10) 
(Iden et al. 2006). Furthermore, α-catenin and Par3 seem to be involved in VE-cadherin and Par3 
mediated orientation of the Golgi apparatus (Odell et al. 2012). In addition, recent studies suggested 
that α-catenin participates in the front-rear determination of migratory cells (Vassilev et al. 2017). 
As a class III PBM is present at the C-terminus of aPKC, I investigated whether the aPKC PBM acts as 
an additional interaction site between Par3 and aPKC. As it is known for the KBD of Par3 to be a 
substrate and inhibitor of the kinase domain of aPKC (Wang et al. 2012; Soriano et al. 2016), the 
interaction of the aPKC PBM with a Par3 PDZ domain (Figure 10) would add an additional interaction 
mechanism which would ensure association of aPKC with Par3 after phosphorylation of the 
inhibitory Par3 KBD. 
The internal PBM of Std, a member of the Crumbs complex, is the notable exception in this list. 
Although it is a known ligand of the Par6 PDZ which is not regulated by Cdc42 (Penkert et al. 2004; 
Kempkens et al. 2006; Wang et al. 2004), it was not selected as a possible Par3 PDZ domain 
interaction partner with redundant PDZ specificities inside the PAR complex as the Crb PBM. It was 
rather selected as a negative control since Std recruitment to adherens junctions is dependent on 
the Std PDZ domain as well as a region C-terminal of the Par3 KBD (Krahn, Bückers, et al. 2010). 
Taken together, many different ligands of the dmPar3 PDZ domains can be found in literature. 
However, in many cases the PDZ:PBM interactions were not mapped to individual PDZ domains or 
described as PDZ:PBM interactions. In addition, the individual specificities of the dmPar3 PDZ 
domains have not been investigated thoroughly. For that reason, I want to investigate the dmPar3 
PDZ domains and their ligand interactions in greater detail.  
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2. Aims and significance 
 
Three distinct activities of Par3 clusters have been suggested (Harris 2017). First, Par3 acts as a 
scaffold for adherens junction assembly (Figure 2A). Second, Par3 inhibits aPKC at the apical-
basolateral border by sequestration (Figure 2A). Third, Par 3 acts as a cortical assembly site for the 
Pins complex during asymmetric cell division (Figure 2B). Recently, it became obvious that those 
functions rely on the one hand on distinct OD mediated clustering of Par3 (Harris 2017; Rodriguez et 
al. 2017; Dickinson et al. 2017; Wang et al. 2017). Yet, a thorough investigation of the Par3 PDZ 
domain mediated protein-protein interactions (Figure 10) underlying the various functions of the 
Par3 clusters remained absent. In addition, there is only limited information about the specificities of 
the dmPar3 PDZ domains available (Yu et al. 2014). Therefore, I investigated the following two topics 
in my PhD thesis in order to provide more details for the interactions of the Par3 PDZ domains. 
 
1. Investigate the molecular details of the controversial interaction of Par3 and Par6. 
2. Investigate specificities of the individual Par3 PDZ domains in order to reveal a specificity 
profile against physiological relevant PBMs in the context of the different Par3 functions. 
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3. NMR spectroscopy and x-ray crystallography 
3.1 Nuclear magnetic resonance spectroscopy as a tool to study protein 
interactions 
3.1.1 Fundamentals of NMR spectroscopy 
The nuclei of atoms have a quantum mechanical property called nuclear spin I. This spin is the sum 
of the orbital total angular momenta and the intrinsic spins of all protons composing the nucleus 
(Table 3). Each proton and neutron has an interger orbital angular momentum and a spin of 1/2. 
Therefore, in nuclei with even numbers of protons and neutrons (e.g. 12C), the nuclear spin is 0 due 
to spin pairing. If the numbers of both protons and neutrons is uneven, two unpaired spins are 
present and result in an integer nuclear spin e.g. 1 in the case of 14N. Moreover, nuclei where the 
sum of protons and neutrons is odd (e.g. 15N), I is half-integer since one unpaired spin is present. In 
addition, the nuclear spin results in the nuclear magnetic moment which can be depicted as a 
magnetic dipole. Hence, the nuclear magnetic moment leads to the interactions of nuclei with 
magnetic fields. However, if no magnetic field is present, all spins are oriented randomly. 
 
Table 3: Properties of atoms used in protein NMR spectroscopy 
Element Isotope Nuclear spin (I) Natural Abundance Gyromagnetic ratio1 γ 
Hydrogen 1H 1/2 99.98 % 26.75 
Deuterium 2H 1 0.02 % 4.10 
Carbon 12C 0 98.90 % 0.00 
 13C 1/2 1.11 % 6.73 
Nitrogen 14N 1 99.63 % 1.93 
 15N 1/2 0.37 % -2.71 
1
 in 10
7
 T
-1
s
-1
, (Rattle 1995; Czeslik et al. 2007) 
 
If a sample containing nuclei with I = 1/2 is placed into an external magnetic field with a field 
strength of B0 in the direction of the z-axis, the spins of the nuclei will align along B0 after an 
equilibration period. Since 2*I+1 orientations are possible, spin 1/2 nuclei can orient themselves in 
two directions, one parallel (α state) and one anti-parallel (β state) to B0 (Figure 11A).  
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Figure 11: Fundamentals of NMR spectroscopy. (A) The nuclear spins of the atomic nuclei inside a magnetic field B0 along 
the z-axis align parallel (α state) and antiparallel (β state) along B0. The α state is slightly more populated due to its lower 
energy. The bulk magnetization (cyan arrow) points along the magnetic field. (B) The bulk magnetization moves around the 
z-axis after a short radiofrequency pulse flipped it along the x-axis. The precession motion (black arrow) of the bulk 
magnetization in the xy-plane (Mxy) can be detected by detector coils along the x-axis (black). (C) The recorded signal 
oscillates and decays over time since the magnetization finally returns to equilibrium. After Fourier transformation (FT) the 
time depend signal is converted to a frequency signal (ν0). 
After equilibration, the population of the α state will be populated slightly more due to its lower 
energy level. Furthermore, the spins describe a precession motion around the B0 field which can be 
described by their Larmor frequency. The velocity ω0 of this precession motion is given by 
Equation 1: 
𝜔0 = −𝐵0𝛾 
with γ being the gyromagnetic ratio. γ is thus a sensitivity measure of the observed nuclei for the 
magnetic field (Table 3). The frequency ν0 (in Hz) by which the spins rotate in the xy-plane can be 
derived from Equation 1: 
Equation 2: 
𝑣0 =
𝜔0
2𝜋
= −
𝐵0𝛾
2𝜋
 
The spins add up to the so-called equilibrium magnetization or bulk magnetization Mz of the sample 
that is aligned along B0 (Mz) (Figure 11A, cyan arrow). The equilibrium magnetization can be 
manipulated by a magnetic field B1 perpendicular to B0. To this end, electromagnetic waves usually 
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in the frequency range of radiofrequencies are used. A short radiofrequency pulse will tilt Mz away 
from the z-axis since the spins start to align with the B1 field and therefore are in phase coherence 
with the B1 field. If this pulse is long enough to tilt the Mz magnetization completely into the xy-
plane, it is called a 90° pulse. After the pulse, the magnetization moves around a circle in the xy-
plane (Figure 11B black arrow) and induces an electric current in a receiver coil along the x-axis. 
However, the magnetization will slowly return towards the equilibrium and therefore, the 
detectable magnetization in the xy-plane will decline exponentially over time (Figure 11C left). This is 
called the free induction decay (FID). 
The time dependent decay of the magnetization ρ of a single 1/2 spin in the xy-plane can be 
described as a first order differential equation: 
Equation 3: 
𝜕
𝜕𝑡
𝜌 = (𝑖𝑣0 − 𝑅2)𝜌 
with 𝑅2 being the decay (relaxation) rate of the transverse magnetization. Equation 3 can be solved 
as 
Equation 4: 
𝜌(𝑡) = 𝜌(0)𝑒𝑖𝑣0𝑡𝑒−𝑅2𝑡 
Equation 4 tells us that ρ oscillates with ω0 and decays with 𝑅2. The spectrum in the frequency 
domain in Figure 11 C (right) is the result of the Fourier transformation of Equation 4 as a function of 
the frequency ω: 
Equation 5: 
𝜌(𝑣) = 𝜌(0)
1
𝑖(𝑣0 − 𝑣) − 𝑅2
= −𝜌(0) (
𝑟
(𝑣0 − 𝑣)
2 + 𝑅2
2 + 𝑖
(𝑣0 − 𝑣)
(𝑣0 − 𝑣)
2 + 𝑅2
2) 
Equation 5 describes a Lorentzian line at ν0 with a line width determined by 𝑅2. After phase 
correction in order to display the real part of Equation 5 the absorption spectra can be displayed 
(Figure 11 C right). 
However, in a molecule, each atom has a unique chemical environment. This local chemical 
environment is determined by charges in proximity and shielding effects (e.g. ring currents induced 
in aromatic ring systems) among others which result in a local magnetic field Blocal. Therefore, each 
nucleus inside a molecule has its own resonance frequency νlocal determined by Blocal and hence gives 
rise to an individual peak in a NMR spectrum. 
Equation 6: 
𝑣𝑙𝑜𝑐𝑎𝑙 = −
𝐵𝑙𝑜𝑐𝑎𝑙𝛾
2𝜋
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Nonetheless, in all equations which describe a single atom spin (Equation 3 – Equation 5), ω0 can be 
replaced by ωlocal in order to describe the nuclei of the same isotope inside a molecule. The local 
magnetic field and the consequently unique resonance frequencies of atoms in a molecule form the 
basis for the structural information that can be gained with NMR spectroscopy. 
The loss of magnetization or coherence, to be precise the return of the Mxy magnetization to the Mz 
magnetization is called relaxation. There are two processes involved in relaxation. Longitudinal 
relaxation, T1 or spin-lattice relaxation is caused by the Brownian motions of molecules. Since 
Brownian motion is random, all molecules and therefore all nuclei inside a molecule experience 
random reorientation and thus eventually return to thermal equilibrium. This reorientation of nuclei 
causes the spins to realign with the B0 field in the absence of a B1 field. Transversal relaxation, T2 or 
spin-spin relaxation describes the loss of phase coherence. During the duration of the pulse, the 
spins orient themselves along the B1 field. After the pulse, the spins start to rotate (Figure 11B). 
However, not all spins rotate at exactly the same frequency since local inhomogeneities of the B0 
field are present and lead to the loss of phase coherence. 
 
3.1.2 J-coupling and protein NMR 
Not only are external magnetic fields able influence the spin of a nucleus. Phase coherence can also 
be interchanged between atom nuclei with the same spin quantum numbers. This process is called J-
coupling. In order to achieve J-coupling, two prerequisites have to be met. First, the coupling nuclei 
have to be connected by covalent bonds since J-coupling is a scalar coupling, i.e. it occurs through 
bonds. Second, J-coupling has not to be suppressed i.e. no decoupling pulses are present in the pulse 
sequence (see below). Each coupling constant is characteristic and depends on the nature of the 
nuclei involved as well as their distance in terms of separating chemical bonds (Table 3 and Figure 
12) and their conformation. In small molecule NMR spectroscopy, J-couplings are used to decipher 
details about the structure directly from one-dimensional experiments where J-coupling causes 
single peaks to split into multiplets. In protein NMR however, the use of one-dimensional spectra is 
limited due to the fact that proteins usually contain far more nuclei than small molecules. Therefore, 
multidimensional correlation spectra have been developed (Aue et al. 1976; Ernst et al. 1987). 
Multidimensional correlation spectra use J-couplings to selectively transfer the magnetization form 
one nucleus (e.g. 1H) to another (e.g. 15N) in order to record the resonance frequencies of both 
nuclei in correlation with each other. These correlation spectra have proven to be very useful for 
structure determination of small proteins (≥ 30 kDa) (Kwan et al. 2011) as well as for investigating 
dynamic processes such as folding, conformational sampling and ligand binding (Bieri et al. 2011; 
Wiesner & Sprangers 2015; Barrett et al. 2013). 
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Figure 12: J-couplings inside proteins. 
1
J-couplings (J-couplings via one chemical bond) are depicted as solid black lines 
whereas 
2
J-couplings are depicted as dashed black lines. In order to have J-couplings, all nuclei have to have the same spin 
of 1/2, that is 
1
H, 
15
N and 
13
C. The figure was adapted from van de Ven (van de Ven 1995). 
 
3.1.3 1H,15N-HSQC experiments 
One of the most frequently used NMR experiments for proteins smaller than 30 kDa is the 
heteronuclear single quantum coherence (HSQC) experiment. In a 1H,15N-HSQC experiment, each HN 
atom pair of a uniformly 15N-labeled protein gives rise to one cross peak in the spectrum since a 
1H,15N-HSQC experiments correlates the proton chemical shifts with covalently bound nitrogen 
atoms via 1J-coupling of the HN-bond (Figure 12). Therefore, all backbone amides except Prolines as 
well as HN pairs occurring in Asparagine, Glutamine, Histidine, Arginine and Lysine can be observed 
in a 1H,15N-HSQC spectrum. However, due to the proton exchange at neutral pH of Histidine, Lysine 
and Arginine HN pairs with water molecules, these protons be difficult to observe. Hence, only cross 
peaks from backbone amides as well as Asparagine and Glutamine side chain amides are usually 
present in a 1H,15N-HSQC spectrum. In addition, the presence of at least one cross peak per residue 
gives the possibility to resolve structural and dynamic changes in a protein by 1H,15N-HSQC 
experiments on a per residue basis. This resolution can be used to track changes in the protein such 
as binding events, structural changes, chemical or conformational exchange processes and 
aggregation. The basis of these observations is the same as for all NMR measurements that is that 
the chemical environment of the observed spin system determines it resonance frequency. If the 
chemical environment of a HN pair changes, e.g. due to ligand binding, the position of the 
corresponding cross peak in a 1H,15N-HSQC spectrum will change in the absence and presence of 
ligand. The following pulse sequence is used to transfer the magnetization in order to observe HN 
cross peaks in a 1H,15N-HSQC spectrum (Figure 13). 
40 
 
 
Figure 13: Pulse sequence and coherence transfer pathway of a 2D 
1
H,
15
N-HSQC experiment. The narrow bars represent 
90° pulses, the wide bars 180° pulses. If no pulse phases are indicated, pulses are along the x-axis. The coherence pathway 
leading to the observed cross peaks is represented ignoring the relaxation. 𝝉 = 𝟏 𝟒𝑱𝑯𝑵
⁄ . 
First, the magnetization is transferred from protons to nitrogen via 1J-couplings (1J2τ) in a so-called 
insensitive nuclei enhanced by polarization transfer (INEPT) step (Morris & Freeman 1979). Next, 
chemical shift evolution of the nitrogen chemical shifts (ωN) is detected during delay t1. At the same 
time, HN 1J-coupling is suppressed by a 180° pulse in the middle of t1. Then, the magnetization is 
transferred back to the protons via another INEPT step. Finally, the FID containing proton chemical 
shifts (ωH) is recorded during t2 with decoupling of nitrogen by a series of 180° pulses in the nitrogen 
dimension in order to suppress HN 1J-coupling. Due to the decoupling of protons and nitrogens 
during data acquisition, only one peak per HN pair is visible in the HSQC spectrum. 
 
3.1.4 1H,15N-TROSY experiments 
The quality of NMR spectra of large proteins (> 30 kDa) is poor for two reasons. First, large proteins 
contain more residues leading to an increased number of peaks in the spectra. Second, large 
proteins tumble slower in solution. The average tumbling time of a 50 kDa protein is around 20 ns 
whereas the tumbling time of a 150 kDa protein is around 60 ns. Hence, large proteins have an 
increased transverse spin relaxation leading to line broadening. Both reasons result in poor peak 
dispersion (signal overlap) in the NMR spectra of large proteins. Therefore, methods have been 
developed to circumvent these problems. Transverse relaxation-optimized spectroscopy (TROSY) 
enhances transverse relaxation by selection of the slow relaxing component of a spin system. If two 
spins are coupled (e.g. a backbone HN pair) only the slow relaxing component of the multiplet can 
be selected by TROSY pulse sequences (Figure 14) (Pervushin 2000; Keeler 2010). 
41 
 
 
Figure 14: Pulse sequence of a 2D 
1
H,
15
N-TROSY experiment. The narrow bars represent 90° pulses, the wide bars 180° 
pulses. If no pulse phases are indicated, pulses are along the x-axis. 𝝉 = 𝟏 𝟒𝑱𝑯𝑵
⁄ . 
As in the HSQC experiment, the magnetization is first transferred from a proton to a nitrogen via an 
INEPT step. Then, chemical shift evolution of the nitrogen chemical shifts is recorded. At the same 
time 1J-coupling between protons and nitrogen (1JHN) takes place during delay t1. In contrast to a 
HSQC pulse sequence (Figure 13), the HN coupling is retained in each dimension. Therefore, the 
multiplet does not collapse and the slow relaxing components can be selected. In TROSY 
experiments, the selection of slow relaxing components is facilitated by the implementation of line-
selective pulse elements (Figure 14, sequence a and b) to select only one of the two spin doublets. 
By alternating the doublet selection by changing the phases of the last 90° pulses in sequence a and 
b (Figure 14), respectively, and subsequent processing of the acquired data, selection of the slow 
relaxing components is achieved (Keeler 2010). 
 
3.1.5 Observing protein-protein interactions by NMR spectroscopy 
NMR is a useful tool to investigate protein-protein interactions since it offers a close to atomic 
resolution of interaction surfaces as well as the underlying kinetics (Bieri et al. 2011; Kwan et al. 
2011). Since the position of a cross peak inside a two dimensional NMR correlation spectrum is 
determined by the chemical environment of the observed nuclei, every change in this environment 
is reflected by a change of the position inside the NMR spectrum. Therefore, binding events can be 
observed by NMR spectroscopy. In addition, investigation of binding events by NMR spectroscopy do 
not only provide a spatial resolution via the assignments of the affected cross peaks but also allow to 
deduce kinetic parameters such as binding affinities (Barrett et al. 2013). 
When observing protein interactions by NMR spectroscopy of small proteins (< 30 kDa) or larger 
proteins (30-45 kDa), 1H,15N-correlation spectra such as 1H,15N-HSQC or 1H,15N-TROSY are used which 
contain information about each backbone amide inside a 15N-labeled protein (Figure 15). First, a 
reference spectrum is recorded in the absence of the ligand. In combination with backbone 
assignment experiments, the cross peaks can be assigned to the amino acids of the protein. Next, 
unlabeled ligand is added step-wise and chemical shift perturbations (CSPs) that depend on the 
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ligand concentration are observed on a subset of peaks since only a subset of the chemical 
environments of the amino acids inside the protein experience changes upon ligand binding (Figure 
15). If the linear CSPs can be tracked, the interaction surface can now be mapped using the 
assignment of the free protein. Otherwise a resonance assignment of the saturated complex has to 
be performed. 
 
Figure 15: Chemical shift perturbation experiment. (A) 
1
H,
15
N correlation spectra of a 
15
N-labeled protein during the 
course of a chemical shift perturbation experiment. Upon addition of unlabeled ligand, the cross peaks of amino acids (aa 
#1) which experience a change in their chemical environment upon ligand binding shift. Whereas peaks from amino acids 
experiencing no change in their chemical environment (aa #2) do no display any chemical shift perturbations. Chemical 
shift perturbations in the proton (Δδ1H) and nitrogen dimension (Δδ15N) in ppm can be used to quantify the interaction. (B) 
The chemical environment of a subset of amino acids of a protein changes upon ligand binding. Chemical environments of 
aa #1 and aa #2 are depicted as red and blue circle, respectively. Unlabeled ligand is depicted as orange sphere and green 
circles highlight 
1
H,
15
N pairs observed by 
1
H,
15
N correlation experiments. Adapted from Renschler et al. (Renschler et al. 
2018) and reprinted with permission from AAAS.  
Besides the mapping of interaction surfaces onto protein sequences and, if available, structures, it is 
possible to extract dynamic information from NMR binding studies (Bain 2003; Waudby et al. 2016). 
In the case of reversible binding to a single site the following equilibrium exists: 
Equation 7: 
𝑃 + 𝐿 ⇌  𝑃𝐿 
with the free protein P, the free ligand L and the protein-ligand complex PL. The exchange rate kex is 
given by 
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Equation 8: 
𝑘𝑒𝑥 = 𝑘𝑜𝑛[𝐿] + 𝑘𝑜𝑓𝑓 
where kon is the on rate, koff is the off rate and [L] is the ligand concentration. The dissociation 
constant Kd is given by 
Equation 9: 
𝐾𝑑 =
𝑘𝑜𝑛
𝑘𝑜𝑓𝑓
=
[𝑃][𝐿]
[𝑃𝐿]
 
Where [P] is the protein concentration and [PL] is the protein-ligand complex concentration. 
Different exchange regimes, that is, different off-rates at constant Kd values, give rise to different 
line shapes (Figure 16) during NMR titration experiments. If the frequency difference between 
bound and unbound state in Hz (Δω) is much slower than the exchange rate kex (kex << Δω), the peak 
of the unbound state disappears while the peak of the bound state starts to appear (Figure 16 top). 
Whereas, if the frequency difference between bound and unbound is much faster than the exchange 
rate (kex >> Δω), the peak displays a constant shift during the course of the titration (Figure 16 
bottom). At intermediate exchange rates, the intensities of the cross peak experience and decrease 
with a subsequent increase as well as a shift. 
 
Figure 16: The line shape of cross peaks of an NMR spectrum contains information about exchange rates. Upon ligand 
addition to a 
15
N-labeled protein, the line shape of cross peaks that are affected by ligand binding change in an exchange 
regime dependent manner. P depicts the reference state without ligand; PL depicts the ligand bound state. kex is the 
exchange rate and Δω the frequency difference between the bound an unbound state. The ligand concentration increases 
successively from 0 equivalents (eq, dark blue) to 1 eq of ligand (red). The figure was adapted from Waudby et al. and was 
simulated with the following parameters: Kd = 2 µM, ΔωH = 4400 Hz, ΔωN = 220 Hz, [P] = 1 mM, data recorded at 700 MHz 
(Waudby et al. 2016). 
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In this thesis, NMR spectroscopy was used to investigate the PDZ:PBM interactions of the dmPar3 
PDZ domains with selected ligands. In addition, the influence of the dmPar3 FID-motif upon the 
dmPar3 PDZ3 domain was investigated by NMR spectroscopy. 
 
3.2 X-ray Crystallography 
The three dimensional structure of a protein defines its function. Hence, the determination of the 
protein structure enables valuable insights into protein function. One major method to determine 
protein structures is x-ray crystallography. In x-ray crystallography, protein crystals are exposed to x-
rays in order to generate a diffraction pattern. This diffraction pattern can be used to determine the 
three dimensional structure of the protein inside the crystal. 
 
3.2.1 Crystals 
Crystals are repetitions of their smallest non-self-repeating unit, called the asymmetric unit. The 
asymmetric unit contains the building blocks of a crystal which could be theoretically anything from 
identical atoms, molecules or ducks (Rupp 2009; Blow 2010). After application of the symmetry 
operations, defined by the space group of the crystal, the complete crystal unit cell is generated. In 
turn, the unit cell is repeated via translations in all three dimensions to generate the crystal. 
Therefore, the crystal is defined by its asymmetric unit together with its space group.  
When working with biological macromolecules, such as proteins, the molecules inside a crystal have 
a fixed stereochemistry. All symmetry operations which facilitate the inversion of such a stereo 
center, that is mirror planes, inversion centers and gliding planes (combination of mirror planes with 
translation), cannot be present in protein crystals. Hence, only translation, rotation and 
combinations thereof (screw axis) are present in protein crystals. Consequently, 65 possible space 
groups are possible for such crystals (Rupp 2009; Blow 2010).  
 
3.2.2 X-ray diffraction 
The key principle underlying x-ray crystallography is the diffraction of x-rays by crystals. The 
diffraction pattern recorded during an x-ray diffraction experiment contains information about the 
crystal and its constituents. Information about the electron density inside the crystal is encoded by 
the intensities of the spots or reflexes of which a diffraction pattern consists. Furthermore, their 
symmetry and systematic absences of reflexes in the diffraction pattern contain information about 
the space group. Whereas the position of the reflexes and their distances in respect to each other 
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encode data about the unit cell angles and dimensions. However, the distances are reciprocal to real 
space since the diffraction of x-ray is basically a Fourier transformation.  
If x-ray waves are passing a crystal, some are scattered by the electrons of the atoms inside the 
crystal. As all waves, these scattered waves can interfere in a constructive or destructive manner 
with each other. Only constructive interference results in a diffraction pattern. The condition of 
constructive interference is described by Bragg’s law (Figure 17). In essence, the path difference 
2𝑑 sin 𝜃 between two or more lattice planes of the crystal with the distance d must be an integer 
multiple of the wavelength 𝜆 (Equation 10). 
Equation 10: 
𝑛𝜆 = 2𝑑 sin 𝜃 
with 𝑛 ∈ ℕ and the glacial angle 𝜃. In cases where Bragg’s law is not fulfilled, the small variances in 
path difference will lead to destructive interference between the scattered waves, hence canceling 
each other out.  
 
Figure 17: X-ray diffraction represented as reflection on a lattice plane illustrating Bragg’s Law. With λ depicting the 
wavelength of the x-ray beam, Θ depicting the glancing angle between the incident beam and the lattice planes and d 
depicting the distance between two lattice planes. 
The diffraction spots are the result of a Fourier transformation of the x-ray beam with the electron 
density of the crystal. Therefore, the diffraction pattern describes the electron density in reciprocal 
space. The structure factor 𝑭𝑘ℎ𝑙 (Equation 11) describes this reciprocal space as the sum of all 
atomic scattering contributions inside the unit cell (Rupp 2009). 
Equation 11: 
𝑭𝑘ℎ𝑙 = |𝑭𝑘ℎ𝑙|𝑒
𝑖Φℎ𝑘𝑙 = ∑ 𝑓𝑗𝑒
2𝜋𝑖(ℎ𝑥𝑗+𝑘𝑦𝑗+𝑙𝑧𝑗)
𝑎𝑙𝑙 𝑎𝑡𝑜𝑚𝑠
𝑗=1
 
with 𝑭𝑘ℎ𝑙 the structure factor, |𝑭𝑘ℎ𝑙| being the amplitude 𝐹𝑘ℎ𝑙 of the structure factor, that is the 
intensity of a reflex with the coordinates h, k and l in the reciprocal space, φ being the phase of 𝑭𝑘ℎ𝑙 
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and 𝑓𝑗 the scattering factor of the j
th atom. In order to transform the measured intensities into an 
electron density, Fourier transformation of the structure factor equation (Equation 11) has to be 
performed and results in the electron density equation (Equation 12). 
Equation 12: 
𝜌𝑥𝑦𝑧 =
1
𝑉
∑ ∑ ∑ 𝐹𝑘ℎ𝑙  𝑒
−2𝜋𝑖(ℎ𝑥+𝑘𝑦+𝑙𝑧)
𝑙𝑘ℎ
 
with 𝜌𝑥𝑦𝑧 being the electron density in real space. However, no phase information is present in the 
recorded data of an x-ray diffraction experiment since only the intensities can be measured. 
In order to determine the phases, several methods have been developed. One such method is 
molecular replacement. During molecular replacement, a structure of a homologous protein is used 
to search for the localization and orientation of the target structure. Based on the placement of the 
search model, the phases can be back-calculated which finally enables the Fourier transformation of 
the structure factor equation (Equation 11) into the electron density equation (Equation 12). The 
resulting electron density is then used to model the protein structure in an iterative manner. 
In this thesis x-ray crystallography has been used to determine the structure of the dmPar3 
PDZ2:Insc PBM complex. 
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4. Results and discussion 
4.1 Structural basis for the interaction between the cell polarity proteins 
Par3 and Par6 
4.1.1 Contributions 
The results presented here are part of the research article “Structural basis for the interaction 
between the cell polarity proteins Par3 and Par6” published in Science Signaling in 2018 (Renschler 
et al. 2018). Contributions form coauthors are indicated as follows: SRB (Susanne R. Bruekner), PLS 
(Paulin L. Salomon), MCS (Mira C. Schütz-Stoffregen), CH (Christine Henzler), AM (Amrita Mukherjee) 
and SW (Silke Wiesner). 
 
4.1.2 Par6 contains a PBM that associates with the Par3 PDZ1 domain 
The Par3:Par6 interaction was previously reported to depend on the PDZ1 domain of Par3 and the 
PDZ domain of Par6 (Joberty et al. 2000; Lin et al. 2000; Li et al. 2010). In addition, all these reports 
disagree whether or not the Par6 Crib-motif N-terminal to the PDZ domain is essential for this 
interaction. Furthermore, the relevance of this interaction in vivo has been under debate (Li et al. 
2010) and aPKC has been reported as linker, suggesting an indirect Par3:Par6 interaction (Suzuki et 
al. 2001; Nagai-Tamai et al. 2002). Moreover, PLS, MCS and SW could not show a direct interaction 
between the Par3 PDZ1 and the Par6 PDZ domain by NMR spectroscopy for several organisms 
(Renschler et al. 2018). These observations led to the search for an alternative interaction mode 
between Par3 and Par6. Therefore I revisited the Par6 protein sequence and identified a previously 
unrecognized class II (-X--COO-) PBM at its C-terminus. Since the motif is highly conserved in 
metazoans with the notable exception of nematodes (Figure 18), SRB performed NMR CSP 
experiments with the Drosophila proteins. 
She observed large chemical shifts perturbations (more than one peak width) and line broadening 
for numerous residues in the 15N-labeled Drosophila Par3 (dmPar3) PDZ1 domain upon addition of 
an unlabeled peptide containing the eight C-terminal residues of dmPar6 (Figure 19) (Renschler et al. 
2018).  
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Figure 18: The PBM inside the Par6 C-
terminus is highly conserved. Sequence 
alignment of the C-termini of Par6 proteins 
from vertebrates (top), invertebrates without 
nematodes (mid) and nematodes (bottom) 
are color coded according to conservation by 
ClustalX (Larkin et al. 2007). The class II PBM 
discovered that I identified is boxed in red. 
Adapted from Renschler et al. (Renschler et 
al. 2018) and reprinted with permission from 
AAAS. 
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Figure 19: The Par6 PBM interacts with the Par3 PDZ1 domain. 
Overlay of a representative region of the 
1
H,
15
N-HSQC spectra of the 
dmPar3 PDZ1 domain in the absence (black) and presence of 
increasing stoichiometric amounts of dmPar6 PBM as indicated. For 
the most affected peaks, chemical shift assignments are shown and 
underlined if the peaks broaden beyond detection upon binding. 
Directions of the chemical shift exchanges are indicated by dashed 
lines. NMR assignments of dmPar3 PDZ1 are available under the 
following BMRB accession code 27197. Spectra were recorded by 
SRB. Adapted from Renschler et al. (Renschler et al. 2018) and 
reprinted with permission from AAAS. 
 
This observation is anticipated for two proteins that interact with each other (Figure 15). These 
results showed that in the Drosophila proteins the Par3 PDZ1 domain directly interacts with the Par6 
PBM in vitro. In support of this, epithelial cell polarity also critically depends on interactions of the 
Par3 PDZ domains with cell adhesion proteins through PBMs that are highly similar to the Par6 PBM 
(Figure 26) (Takekuni et al. 2003; Iden et al. 2006; Itoh et al. 2001; Ebnet et al. 2003; Lin et al. 1999). 
 
4.1.3 The Par6 PBM is important for Par3 interaction in vitro, in cell culture and in vivo 
In order to test the importance of the dmPar6 PBM in the context of the full length Par6 protein, I 
performed in vitro GST pull down experiments using a recombinant GST-tagged dmPar3 fragment 
containing all three PDZ domains and Sumo-tagged dmPar6 variants (Figure 20A).  
The PDZ1-3 domains of Par3 were able to pull down efficiently wild-type Par6 (Figure 20B; lane 10). 
In essence, this interaction was lost upon deletion of the PBM (PBM) (Figure 20B; lane 12), the 
region C-terminal of the PDZ domain (PB1-CribPDZ) (Figure 20B; lanes 14) or the region C-terminal of 
the Crib motif (PB1-Crib) (Figure 20B; lanes 16). Notably, GST on its own was not able pull down any 
of the Par6 constructs in a control experiment (Figure 20B; lanes 9, 11, 13, and 15). Therefore, the 
pull down experiments confirmed the NMR experiments and showed a direct and crucial in vitro 
interaction of the Par6 PBM with the Par3 PDZ domains. 
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Figure 20: The dmPar6 PBM is essential for Par3 interaction. (A) Schematic representation of the dmPar3 and dmPar6 
constructs used for GST pull down experiments. (B) GST pull down experiments: GST-tagged dmPar3 PDZ1-3 module was 
incubated with WT or truncated Sumo-tagged dmPar6 as indicated. Coomassie staining was used to detect input and 
associated Par6 as well as GST and GST-dmPar3 PDZ1-3. Asterisks highlight Par6 proteins in the pull downs. The pull down 
is representative of at least three independent experiments. Adapted from Renschler et al. (Renschler et al. 2018) and 
reprinted with permission from AAAS. 
Moreover, my collaboration partners could show that the co-localization of Par3 and Par6 at the 
plasma membrane in transiently transfected Drosophila S2R cells was highly dependent on the 
presence of the Par6 PBM (Renschler et al. 2018). In addition to the findings in cultured cells, they 
were also able to show that the dmPar6 PBM functions in redundancy with the PDZ domain in Par6 
localization in vivo. To this end, they investigated the role of the Par6 PBM in Par6 localization in 
Drosophila embryo epithelia at various stages in embryogenesis. Deletion of the Par6 PBM led to a 
miss-localization of Par6 in fly embryo epithelia. This effect is enhanced in the absence of the Par6 
PDZ domain suggesting a possible redundancy in function of the Par6 PBM and PDZ domain in vivo 
(Renschler et al. 2018). 
 
4.1.4 Structural analysis of the Drosophila Par3 PDZ1:Par6 PBM complex 
Since we could show the in vivo and in vitro importance of the Par6 PBM in regard of Par3 
interaction and Par3-dependent localization of Par6 in vivo, SRB solved the structure of the dmPar6 
PBM octapeptide in complex with the first PDZ domain of dmPar3 (Figure 29A, PDB ID: 5oak) 
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(Renschler et al. 2018). The structure showed binding of the Par6 PBM by canonical β-sheet 
augmentation to the Par3 PDZ1 domain. Futhermore, a hydrogen bond between H-1 of the Par6 
PBM and T22 of the Par3 PDZ1 domain was observed. 
In order to validate the importance of the observed interactions, I performed NMR titration 
experiments. Therefore, I subsituted successively the three C-terminal amino acids of the dmPar6 
PBM with Alanine (dmPar6 L349A (L-2A), H350A (H-1A) and L351A (L0A)) and investigated by NMR 
experiments their dmPar3 PDZ1 binding capacities (Figure 21). In contrast to the changes observed 
during the titration of the wild type dmPar6 PBM in the 1H,15N-HSQC spectrum of dmPar3 PDZ1 
(Renschler et al. 2018), L-2A and L0A mutations led to almost no CSPs in the 1H,15N-HSQC spectrum 
of dmPar3 PDZ1. In addition, the H-1A mutant weakend the observed CSPs. These observations are 
consistent with our crystallographic data and indicate the crucial importance of the 0 and -2 
positions of the PBM in canonical PDZ PBM interactions as well as the importance of the H-1 
hydrogen bond. 
 
Figure 21: The 0 and -2 position of the dmPar6 PBM are important for PDZ interaction. NMR CSPs experiments with 
15
N-
labeled dmPar3 PDZ1 domain and dmPar6 PBM mutants as indicated. Overlay of a representative region of the 
1
H,
15
N-
HSQC spectra of the dmPar3 PDZ1 domain in the absence (black) and presence of increasing stoichiometric amounts of 
mutant dmPar6 PBMs as indicated. For the most affected peaks, chemical shift assignments are shown and underlined if 
the peaks broaden beyond detection upon binding. Directions of the chemical shift exchanges are indicated by dashed 
lines. NMR assignments of dmPar3 PDZ1 are available under the following BMRB accession code 27197. Adapted from 
Renschler et al. (Renschler et al. 2018) and reprinted with permission from AAAS. 
 
4.1.5 The Par3 PDZ1 and PDZ3 domains both interact with the Par6 PBM 
Since the residues of the dmPar3 PDZ1 domain contacting the dmPar6 PBM are well conserved in all 
three PDZ domains of Par3 (Figure 27), SRB investigated whether the Par6 PBM can also interact 
with the remaining two dmPar3 PDZ domains. In short, she could show that PDZ2 does not interact 
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with the Par6 PBM whereas the PDZ3 domain interacts with the Par6 PBM (Figure 22) (Renschler et 
al. 2018). 
 
Figure 22: The Par6 PBM interacts with the Par3 PDZ3 domain. (A) Overlay of a representative region of the 
1
H,
15
N-HSQC 
spectra of the dmPar3 PDZ2 domain in the absence (black) and presence of increasing stoichiometric amounts of dmPar6 
PBM as indicated. (B) Overlay of a representative region of the 
1
H,
15
N-HSQC spectra of the dmPar3 PDZ3 Δβ2-3loop domain 
in the absence (black) and presence of increasing stoichiometric amounts of dmPar6 PBM as indicated. For the most 
affected peaks, chemical shift assignments are shown and underlined if the peaks broaden beyond detection upon binding. 
Directions of the chemical shift exchanges are indicated by dashed lines. NMR assignments of dmPar3 PDZ3 Δβ2-3loop are 
available under the following BMRB accession code 27198. Spectra were recorded by SRB. Adapted from Renschler et al. 
(Renschler et al. 2018) and reprinted with permission from AAAS. 
In order to quantify the interactions between the dmPar3 PDZ domains and the dmPar6 PBM, I 
analyzed the NMR titration data by 2D NMR line shape fitting analysis with TITAN (Waudby et al. 
2016) and determined Kd values. Noteworthy, since the dmPar3 PDZ2 domain showed no CSPs upon 
dmPar6 PBM titration (Figure 22A), I did not fit these data. The Par6 PBM interacts with the PDZ1 
domain with a moderate affinity of 216  4 M and with the PDZ3 domain with a tighter affinity of 
54  1 M (Table 5, Figure A 4 and Figure A 23). Furthermore, I quantified the affinities of the 
dmPar6 PBM mutants for the PDZ1 domain (Table 4, Figure A 5 – Figure A 7) to gain further insights 
into the Par3:Par6 interaction. When the C-terminal position (L0A) was mutated, the affinity was 
weakened to 2486  357 M. In the case of the -1 position (H1-A), the affinity was weakened to 964 
 60 M and in case of the -2 position (L-2A), the affinity was weakened to 4049  1113 M, 
respectively. Altogether, the determined affinities showed that mutagenesis of key interacting 
residues led to a loss of affinity, confirming that these residues are indeed important for the 
interaction with the Par3 PDZ1 domain. 
In general, dissociation constants in the range of hundreds of M have been reported for 
physiologically relevant PDZ-PBM interactions (Wiedemann et al. 2004; Stiffler et al. 2007; Fujiwara 
53 
 
et al. 2015). This as well as the results from cultured S2R cells and Drosophila embryos (Renschler et 
al. 2018) shows that the interaction of the Par6 PBM with the Par3 PDZ domains is of importance in 
vitro and in vivo. 
Table 4: Dissociation constants determined by NMR CSPs experiments and subsequent line shape analysis for the 
dmPar3 PDZ1 domain in complex with different dmPar6 PBM mutants. 
Ligand Kd [μM] 
dmPar6 L-2A 4049 ± 1113 
dmPar6 H-1A 964  ± 60 
dmPar6 L0A 2486 ± 357 
Kd values were determined by line shape fitting of NMR CSP experiments with TITAN (Waudby et al. 2016). Errors were 
estimated with bootstrapping statistics on 100 replica. The number of titration points and cross peaks analyzed for each 
interaction are summarized in Table A 1 and Table A 2. Adapted from Renschler et al. (Renschler et al. 2018) and reprinted 
with permission from AAAS. 
 
4.1.6 Par3 can interact with two Par6 proteins simultaneously in vitro 
It is known that the Par complexes form clusters covering the apical plasma membrane in polarized 
cells. However, the details of this assembly are not well understood. One prerequisite for the 
formation of higher order complexes is that multivalent proteins are involved. Multivalent proteins 
contain multiple independent binding sites which engage in a multitude of weak interactions usually 
in the M-affinity range. Since both, the first and third PDZ domain of dmPar3, fulfill this 
requirement, I recorded 1H,15N-TROSY spectra of the 15N-labeled Par3 PDZ1-3 module containing all 
three PDZ domains (PDZ1-3 2-3loop) and examined its Par6 binding capability. 
The NMR spectra of the individual PDZ domains superimpose well with the NMR spectra of the Par3 
PDZ1-3 module. Therefore chemical shift resonance assignments of the individual domains could be 
transferred to the PDZ1-3 module. As the position of a peak in the NMR spectrum depends on its 
chemical environment, identical chemical shifts mean identical chemical environments. As a 
conclusion, the Par3 PDZ domains are structurally largely independent from each other. Upon 
addition of unlabeled dmPar6 PBM to the PDZ1-3 construct, CSPs were observed (Figure 23D-F) 
which were comparable to the CSPs observed for the individual PDZ domains (Figure 19, Figure 22) 
(Renschler et al. 2018). This confirms that the Par3 PDZ domains can also function independent of 
each other and that in vitro one Par3 molecule can interact with two Par6 proteins via its PDZ 
domains at the same time. For that reason, Par3 potentially engages in weak, multivalent 
interactions with Par6 and might thereby promote the assembly of large Par complex cluster at the 
cell cortex in vivo. 
54 
 
 
Figure 23: dmPar3 can interact simultaneously with two dmPar6 proteins. (A) – (C) Overlay of 
1
H,
15
N-TROSY spectra of the 
dmPar3 PDZ1-3 Δβ2-3loop module with the isolated PDZ1 (A), PDZ2 (B) and PDZ3 Δβ2-3loop domains (C). Resonance 
assignments are shown for the individual PDZ domains. (D) – (F) Overlay of 
1
H,
15
N-TROSY spectra of the dmPar3 PDZ1-3 
Δβ2-3loop module in the absence (black) and presence of dmPar6 PBM as indicated. To highlight the changes of the single 
domains in the PDZ1-3 Δβ2-3loop module, all peaks not corresponding to PDZ1 (D), PDZ2 (E) and PDZ3 Δβ2-3loop domains 
(F) are shown in opaque. NMR assignments were kindly provided by SW, PLS and SRB and are available under BMRB 
accession codes 27197 (dmPar3 PDZ1), 27203 (dmPar3 PDZ2) and 27198 (dmPar3 PDZ3 Δβ2-3loop). Adapted from 
Renschler et al. (Renschler et al. 2018) and reprinted with permission from AAAS. 
 
4.1.7 The Par6 PBM can compete with the PBM of E-cadherin for Par3 binding 
It is known that cell adhesion molecules from the nectin and cadherin families interact with Par3 and 
that they contain a conserved class II PBM which is highly similar to the Par6 PBM (Figure 26) 
(Renschler et al. 2018). For example, the mouse VE-cadherin PBM interacts with the third PDZ of the 
mouse Par3 protein (mmPar3) with a Kd of ~ 6 μM (Tyler et al. 2010) and therefore ~ 9-fold (PDZ3) 
and ~36-fold (PDZ1) tighter when compared to the Drosophila Par6 PBMs (Table 5). To investigate if 
the Par6 PBM could compete with such ligands, SRB performed NMR CSP-studies with the PBM of 
the Drosophila E-cadherin Shotgun (Shg).  
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Figure 24: The Shg PBM binds to the Par3 PDZ1 and PDZ3 domains and competes with Par6 for Par3 binding. (A) Overlay 
of 
1
H,
15
N-HSQC spectra of the 
15
N-labeled dmPar3 PDZ1 (left, black), PDZ2 (mid, black) and PDZ3 Δβ2-3loop domains (right, 
black) in absence and upon step-wise addition of the Shg PBM as indicated. NMR spectra were recorded by SRB. (B) 
Overlay of 
1
H,
15
N-HSQC spectra of the 
15
N-labeled GB1-Shg PBM fusion in the absence (black) or presence of dmPar3 PDZ1 
domain (purple) and upon step-wise addition of the dmPar6 PBM (red and orange). Arrows indicate the successive reversal 
of the chemical shifts from the Shg PBM:PDZ complex towards the unbound Shg PBM. Spectra were recorded by SW and 
me. (C) as (B), but for the dmPar3 PDZ3 Δβ2-3loop domain. Adapted from Renschler et al. (Renschler et al. 2018) and 
reprinted with permission from AAAS. 
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To this end, she added increasing amounts of unlabeled Shg PBM to 15N-labeled dmPar3 PDZ 
domains (Figure 24A). These studies revealed that PDZ1 and PDZ3 interact with the Shg-PBM similar 
to the Par6 PBM and show large CSPs for numerous cross peaks in the 1H,15N-HSQC spectra during 
the course of the titration (Figure 24A) (Renschler et al. 2018).  
Contrary to PDZ1 and PDZ3, PDZ2 showed only few changes (Figure 24A) (Renschler et al. 2018). 
Subsequent line shape fitting analysis performed by me yielded Kd values 128 ± 4 μM for the PDZ1, 
954 ± 45 μM for the PDZ2 and 0.6 ± 0.1 μM for the PDZ3 domain (Table 5, Figure A 8, Figure A 13 and 
Figure A 22). 
Next, I used 15N-labeled Shg PBM to investigate whether the Par6 PBM can compete with the Shg 
PBM for Par3 PDZ binding in a series of NMR experiments that SW and I recorded. First, we 
investigated the interaction of PDZ1 or PDZ3 domain with 15N-labeled Shg PBM by recording 1H,15N-
correlation spectra of the peptide without and with unlabeled dmPar3 PDZ1 or PDZ3 domain. For 
both PDZ domains, complex formation could be observed by chemical shift changes in the 1H,15N-
correlation spectra of the Shg PBM (Figure 24B, C). Then, unlabeled Par6 PBM was added step-wise. 
This led to changes in the spectra of the Shg-PBM indicating the release of Shg from the Shg 
PBM:PDZ complex since the chemical shift changes reverted towards the free state of the Shg PBM 
(Figure 24B, C). This proves the Par6 PBM can directly compete with the Shg PBM for Par3 PDZ 
binding. Of note, the large difference in binding affinities is reflected in the high stoichiometric 
excess of Par6 PBM over Shg PBM necessary for PDZ3 competition (Figure 24C). Finally, to address 
the question of direct competition of different PBMs for Par3 PDZ binding in vivo would require 
additional information. Detailed analyses in cells of the subcellular concentrations of Par3, Par6 and 
other binding partners, of the dissociation constants of the ligands within the fully assembled Par 
complex as well as an exact chronological determination of the binding process would be required to 
answer this question. Without doubt, these questions are challenging but indeed very interesting. A 
step in this direction is presented in the next chapter of my thesis where I investigate the 
specificities of the individual Par3 PDZ domains towards different ligands. 
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4.1.8 The PDZ:PBM interaction is conserved in the human Par3 and Par6 proteins 
Co-immunoprecipitation experiments performed by CH and AM with human embryonic kidney (HEK) 
293T cells cotransfected with human Par3 (hsPar3) and Par6α (hsPar6α) constructs demonstrated, 
that the human Par3 and Par6α proteins also interact in a PBM dependent manner as their 
Drosophila orthologs (Renschler et al. 2018). 
In order to investigate whether the specificities as well as the interaction mode of the individual Par3 
PDZ domains are conserved between the human and the Drosophila proteins, I performed NMR 
studies on the human Par3 and Par6 proteins. Interestingly, the 1H,15N-HSQC spectra of the human 
PDZ1 domain of Par3 did not show well dispersed cross peaks (Figure 25A) (Renschler et al. 2018) 
(PLS and A. Kiessling, personal communication) and thus is characteristic of an unfolded protein 
(Kwan et al. 2011). Therefore, NMR titration experiments were not feasible. However, fusing the 
hsPar6α PBM to the C-terminus hsPar3 PDZ1 separated by a 15-aa GS-linker dramatically increased 
the quality of the 1H,15N-HSQC spectra and showed well dispersed cross peaks (Figure 25A). For that 
reason we can conclude that the hsPar6α PBM induces the folding of the PDZ1 domain and thus 
interacts with the hsPar3 PDZ1 domain. In contrast to the PDZ1 domain, the PDZ2 and PDZ3 domains 
of the human protein showed well dispersed cross peaks of folded proteins in the 1H,15N-correlation 
spectrum. Hence, NMR titration experiments could be performed. The 1H,15N-correlation spectrum 
of 15N-labeled hsPar3 PDZ2 domain displayed some but substantial CSPs (Figure 25B), whereas the 
1H,15N-correlation spectrum of 15N-labeled hsPar3 PDZ3 domain displayed numerous large CSPs upon 
Par6α addition (Figure 25C). All CSPs of PDZ2 and PDZ3 could be mapped to the PBM binding groove 
of the respective PDZ domains from human (PDZ2) or rat (PDZ3) indicating a canonical PDZ:PBM 
interaction (Figure 25D, E). Taken together, these results show that the Par3 PDZ : Par6 PBM 
interactions and the Par3 PDZ domain functions are conserved to a large extent in humans and flies. 
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Figure 25: The PDZ:PBM interaction is conserved in the human Par3:Par6 complex. (A) Overlay of 
1
H,
15
N-correlation 
spectra of the hsPar3 PDZ1 domain in isolation (black) and the hsPar3 PDZ1 domain fused to the hsPar6α PBM (red). The 
absence of well dispersed cross peak indicates the unfolded state of the isolated PDZ1 domain. Data are representative of 
at least four independent experiments for the PDZ1 domain. (B,C) Overlay of 
1
H,
15
N-correlation spectra of the PDZ2 (B) and 
the PDZ3 (C) domains in the absence and presence of hsPar6α PBM peptide as indicated. Assignments of hsPar3 PDZ2 and 
PDZ3 domains were kindly provided by SW and are available under the BMRB accession codes 27204 (hsPar3 PDZ2) and 
27205 (hsPar3 PDZ3). (D,E) hsPar6α induced CSPs mapped onto the human Par3 PDZ2 domain (D) (PDB ID: 2kom (Jensen et 
al. 2010)) and rat Par3 PDZ3 domain (E) (PDB ID: 2k20 (Feng et al. 2008)) and colored from white (CSP ≤ 0.05 ppm) to green 
(D) or blue (E) (CSP = 0.35 ppm). Dark blue indicates residues broadened beyond detection in PDZ3. Secondary structure 
elements are labeled (for PDZ2 β1: aa 5-12, β2: aa 20-24, β3: aa 35-40, α1: aa 45-49, β4: aa 56-61, β5: aa 64-65, α2: aa 71-
80, β6: aa 86-93; for PDZ3 β1: aa 6-14, β2: aa 25-31, β3: aa 38-46, α1: aa 51-54, β4: aa 62-67, β5: aa 70-71, α2: aa 77-89, 
β6: aa 97-105). The Par6 core PBM is shown in yellow and was modeled by superposition of the dmPar3 PDZ1:PBM and 
PDZ2 and PDZ3 structures. Adapted from Renschler et al. (Renschler et al. 2018) and reprinted with permission from AAAS. 
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4.1.9 The Par6 PBM is important for PAR complex formation 
In this study, I identified a previously unknown PBM in the C-terminus of Par6 that interacts 
canonically with the Par3 PDZ1 and PDZ3 domains. I could show that this interaction is conserved in 
human and drosophila Par3 and Par6 proteins. Furthermore, I was able to show that the interaction 
is crucial in vitro. However, in vivo data suggests that the PBM and the PDZ domain of Par6 function 
in redundancy for Par6 localization in Drosophila embryonic epithelia (Renschler et al. 2018). 
In previous studies, the Par3:Par6 interaction has been controversial (Joberty et al. 2000; Li et al. 
2010; Lin et al. 1999; Nagai-Tamai et al. 2002; Suzuki et al. 2001). However, no heterodimerization of 
the Par3 PDZ1 and Par6 PDZ domains was detected by GST-pull down (Figure 20), NMR or CoIP 
studies or in recruitment assays in S2R cells (Renschler et al. 2018). Worth mentioning are the 
interactions of the first PDZ domain Par3 homologs in humans and mice with highly similar class II 
PBM ligands of cell adhesion proteins (Figure 26) (Ebnet et al. 2001; Takekuni et al. 2003; Iden et al. 
2006; Itoh et al. 2001; Ebnet et al. 2003; Lin et al. 1999; Latorre et al. 2005; Nakayama et al. 2013).  
 
Figure 26: Known cell adhesion interaction partners of Par3. Amino acid 
sequences of known Par3 interaction partners in the context of cell adhesion 
(Ebnet et al. 2001; Takekuni et al. 2003; Iden et al. 2006; Itoh et al. 2001; Ebnet 
et al. 2003; Lin et al. 1999; Latorre et al. 2005; Nakayama et al. 2013) are aligned 
with the dmPar6 PBM and color coded according to conservation by ClustalX 
(Larkin et al. 2007). PBMs used for NMR competition assays (Figure 24) as well 
as the 0Par6α (Figure 25) are underlined. The residues equivalent to the dmPar6 
PBM facilitating interactions with the dmPar3 PDZ1 (Figure 29A) (Renschler et al. 
2018) are boxed in red. Adapted from Renschler et al. (Renschler et al. 2018) 
and reprinted with permission from AAAS. 
In addition, SRB showed that the class II PBM of Shg (the Drosophila E-cadherin) interacts with 
dmPar3 PDZ1 and PDZ3 domain (Figure 19 and Figure 22) (Renschler et al. 2018). Hence, the 
Par3:Cadherin interaction is also conserved between Drosophila and humans. Taken together, there 
is strong support of the Par3 PDZ1 and PDZ3 favoring class II PBMs to recruit cell adhesion and 
polarity proteins in order to establish and maintain cell polarity via the PAR complex. However, a 
more detailed analysis of the individual binding specificities of the Par3 PDZ domains including a 
broader range of ligands is needed to support this notion. Scaffolding complexes often use 
multivalent interactions to assemble different parts of signaling cascades since protein domains can 
fold and function independently (Pawson & Nash 2003). One well-known mechanism is the tandem 
arrangement of PDZ domains inside scaffolding proteins (Tsunoda et al. 1997). This holds true for 
Par3 as PDZ1 and PDZ3 can independently interact with the Par6 and Shg PBM in vitro (Figure 24) 
(Renschler et al. 2018). Therefore, the Par3 PDZ1 and PDZ3 domains function redundantly and allow 
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one Par3 molecule to interact with two PBMs simultaneously. Additionally, homo-oligomerization of 
Par3 (Zhang et al. 2013) and hetero-dimerization of Par6 and aPKC (Hirano et al. 2005) provide 
further scaffolds to assemble large self-organizing PAR complex networks at the cell cortex in vivo. 
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4.2 Specificities of the individual dmPar3 PDZ domains for cell polarity 
proteins 
Many different ligands of the Par3 PDZ domains which interact with at least one of the three Par3 
PDZ domains have been reported in literature (Figure 10). Those ligands include class I PBMs such as 
Smash (Beati et al. 2018), Insc (Schober et al. 1999; Wodarz et al. 1999; Culurgioni & Mapelli 2013; 
Lu & Johnston 2013) and Stan (Wasserscheid et al. 2007), class II PBMs such as Ed (Wei et al. 2005), 
Shg (Figure 24A) (Wei et al. 2005; Bulgakova et al. 2013; Renschler et al. 2018) and Par6 (Figure 19 
and Figure 22) (Renschler et al. 2018) as well as the class III PBM of α-cat (Iden et al. 2006). Besides 
known interaction partners, other PBMs are present within the cellular environment of Par3 (Figure 
2 and Figure 5) such as the Crb class I PBM and the aPKC class III PBM. The Crb PBM has been 
reported to interact with the PDZ domains of Par6 (Lemmers et al. 2004; Whitney et al. 2016) and 
Pals1/ Std (Li et al. 2014; Ivanova et al. 2015) whereas no interaction partners of the aPKC PBM are 
known to date. All those PBMs might link Par3 with its functions in adherens junction assembly 
(Figure 2), sequestration of the Par6/aPKC module (Figure 2) as well as cortical assembly of the Pins 
complex (Figure 5) (Harris 2017). However, only sparse information about the specificities of the 
Par3 PDZ domain is available. These specificities are derived from biased phage display data over-
represented in hydrophobic amino acids (Yu et al. 2014). In addition, structural information of the 
Par3 PDZ domains in complex with ligands is limited to the third PDZ domain of the rodent proteins 
(Feng et al. 2008; Tyler et al. 2010). Of note, sequence comparison between the Par3 PDZ domains 
revealed a high degree of similarity between the individual domains (Figure 27). However, based on 
the structural information and the sequence comparison it seemed unlikely to expect large 
differences in the specificities between the Par3 PDZ domains. 
 
 
 
Figure 27: (continued) Par3 PDZ domain protein sequences were aligned with MUSCLE (Edgar 2004), edited manually if 
necessary to match Par3 PDZ structures (PDB ID: 5oak for PDZ1, the PDZ2:Insc complex presented in Figure 29C and D for 
PDZ2 and PDB ID 2koh for PDZ3) and color-coded with ClustalX according to conservation (Larkin et al. 2007). Secondary 
structure elements are depicted as blue boxes. Residues interacting with the dmPar6 PBM (Figure 29A), the Shg PBM 
(Figure 29B), or the Insc PBM (Figure 29C, D) are indicated by cyan, dark blue and green spheres on top of the 
corresponding PDZ domain. The region deleted in the dmPar3 PDZ3 Δβ2-3 loop construct is indicated by a black box. 
Dashed lines highlight conserved residues in PDZ3 important for ligand binding in PDZ1 and PDZ2. Residues interacting with 
the dmPar3 FID-motif (Figure 35C, D) are highlighted by purple spheres on top of the sequence of the dmPar3 PDZ3 
domain. 
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Figure 27: Structure-based sequence alignment of the Par3 PDZ domains. Legend continued on previous page. 
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In order to provide insights into the specificities of the Par3 PDZ domains and to provide information 
about the structural basis of these specificities, I performed NMR and x-ray crystallography studies 
of the PBM listed above and the dmPar3 PDZ domains.  
Furthermore, I included the internal PBM of Std in this analysis. The Std PBM interacts with the Par6 
PDZ domain (Penkert et al. 2004; Wang et al. 2004; Kempkens et al. 2006). At the same time, Std and 
Par3 interact independently of the Std PBM (Krahn, Bückers, et al. 2010). However, the Par3:Std 
interaction relies on a region C-terminal of the Par3 KBD (Krahn, Bückers, et al. 2010). Therefore, the 
Std PBM serves as a negative control. 
 
4.2.1 Contributions 
The results presented here have been obtained during the course of my PhD thesis. Previous 
diploma and bachelor studies conducted in the laboratory of Silke Wiesner by Paulin L. Salomon 
(Salomon 2012), myself (Renschler 2013), Susanne R. Bruekner (Brückner 2014) and Benjamin 
Schroeder (Schroeder 2014) already set the foundation of this research and contributions are 
indicated as follows: SRB (Susanne R. Bruekner), PLS (Paulin L. Salomon), BS (Benjamin Schroeder), 
SW (Silke Wiesner). Results obtained by myself and already published are indicated by citing the 
respective papers (Renschler et al. 2018; Beati et al. 2018). 
 
4.2.2 dmPar3 PDZ1 and PDZ2, but not the PDZ3 have distinct ligand specificities 
To assess the specificities of the individual Par3 PDZ domains in greater detail, I examined the 
binding capabilities of a variety of reported Par3 PDZ ligands with biological relevance in order to 
sample the natural PBM sequence space of the dmPar3 PDZ domains. 
To this end, the C-terminal eight amino acids of the class I PBMs of Insc, Crb and Stan as well as the 
class II PBMs of Ed and the class III PBM of α-cat were fused to GB1, expressed and purified for NMR 
titration experiments (Figure 15 and Figure 28). In addition, the previously published interactions of 
the class I PBM of Smash (Figure 28) (Beati et al. 2018) and the class II PBMs of dmPar6 (Figure 19 
and Figure 22) and Shg (Figure 24A) (Renschler et al. 2018) with the dmPar3 PDZ domains were 
included in this analysis. Furthermore, the class III PBM of aPKC was added to investigate the 
possibility of an additional interaction site between aPKC and Par3 besides the well-studied Par3 
KBD:aPKC kinase domain interaction (Figure 28) (Wang et al. 2012; Soriano et al. 2016). In order to 
probe binding to an internal PBM, we choose the Std PBM that is a known ligand of the Par6 PDZ 
domain (Penkert et al. 2004; Wang et al. 2004; Kempkens et al. 2006).  
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Figure 28: NMR titration experiments of the dmPar3 PDZ domains with different PBMs. Legend continued on next page. 
65 
 
Figure 28: (continued) Overlay of a representative region of the 
1
H,
15
N-correlation spectra of the dmPar3 PDZ1, PDZ2 and 
the PDZ3 Δβ2-3loop domains in the absence (black) and presence of stoichiometric amounts of PBM peptides as indicated. 
SRB recorded data of the Insc and Ed PBMs. BS recorded data of the α-cat and aPKC PBMs. Spectra of the Smash NMR 
titration experiments are already published (Beati et al. 2018). 
Interestingly, despite containing an internal PBM the Std PDZ domain can interact with Par3 via a 
region C-terminal of the Par3 KBD (Krahn, Bückers, et al. 2010). 
 
Binding affinities of the individual dmPar3 PDZ domains reveal a distinct specificity profile for 
PDZ1 and PDZ2 
To obtain specificity profiles for the individual dmPar3 PDZ domains, I evaluated existing NMR CSP 
data recorded by SRB (Insc, Ed, Shg and dmPar6 with PDZ1, PDZ2 and PDZ3 Δβ2-3loop, Figure 19, 
Figure 22, Figure 24A and Figure 28, respectively) (Brückner 2014; Renschler et al. 2018) and BS (α-
cat and aPKC with PDZ1, PDZ2 and PDZ3 Δβ2-3loop, Figure 28) (Schroeder 2014) by 2D lineshape 
fitting analysis with TITAN (Waudby et al. 2016). Additionally, I performed CSP experiments and 
analyzed CSP data for Smash, Crb, Stan and Std for PDZ1, PDZ2 and PDZ3 Δβ2-3loop (Figure 28). 
Lineshape fits are presented in Figure A 3 to Figure A 25 in the appendix. 
Interestingly, the dmPar3 PDZ1 domain shows a clear selectivity profile. Out of the ten tested PBMs, 
the dmPar3 PDZ1 domain only interacts with class II ligands (Ed, Shg and dmPar6) and shows a clear 
preference for PBMs with a large hydrophobic residue at the very C-terminus of the PBM as in Shg 
(128 ± 4 µM) and dmPar6 (216 ± 4 µM) (Table 5). No significant CSPs were observed for the other 
PBMs (Figure 28) and therefore Kd values could not be determined for these ligands. In contrast, the 
Par3 PDZ2 domain showed a clear preference for a number of PBMs (Table 5). However, in contrast 
to the PDZ1 domain this specificity does not seem to be limited to the general classification of PBMs. 
The PDZ2 domain interacted with the class I PBM of Stan (31 ± 1 µM) and Insc (107 ± 2 µM), the class 
III PBM of aPKC (22 ± 1 µM) and α-cat (84 ± 2 µM) and with the class II PBM of Ed (226 ± 6 µM) 
(Table 5). In contrast, binding of the PBMs of Smash (880 ± 33 µM), Shg (954 ± 45 µM) and Std (762± 
60 µM) was weak (Table 5) or not detectable in the case of Crb (Figure 28) and Par6 (Figure 22) 
(Renschler et al. 2018). The weak interaction with the Std PBM may be expected as this PBM was 
selected as a negative control since the Par3:Std interaction relies on the Std PDZ domain and not on 
the Std PBM (Krahn, Bückers, et al. 2010). This is supported by the notion that high micromolar 
PDZ:PBM affinities may not be physiological relevant. 
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Table 5: Dissociation constants determined by NMR CSPs experiments and subsequent 2D line shape fitting analysis for 
the dmPar3 PDZ domains in complex with different PBMs. 
ligand class sequence 
Kd [μM] 
PDZ1 PDZ2 PDZ3 Δβ2-3loop 
Smash I DGIKFSCV n.d. 880 ± 33 561 ± 29 
Insc LTRQESFV n.d. 107 ± 2 275 ± 8 
Crb KPPPERLI n.d. n.d. 16 ± 1 
Stan IDDDETTV n.d. 31 ± 1 5.5 ± 0.3 
Ed II RVIREIIV 656 ± 58 226 ± 6 19 ± 1 
Shg * DDDQGWRI 128 ± 4 954 ± 45 0.6 ± 0.1 
dmPar6 * VKDGVLHL 216 ± 4 n.d. 54 ± 1 
α-cat III FQSPADAV n.d. 84 ± 2 643 ± 30 
aPKC LMSLEDCV n.d. 22 ± 1 101 ± 3 
Std internal PHREMAVDCPD n.d. 762 ± 60 n.d. 
Kd values were determined by 2D line shape fitting of NMR CSP experiments with TITAN (Waudby et al. 2016). Errors were 
estimated with bootstrapping statistics on 100 replicates. The number of titration points and cross peaks analyzed for each 
interaction as well contributions from others are summarized in Table A 1 and Table A 2. n.d. refers to not detectable and 
means no detectable CSPs in NMR CSPs experiments. Asterisks indicate Kd values already published in Renschler et al. 
(Renschler et al. 2018) and reprinted with permission from AAAS. 
 
The dmPar3 PDZ3 has highly promiscuous binding capabilities 
In contrast to the PDZ1 and PDZ2 domain, the third PDZ domain of dmPar3 did not show a distinct 
specificity profile in my CSP studies. CSPs in the 1H,15N-HSQC spectrum of dmPar3 PDZ3 Δβ2-3loop 
were observed for all tested PBMs with the notable exception of the internal PBM of Std (Figure 28 
and Table 5). Subsequent line shape fitting analysis revealed a very tight binding of the Shg PBM 
(class II) with a dissociation constant of 0.6 ± 0.1 µM. Nonetheless, other tight interactions include 
Stan (5.5 ± 0.3 µM, class I), Crb (16 ± 1 µM, class I), Ed (19 ± 1 µM, class II), dmPar6 (54 ± 1 µM, class 
II) and somewhat weaker aPKC (101 ± 3 µM, class III) and Insc (275 ± 8 µM, class I). Besides, the class 
I PBM of Smash (561 ± 29 µM) and the class III PBM of α-cat (643 ± 30 µM) bind the dmPar3 PDZ3 
domain with affinities in the high micromolar range. We can thus conclude that the third PDZ 
domain of dmPar3 has a unique but highly promiscuous specificity. 
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4.2.3 The ligand specificities of dmPar3 PDZ1 and PDZ2 can be related to their complex 
structures 
To investigate the interactions probed by NMR CSPs experiments in more detail, we aimed at solving 
the 3D structures of Par3 PDZ:PBM complexes for each PDZ domain with ligands of the different 
PBM classes.  
 
Figure 29: Ligand recognition by the dmPar3 PDZ1 and PDZ2 domains. (A) Cartoon representation of the dmPar3 PDZ1 
domain (white) in complex with the dmPar6PBM (cyan) (pdb ID: 5oak). Hydrogen bonds are depicted as dashed black lines. 
Adapted from Renschler et al. (Renschler et al. 2018) and reprinted with permission from AAAS. (B) Cartoon representation 
of the dmPar3 PDZ1 domain (white) in complex with the Shg PBM (darkblue) (PLS and (Renschler 2013)), otherwise as in 
(A). (C) Cartoon representation of the dmPar3 PDZ2 domain (grey) in complex with the Insc PBM (green), otherwise as in 
(A). The structure statistics for the dmPar3 PDZ2:Insc PBM complex are detailed in Table 32. (D) Cartoon representation of 
the dmPar3 PDZ2 domain (grey) in complex with the Insc PBM. The atoms of the PBM are colored according to their B-
factor ranging from blue (25 ≤ Å) to red (60 ≥ Å), otherwise as in (C). The iterative-build OMIT electron density map 
(Terwilliger et al. 2008) of the Insc PBM is shown as 2Fo-Fc map contoured at a sigma level of 1.0 to highlight the presence 
of the PBM in the PBM binding groove. 
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So far, we were successful in determining two crystal structures of the dmPar3 PDZ1 domain, namely 
the PDZ1 domain in complex with the class II PBMs of Par6 (SRB; PDB ID: 5oak; Figure 29A) 
(Renschler et al. 2018) and Shg (PLS and (Renschler 2013); Figure 29B) as well as the crystal structure 
of the PDZ2 domain in complex with the class I PBM of Insc (Figure 29C, D and Table 32). All 
structures show the canonical interaction of a PBM with a PDZ domain by augmentation of the β-
sheet consisting of the PDZ β2- and β3-strands (Figure 29). That is, the backbone NH and CO groups 
of the PBM positions 0, -1 and -2 participate in hydrogen bonds with the backbone NH and CO 
groups of the β2-strand of the PDZ domain. In addition, as for all canonical PDZ-PBM interactions, 
the C-termini are forming extensive hydrogen bonding networks with the respective carboxylate 
binding loops comprising of L19, G20 and L21 (Figure 29). 
The structures of the Par3 PDZ1 domain in complex with the PBMs of dmPar6 (Figure 29A) 
(Renschler et al. 2018) and Shg (Figure 29B) reveal the structural basis for the narrow specificity 
profile of PDZ1 domain (Figure 31A and Table 5). The residues of both PBMs at the 0 position, I and 
L, respectively, are buried in a deep hydrophobic pocket of the PDZ1 domain. This pocket consists of 
residues in the carboxylate binding loop (L19), the β2- (L21, A23) and β6- strands (L84, V86) and the 
α2-helix (L75, L79). The hydrophobic residues at the -2 position W (Shg) and L (dmPar6) are inserted 
into a wide hydrophobic pocket consisting of residues in the β2- (A23, P25) and β3- strands (L33) and 
the α2-helix (V71, L75). In contrast to the dmPar3 PDZ1:Shg complex, the dmPar3 PDZ1 domain and 
the dmPar6 PBM engage in additional interactions. H-1 of the dmPar6 PBM forms a hydrogen bridge 
to the hydroxyl group of T22 of the PDZ1 domain and V-3 interacts with a hydrophobic patch formed 
by the methyl group of T22 and L24. Noteworthy, the CO group of G-4 of the dmPar6 PBM forms a 
hydrogen bond network mediated by two water molecules with the sidechains of E68 and Q72 
(Figure 29A). In contrast, only the side chain of E68 is involved in a water mediated hydrogen bond 
network with the W-2 indole NH group in the dmPar3 PDZ1:Shg complex (Figure 29B). In the dmPar3 
PDZ1:dmPar6 complex, the hydrophobic pocket surrounding the -2 PBM position is sealed by water-
mediated hydrogen bond network between the E68-Q72 residues that orients Q72 towards the -2 
binding groove. Moreover, electron density was observed for additional residues of the Par6 PBM 
forming a second antiparallel β-strand (Renschler et al. 2018). However, since those residues 
displayed a high B-factor, it is not likely that those residues form a stable structure. In line with this 
argument, additional NMR experiments conducted by SRB and SW did not provide any evidence of 
the presence of the second β-strand in the dmPar3 PDZ1:dmPar6 complex in solution (SW, SRB 
personal communication). 
To determine the structure of the dmPar3 PDZ2 domain in complex with a class I ligand, I fused the 
Insc PBM (LTRQESFV) with a seven amino acid long GS linker sequence to the C-terminus of the 
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dmPar3 PDZ2 domain. Crystals of this construct diffracted to 1.8 Å and I was able to determine the 
crystallographic phases by molecular replacement using the second PDZ domain of hsDlg3 (PDB ID: 
2fe5) as well as the PDZ domain variant C378S of the rat homolog of Dlg (2awx) as search models 
(Figure 29C, D, Table 32). 
The structure of the dmPar3 PDZ2:Insc complex highlights the structural differences in ligand 
recognition between the Par3 PDZ1 and PDZ2 domains. The hydrophobic binding pocket enclosing 
the valine side chain of the 0 position (Figure 29C) is smaller than the pocket of the PDZ1 domain 
(Figure 29A, B). The PDZ2 pocket consists of the carboxylate binding loop (L21), the β2-strands (F23) 
and the α2-helix (L81). In contrast to the PDZ1 domain, there is no hydrophobic pocket present at 
the -2 position since the β2-strand (V25) and the α2-helix (V78) are spatially too close. Furthermore, 
the F-1 of the Insc PBM lies on a hydrophobic surface containing L44 of the dmPar3 PDZ2 domain. 
The serine side chain at the -2 position of the Insc PBM forms a hydrogen bond with Q74 of the α2-
helix of the PDZ2 domain. Q74 also participates in a hydrogen bond with the backbone CO group of 
Q-4 of the Insc PBM. Of note, the glutamine at the -3 position of the Insc PBM engages in a hydrogen 
bond network with S24 and N42 of the PDZ2 domain. Worth mentioning is the close distance of the 
amino group of the K41 side chain to the carboxylate group of the E-3 side chain. However, the 
amino group faces into the opposite direction since it is part of a crystal contact involving a sulfate 
ion. The presence of the Insc PBM in the PBM binding groove of the dmPar3 PDZ2 domain was 
verified by calculating a iterative built OMIT electron density map (Terwilliger et al. 2008) and 
critically observing the B-factors of the PBM (Figure 29D). The OMIT map shows clear density for the 
PBM positions 0 to -3. Noteworthy, the side chain of Q-4 shows no OMIT density and high B-factors 
indicating no stable conformation. However, the backbone CO group involved in the hydrogen bond 
with Q74 shows a lower B-factor and OMIT map electron density. In addition, the density of the C-
terminal carboxyl group of the Insc PBM is incomplete and B-factors associated with the 
corresponding oxygen and carbon atoms are higher than for the surrounding residues. This might be 
the result of radiation damage of the crystal which can lead to the decarboxylation of carboxyl 
groups (Weik et al. 2000; Garman 2010). 
In sum, the distinct specificity profiles of the dmPar3 PDZ2 domain in comparison to the PDZ1 
domain can be explained on a structural level. The most striking difference between the two PDZ 
domains is the size of the pocket facilitating the interaction with the -2 PBM position. In the dmPar3 
PDZ1 domain, this pocket is large enough to encompass a large hydrophobic residue such as leucine 
or trypthophane (Figure 29A, B) whereas the PDZ2 binding pocket is very shallow (Figure 29C, D). 
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Figure 30: Structural comparison of the dmPar3 PDZ1 and PDZ2 domains. (A) Cartoon representation structural alignment 
of the dmPar3 PDZ1 domain (white) in complex with the Shg PBM (dark blue sticks) (PLS and (Renschler 2013)) and of the 
dmPar3 PDZ2 domain (grey) in complex with the Insc PBM (green sticks). The rmsd between the two structures is 2.725 Å. 
(B) As (A) but without the PBMs. The distances between the Cα-atoms of equivalent positions in the β2-strand and α2-helix 
of the PDZ domains (A23 and Q72 in the case of PDZ1 and V25 and V78 in the case of PDZ2, respectively) are given as dark 
blue and green dashed lines for the dmPar3 PDZ1 and PDZ2 domains, respectively. 
This difference results in the displacement of the α2-helix of the PDZ domain in respect of the β2-
strand (Figure 30). This fact is reflected in the high rmsd of 2.725 Å between the two structures as 
well as the larger difference in distance between equivalent positions inside the 2-helix and the β2-
strand (Cα-atoms of A23 and Q72 in the case of PDZ1 and V25 and V78 in the case of PDZ2, 
respectively). The distance between these atoms in the dmPar3 PDZ1 domain is 11.0 Å compared to 
7.8 Å in the PDZ2 domain. Therefore, the dmPar3 PDZ1 domain is able to interact with bulkier 
residues as compared to the dmPar3 PDZ2 domain.  
Despite my efforts to crystallize various combinations of the dmPar3 PDZ3 domain with different 
PBMs and different GS-linker, no high quality diffraction data could be collected (Table 31). 
 
4.2.4 Discussion 
The dmPar3 PDZ domains have unique but redundant binding specificities 
Despite high levels of sequence conservation of the residues forming the PBM binding pocket (Figure 
27), my analysis of the binding specificities of the dmPar3 PDZ domains (Figure 28, Table 5) revealed 
that the first PDZ domain of dmPar3 prefers class II ligands with large hydrophobic residues at the 0 
and -2 position (Table 5, Figure 29A, B, Figure 30 and Figure 31A), while the second PDZ domain 
selects class I and class III PBMs with negatively charged or polar residues at the -2 position as well 
as glutamine at position -3 and valine at position 0 (Table 5, Figure 29C, D, Figure 30 and Figure 31B). 
Moreover, the PDZ2 domain is capable of recognizing class II PBMs (Ed), containing V at position 0 
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and E at position -3, to some extent. Surprisingly, the dmPar3 PDZ3 domain displays a highly 
promiscuous binding profile (Table 5 and Figure 31C) preferring hydrophobic residues at position 0 
and E at position -3. 
 
Figure 31: Selectivity profiles of the individual dmPar3 PDZ domains. (A) PBMs interacting with the dmPar3 PDZ1 domain. 
PBMs are aligned according to their Kd values (Table 5) and colored with ClustalX according to conservation (Larkin et al. 
2007), red boxes indicate interactions between side chain atoms of the PBM with the respective PDZ domain (Figure 29), 
conservation and consensus sequences were generated in Jalview (Waterhouse et al. 2009). (B) PBMs interacting with the 
dmPar3 PDZ2 domain, otherwise as in (A). (C) PBMs interacting with the dmPar3 PDZ3 Δβ2-3loop domain, otherwise as in 
(A).  
Of note, artificial high affinity PBMs for the dmPar3 PDZ domains have been identified by phage 
display screens (Yu et al. 2014) which coincide partially with the results of my 2D line shape fitting 
data (Table 5 and Figure 31). In short, PDZ1 interacts with class II PBMs containing W at position -2 
and F at position 0, PDZ2 interacts with class II PBMs containing E at position -3 and V at position 0, 
and PDZ3 interacts with class II PBMs preferring F or in rare cases I at position 0 with very high 
affinities in the nanomolar range (Yu et al. 2014). However, phage display screens tend to be biased 
to select for PBMs containing Tryptophan or Phenylalanine residues at various positions as well as 
artificially low Kd values (Yu et al. 2014; Luck & Travé 2011). Therefore, it is not surprising that Yu et 
al. found only class II ligands. In addition, protein-protein interactions are not necessary optimized in 
vivo.  
 
The redundant and distinct binding specificities of the dmPar3 PDZ domains may enable the 
assembly of large polarity protein networks 
Overall, the specificities of the three dmPar3 PDZ domains share overlapping specificities (Figure 31, 
Table 5). This observation is intriguing taking into account that one Par3 molecule can 
simultaneously interact with two Par6 PBMs in vitro (Figure 20 and Figure 23) (Renschler et al. 2018) 
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and probably also with any other PBM which interacts with two Par3 PDZ domains. However, Par3 
contains three PDZ domains of which at least one would be able to interact with another PBM if two 
of its PDZ domains are occupied. Therefore, it is highly possible, that Par3 forms large networks at 
the cell cortex involving a vast variety of different ligands (Figure 32). However, there is also 
evidence present for the crucial role of the Par3 oligomerization in Par3 function (Rodriguez et al. 
2017; Dickinson et al. 2017; Wang et al. 2017). Hence, large assemblies of Par3 containing several 
PDZ modules are present in polarized cells. These Par3 clusters are therefore able to interact with 
many different PBMs at once (Figure 32). 
 
Figure 32: Par3 is a multivalent interaction hub. The Par3 PDZ domains can form multivalent interaction networks in 
various cellular contexts e.g. in epithelia cells (left) or during asymmetric cell division (right). 
Moreover, a study in the Drosophila embryo ectoderm indicated specialized functions for the 
dmPar3 PDZ domains (McKinley et al. 2012). The authors proposed that dmPar3 recruitment to the 
apical domain depends on PDZ1 and PDZ3 while PDZ2 mediates downstream effects on epithelial 
structure. In addition, dmPar3 removal form the apical cell cortex is increased by PDZ1. In agreement 
with the reported functions of the dmPar3 PDZ domains, the ligands assigned here (Table 5 and 
Figure 31) can be related to the individual functions. As for PDZ1, apical recruitment is probably due 
the interaction with Shg (Figure 32) (Wei et al. 2005; Bulgakova et al. 2013), the E-cadherin of 
Drosophila, whereas dmPar3 turnover is probably linked with the dmPar6 interaction (Renschler et 
al. 2018) which might result in a recruitment of the Par6/aPKC module. The downstream effects such 
as planar cell polarity, Golgi orientation, asymmetric cell division and maybe apical constriction are 
probably mediated by the interactions of the Par3 PDZ2 domain with Stan (Wasserscheid et al. 
2007), α-cat (Odell et al. 2012), Insc (Lu & Johnston 2013; Culurgioni & Mapelli 2013; Lang & Munro 
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2017) and Smash (Beati et al. 2018), respectively. In addition, the interaction of aPKC via its PBM 
with the Par3 PDZ2 domain might facilitate Par3 mediated recruitment of aPKC to various substrates 
independent of the Par3 KBD. The interactions of the third dmPar3 PDZ domain with Shg (Wei et al. 
2005; Bulgakova et al. 2013), with Crb during epitheliogenesis (Tepass 2012; Lang & Munro 2017) 
and with Ed (Wei et al. 2005) most probably result in its apical localization (Figure 32). The 
interactions of the dmPar3 PDZ3 domain with Stan, aPKC and Insc (Figure 31C) might result in 
additional redundancies enabling Par3 to interact with multiple downstream effectors at the same 
time similar to the multiple interactions between dmPar3 and dmPar6 (Renschler et al. 2018). 
In addition to the multiple possible interactions, the regulation of the involved proteins plays an 
important role. Surprisingly, my analysis of the Par3 PDZ domain specificities revealed that the third 
dmPar3 PDZ domain is able to interact with the well-studied Par6 PDZ domain interaction partner 
Crb (Whitney et al. 2016) (Figure 31C and Table 5). However, those two interactions might be linked 
with different stages of epitheliogenesis. After formation of initial spot-like cell-cell junctions, Par3 
recruits members of the Crumbs and PAR complex to these initial junctions (Tepass 2012; Lang & 
Munro 2017). At this stage, the interaction between the Crb PBM and the dmPar3 PDZ3 domain 
might be of importance. After maturation of the cell-cell junctions and exclusion of Par3, Par6 and 
aPKC localize with the Crumbs complex (Tepass 2012; Lang & Munro 2017). This is probably a Cdc42-
dependent process since the affinity of the Par6 PDZ domain for the Crb PBM can be increased by an 
factor of 10 in the presence of GTP-bound Cdc42 to Kd ≈ 1.2 µM (Whitney et al. 2016) that is 13-fold 
stronger when compared to the Par3 PDZ3:Crb PBM interaction (Kd ≈ 16 µM, Table 5).  
Additionally, the weak interaction of the Std PBM with the dmPar3 PDZ2 domain (Figure 31B and 
Table 5) was observed. This interaction might be less important compared to the interaction of the 
Std PDZ with the C-terminal region of Par3 (Krahn, Bückers, et al. 2010). However, no biophysical 
data investigating the Std PDZ:dmPar3 complex is present to date. Yet it is known that the Std PBM 
can interact with the Par6 PDZ domain with an Kd ≈ 6 µM (Penkert et al. 2004) that is 127-fold 
stronger than the Par3 PDZ2:Std PBM interaction (Kd ≈ 762 µM, Table 5). 
Furthermore, the cellular context may differ in which those interactions occur. For example, during 
the gastrulation of the Drosophila embryo, Std is expressed and present before stage 6. Crb 
however, is only present at later stages (Krahn, Bückers, et al. 2010; Sen et al. 2015). Therefore, 
multiple and redundant interaction might be necessary to ensure correct cell polarization in various 
developmental and cellular contexts. In line with that is the observation that Par is dispensable for 
the maintenance of cell polarity in the Drosophila follicular epithelium (Shahab et al. 2015). 
Besides the previously reported interaction between the Par6 PBM and the Par3 PDZ1 and PDZ3 
domains (Renschler et al. 2018), I discovered another PBM-based interaction between the aPKC PBM 
74 
 
and the Par3 PDZ2 and PDZ3 domains (Figure 31B, C and Table 5). Interestingly, to date this 
interaction was not reported. Instead much emphasis in the research of the aPKC:Par3 interaction 
was focus on the Par3 KBD and its duality as substrate and inhibitor of the aPKC kinase domain 
(Wang et al. 2012; Soriano et al. 2016). However, the interaction of the aPKC PBM with the Par3 
PDZ2 and PDZ3 domains increases the multivalency and redundancy between the Par6/aPKC module 
and Par3 thereby enabling different binding modes independent of the Par3 KBD. This might be of 
importance since active aPKC seems to be associated with Par3 present at adherens junctions 
enriched with Shg (E-cadherin) (Soriano et al. 2016). As I and my co-authors could show (Figure 19, 
Figure 22, Table 5) (Renschler et al. 2018), the interaction of the Par6 PBM and Par3 relies on the 
interaction with Par3 PDZ1 and PDZ3 and can compete with Shg for Par3 PDZ1 and PDZ3 binding 
(Figure 24). However, an additional interaction between the aPKC PBM and the dmPar3 PDZ2 and 
PDZ3 domains might strengthen the interaction of the Par6/aPKC module. This might be off 
importance keeping active aPKC associated with Par3 at adherens junctions, since the tight 
interaction between the Par6 KBD and the aPKC kinase domain is released upon Par3 KBD 
phosphorylation by aPKC (Wang et al. 2012; Soriano et al. 2016). Nevertheless, detailed in vivo 
analysis of the Par3 PDZ:aPKC PBM interactions has to be done in order to draw further conclusion 
about the function of the aPKC PBM in context of the PAR complex. 
 
Structural investigations are required to decipher the specificity profiles of the Par3 PDZ domains 
The presented x-ray structures of the dmPar3 PDZ1 domain in complex with the dmPar6 PBM (Figure 
29A) (Renschler et al. 2018) and the Shg PBM (Figure 29B, PLS and (Renschler 2013)) as well as the 
dmPar3 PDZ2 domain in complex with the Insc PBM (Figure 29C, D) provide important insights into 
the recruitment of natural ligands to the dmPar3 PDZ domains and their specificities. Although a 
fairly comprehensive structural study (Ernst et al. 2014) has been performed to determine specificity 
determining components of PDZ domains for high affinity ligands derived from phage display 
screens, this approach suffers from the over representation of aromatic residues in the selected 
PBMs as well as very low Kd values (Yu et al. 2014; Luck & Travé 2011; Tonikian et al. 2008; Ernst et 
al. 2014). Yet, the ability of PDZ1 to enclose large hydrophobic residues such as W or L inside its 
position -2 binding pocket was not observed before. In contrast, the strict selectivity for V at position 
0 of dmPar3 PDZ2 ligands (Figure 31) largely confers to the presence of F23 which constricts the 
position 0 binding pocket in PDZ2 (Figure 29C, D) compared to PDZ1 (Figure 29A, B) as described 
previously (Ernst et al. 2014). Moreover, the insights gained from the dmPar3 PDZ2:Insc complex 
(Figure 29C, D) can be extrapolated to explain the PDZ2 specificities (Figure 29 and Figure 31B). K41 
and N42 are the reason for the presence of a glutamine at the PBM -3 position as in the dmPar3 
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PDZ2:Insc complex. In addition, it is possible to substitute S-2 with threonine or aspartate in order to 
form hydrogen bonds with Q74 of the PDZ2 domain. Likewise, the phenylalanine at the -1 position 
can be replaced by other hydrophobic residues such as I, A, C or the methyl group of a threonine in 
order to maintain the hydrophobic interaction with L44. 
Besides, all residues at the interaction surfaces of dmPar3 PDZ1 and PDZ2 are highly conserved 
(Figure 27), suggesting conserved binding specificities of the Par3 PDZ domains. In fact, I also showed 
that PDZ1 and PDZ3 of the human Par3 protein are able to bind to the human Par6 PBM (Figure 25) 
(Renschler et al. 2018). Furthermore, residues involved in PBM binding in dmPar3 PDZ1 and PDZ2 
are conserved to some extent in PDZ3 (Figure 27), highlighting the ability of PDZ3 to interact with 
PBMs also recognized by PDZ1 and PDZ2 (Table 5 and Figure 31). In line with this observation, the 
PDZ3 domains of the human, mice and rat Par3 proteins bind to JAMs, Nectins and Ephrins (Ebnet et 
al. 2001; Takekuni et al. 2003; Iden et al. 2006; Itoh et al. 2001; Ebnet et al. 2003; Lin et al. 1999; 
Latorre et al. 2005; Nakayama et al. 2013) as well as PTEN (von Stein et al. 2005; Feng et al. 2008) 
which contain similar class II PBMs as dmPar6, Ed and Shg in Drosophila (Figure 26). Taking together, 
the structures presented here form the basis for understanding the specificities of the dmPar3 PDZ1 
and PDZ2 domains. 
 
The Par3 PDZ3 domain carries specificity determining residues from both the PDZ1 and PDZ2 
domain 
In addition, the third PDZ domain of dmPar3 seems to be an intermediate of PDZ1 and PDZ2. This is 
reflected in the fact that residues contacting PBMs in dmPar3 PDZ1 and 2 are conserved in PDZ3 
(Figure 27 and Figure 33). All residues identified in the x-ray structures of the dmPar3 PDZ1 domain 
in complex with the dmPar6 PBM (Figure 29A), the Shg PBM (Figure 29B) and the dmPar3 PDZ2 
domain in complex with the Insc PBM (Figure 29C, D) are present in the dmPar3 PDZ3 domain 
(Figure 33). This is most likely the explanation of the promiscuous binding specificity of the dmPar3 
PDZ3 domain (Figure 25, Figure 31C and Table 5). Therefore, the Par3 PDZ3 domain is a chimera of 
the Par3 PDZ1 and PDZ2 domains in regard of ligand selectivity and selectivity determining features. 
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Figure 33: The Par3 PDZ3 domain is a chimera of the Par3 PDZ1 and PDZ2 domains. Detail of the structure-based 
sequence alignment of the Par3 PDZ1, PDZ2 and PDZ3 domains (Figure 27) highlighting the conservation of specificity 
determining residues from the dmPar3 PDZ1 and PDZ2 domains in the dmPar3 PDZ3 domain. Residues interacting with the 
dmPar6 PBM (Figure 29A), the Shg PBM (Figure 29B), or the Insc PBM (Figure 29C, D) are indicated by cyan, dark blue and 
green spheres on top of the corresponding PDZ domain, respectively. Otherwise as Figure 27. 
 
In sum I could show that the dmPar3 PDZ1 and PDZ2 domains have unique ligand binding properties 
(Figure 25, Figure 31A, B and Table 5) which are based on the structure in the case of the PDZ1 
(Figure 29A, B) and PDZ2 domains (Figure 29C, D). However, they share redundant ligand specificities 
with the Par3 PDZ3 domain (Figure 25, Figure 31C and Table 5) enabling Par3 to form multivalent 
interactions networks in different cellular contexts (Figure 32). This redundant ligand specificity of 
the Par3 PDZ3 domain with the PDZ1 and PDZ2 domains are resulting from the fact that the PDZ3 
domain contains all ligand specificity determining residues of the other two Par3 PDZ domains 
(Figure 33). 
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4.3 A short N-terminal motif regulates the function of the dmPar3 PDZ3 
domain 
During my thesis, I discovered that the dmPar3 PDZ3 domain does not display a conclusive specificity 
profile (Figure 31C, Table 5) since it is able to recognize almost all PBMs tested in a promiscuous 
fashion. Moreover, it seems to be a chimera between the Par3 PDZ1 and PDZ2 domains on the 
sequence level (Figure 33) and thus in its PBM binding profile (Figure 31). Of note, during the 
investigation of the Par3 PDZ module comprising all three PDZ domains (Figure 23), all PDZ domains 
seemed to be structurally and functionally largely independent (Renschler et al. 2018). But 
nevertheless, the third PDZ domain showed 1H,15N-chemical shifts changes noticeably larger than 
the first and second PDZ domain (Figure 23). Together with the fact that PDZ domains are known to 
be influenced by sequences adjacent to them (Ivarsson 2012; Luck et al. 2012; Ye & Zhang 2013), I 
wanted to investigate this observation further. 
 
4.3.1 Contributions 
The results presented here have been obtained during the course of my PhD thesis. Results obtained 
by myself and already published are indicated by citing the respective papers. 
 
4.3.2 The dmPar3 PDZ3, but not PDZ1 and PDZ2, displays structural changes when 
embedded in the PDZ module 
NMR spectra of the entire dmPar3 PDZ module (PDZ1-3) in comparison with the individual PDZ 
domains showed, that the PDZ domains of dmPar3 are structurally and functionally largely 
independent (Figure 23) (Renschler et al. 2018). However, changes in the 1H,15N-chemical shifts of 
the third Par3 PDZ domain were consistently larger than for the PDZ1 and PDZ2 domains (Figure 
23C). The fact that the cross peaks originating from PDZ1 and PDZ2 in the 1H,15N TROSY spectrum of 
the PDZ1-3 Δβ2-3loop construct overlaid well with the individual domains (Figure 23A, B) 
demonstrates that a region within the linker sequence between the second and third PDZ domain 
interacts in cis with the PDZ3 domain and thereby causes the CSPs in this domain.  
 
4.3.3 The PDZ2-3 linker contains an FID-motif that interacts in cis with the PDZ3 domain 
To probe which part of the linker between the dmPar3 PDZ2 and PDZ3 domains caused the CSPs in 
the Par3 PDZ3 domain, I generated a construct that comprised of the entire linker sequence starting 
from the C-terminus of the PDZ2 domain and contains the PDZ3 domain without the loop between 
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the second and third β-strand (Figure 34A, linker-PDZ3 Δβ2-3 loop). Comparison of the 1H,15N-HSQC 
spectrum of the 15N-labeled dmPar3 linker-PDZ3 Δβ2-3 loop construct with the 1H,15N-HSQC 
spectrum of the 15N-labeled dmPar3 PDZ3 Δβ2-3 loop construct displayed chemical shift changes in 
the peaks of the PDZ3 domain as observed previously (Figure 34B). This demonstrates that residues 
in the PDZ2-3 linker influence the PDZ3 domain. 
 
Figure 34: The FID-motif N-terminal of dmPar3 PDZ3 causes structural changes in PDZ3. (A) Schematic representation of 
dmPar3 PDZ3 Δβ2-3loop constructs used for mapping the motif N-terminal of PDZ3 which influences PDZ3. The sequence 
of the linker between dmPar3 PDZ2 and PDZ3 is shown and numbered according to FL dmPar3 protein (FBpp0110299). The 
FID-motif folding back onto PDZ3 is highlighted in bold. Numbers to the left indicate construct names and are colored as in 
(B). (B) Overlay of 
1
H,
15
N-HSQC spectra of dmPar3 PDZ3 Δβ2-3loop constructs described in (A). dmPar3 PDZ3 Δβ2-3loop is 
shown in black, dmPar3 linker-PDZ3 Δβ2-3loop in dark blue, dmPar3 linkerΔI-PDZ3 Δβ2-3loop in light blue, dmPar3 
linkerΔII-PDZ3 Δβ2-3loop in green, dmPar3 linkerΔIII-PDZ3 Δβ2-3loop in orange, dmPar3 linkerΔFID-PDZ3 Δβ2-3loop in red. 
Chemical shift assignments are shown according to dmPar3 PDZ3 Δβ2-3loop as published previously under the BMRB 
accession code 27198 (Renschler et al. 2018). 
To map the linker residues involved in the interaction, I truncated the N-terminus of the linker 
sequence in several steps (Figure 34A). Comparison of the 1H,15N-HSQC spectra of these truncation 
constructs displayed changes in the PDZ3 domain similar to the complete linker sequence until a 
sequence of 24 amino acids N-terminal of the Par3 PDZ3 domain was left (Figure 34B, dmPar3 
linkerΔII-PDZ3 Δβ2-3 loop). In contrast, further truncation of the linker (dmPar3 linkerΔIII-PDZ3 Δβ2-
3 loop) leaving just 16 residues N-terminal of the Par3 PDZ3 domain as well excision of the 24 aa N-
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terminal of the Par3 PDZ3 domain (dmPar3 linkerΔFID-PDZ3 Δβ2-3 loop) did not yield significant 
CSPs in the 1H,15N-HSQC spectra between these constructs and dmPar3 PDZ3 domain (Figure 34B). 
Therefore, the 24 amino acids N-terminal of the PDZ3 domain interact with the third PDZ domain of 
dmPar3 in cis.  
 
4.3.4 The FID-motif folds back onto PDZ3 next to the PBM binding grove 
To determine the interaction surface between the linker residues and the PDZ3 domain, I first 
investigated the interaction of the 15N-labeled ten N-terminal linker amino acids with the dmPar3 
PDZ3 domain in trans with NMR CSP experiments.  
To this end, I fused the linker sequence (aa 610-620 of dmPar3) to the B1 domain of the 
streptococcal protein G (denoted as dmPar3 FID-motif) with two linking serine and glycine residues 
and assigned the H,N-resonances of the linker residues in this construct (Figure 35A and Figure A 2). 
In order to assign secondary structure elements to the dmPar3 FID-motif in isolation, I quantified 
3JHN-Hαi-coupling constants which directly correlate with the secondary structure of proteins (Bystrov 
1976) and used qualitative information present in the 3D 1H,15N-HNH-NOESY spectrum of the 
dmPar3 FID-motif to resolve ambiguities. This analysis revealed the presence of one α-helical turn at 
the N-terminus of the FID-motif (aa 610-614) whereas the C-terminal part (aa 615-620) adopts an 
elongated random coil structure (Table 6). 
 
Table 6: Secondary structure assignment of the dmPar3 FID-motif in isolation. 
residue #   610     615     620 
aa S* G* N E S Q H F I D A G S 
3JHN-Hαi (Hz) 6.61 7.17 7.21 6.15 6.66 7.07 4.51 6.32 7.89 6.69 6.69 6.01 7.43 
2
nd
 structure * rc α α α α α α rc rc rc rc rc rc 
* 2
nd
 structure assignment after qualitative inspection of the 3D 
1
H,
15
N-HNH-NOESY strips to resolve ambiguous 
3
JHN-Hαi-
coupling constants (6 ≤ 
3
JHN-Hαi (Hz) ≤ 8). 
 
Next, I added increasing amounts of unlabeled dmPar3 PDZ3 Δβ2-3loop domain to the 15N-labeled 
dmPar3 FID-motif (Figure 35A). As expected for two proteins interacting with each other, I observed 
several CSPs (Figure 35A, B) of the cross peaks of amino acids 610 and 613-618 (QHFIDA) but no CSPs 
for peaks originating from the GB1 domain or from the remaining SG-linker sequence. Of note, N610 
is approximately facing into the same direction as residues 613-618 since it is at the other end of the 
α-helical turn identified previously in the FID-motif in isolation (Table 6). Therefore, the FID motif 
and in particular residues 610 and 613-618 (Figure 35B) interact with a single surface with the third 
PDZ domain of dmPar3.  
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Figure 35: The FID-motif interacts with a surface close to the PBM binding grove of dmPar3 PDZ3. (A) Overlay of a 
representative region of the 
1
H,
15
N-HSQC spectra of the FID-motif containing linker of dmPar3 fused to GB1 domain in the 
absence (black) and presence of increasing stoichiometric amounts of dmPar3 PDZ3 Δβ2-3loop domain as indicated. 
Arrows indicate the direction of chemical shift changes. Chemical shift assignments are shown for the residues originating 
from the dmPar3 FID-motif. (B) CSPs induced by the dmPar3 PDZ3 Δβ2-3loop domain are mapped onto the sequence of the 
FID-motif. Italic residues originate from the linker between GB1 and the dmPar3 FID-motif and core residues of the FID-
motif are highlighted in bold. (C) Overlay of a representative region of the 
1
H,
15
N-HSQC spectra of the dmPar3 PDZ3 Δβ2-
3loop domain in the absence (black) and presence of increasing stoichiometric amounts of the FID-motif containing linker 
of dmPar3 fused to GB1 as indicated. Arrows indicate the directions of chemical shift changes. The 
1
H,
15
N-HSQC spectrum 
of dmPar3 linkerΔII-PDZ3 Δβ2-3loop is shown in green in order to highlight the end point of the titration. Chemical shift 
assignments are shown for the residues of dmPar3 PDZ3 Δβ2-3loop as published previously (Renschler et al. 2018). (D) 
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CSPs induced by the FID-motif containing linker of dmPar3 are mapped onto a homology model of dmPar3 PDZ3 Δβ2-3loop 
(Renschler et al. 2018). Legend continued on next page. 
Figure 35: (D) (continued) CSPs are color coded with a linear gradient from white (CSP ≤ 0.020 ppm) to blue (CSP = 0.085 
ppm). Residues broadened beyond detection are shown in purple and not assigned residues of PDZ3 are shown in dark 
grey. The PBM binding groove of the dmPar3 PDZ3 domain is indicated by the Shg PBM in yellow from the dmPar3 
PDZ1:Shg complex and was generated by aligning both structures in pymol. Secondary structure elements are labeled (α1: 
aa 51-55, α2: aa 76-88, β1: aa 8-15, β2: aa 26-31, β3: aa 38-45, β4: aa 61-66, β5: aa 69-71, β6: aa 97-104). 
 
To map the interaction surface of the FID-motif onto the PDZ3 domain, I added unlabeled dmPar3 
FID-motif to the 15N-labeled dmPar3 PDZ3 Δβ2-3loop domain. Again, CSPs were observed for a 
subset of cross peaks (Figure 35C). As expected, all PDZ3 cross peaks affected by the presence of the 
FID-motif shifted into the direction of the corresponding cross peaks in the dmPar3 linkerΔII-PDZ3 
Δβ2-3loop construct that is the state where the FID-motif is bound in an intramolecular manner. In 
general, the observed CSPs for both, the FID-motif (Figure 35A, B) and the PDZ3 domain (Figure 35C, 
D), are not very pronounced at high stoichiometric ratios which suggests a weak interactions in 
trans. Since the backbone amides of the dmPar3 PDZ3 domain and a homology model of the dmPar3 
PDZ3 Δβ2-3loop domain were published previously (Renschler et al. 2018), I was able to map the 
CSPs onto the PDZ3 domain (Figure 35D). Interestingly, this showed that residues most affected by 
the FID-motif are located β2- and β3-strands and hence in close vicinity to the PBM binding groove. 
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4.3.5 The FID-motif weakens the affinities of dmPar3 PDZ3 
The chemical shift mapping demonstrated that the FID-motif binds to the dmPar3 PDZ3 domain in 
close vicinity to the PBM binding groove (Figure 35D). Additionally, residues involved in the binding 
surface of the FID-motif (Figure 35D) are partially conserved between all three dmPar3 PDZ domains 
(Figure 27) and are likely important for ligand recognition in PDZ1 and PDZ2 (Figure 29). Thus, the 
FID-motif might represent a regulatory element to influence the affinities of the dmPar3 PDZ3 
domain. Therefore, I investigated the effects of the FID-motif onto the specificity of the PDZ3 
domain. As my line shape fitting analysis of the isolated dmPar3 PDZ3 domain reveled a very broad 
specificity of the PDZ3 domain for all tested PBMs (Table 5), I performed CSPs experiments ( 
Figure 36) with 15N-labeled dmPar3 linkerΔII-PDZ3 Δβ2-3loop and the strongest binding ligands (Insc, 
Crb, Stan, Ed, Shg, dmPar6 and aPKC). In order to test the effect on weak interaction partners, the α-
cat PBM (Kd (dmPar3 PDZ3 Δβ2-3loop) = 663 ± 40 µM) was incorporated. Next, I determined Kd 
values (Table 7) using 2D lineshape fitting with TITAN (Figure A 26 – Figure A 32) (Waudby et al. 
2016). 
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Figure 36: NMR titration experiments of the dmPar3 
linkerΔII-PDZ3 Δβ2-3loop domain with different PBMs. 
Overlay of a representative region of the 
1
H,
15
N-
correlation spectra of the dmPar3 linkerΔII-PDZ3 Δβ2-
3loop domain in the absence (black) and presence of 
stoichiometric amounts of PBM peptides as indicated. 
Overall, all affinities were reduced by the 
presence of the FID-motif (Table 7). However, 
the affinities of tight binding PBMs such as 
Shg and Stan were reduced more drastically 
(from 0.6 μM and 5.5 μM to 11 μM and 73 
μM, respectively) which is 18- and 13-fold 
weaker, respectively. In comparison, the 
affinity of dmPar6 which binds with an 
intermediate affinity was only reduced by an 
factor of 3 (Table 7) form 54 μM to 155 μM. In 
addition, the interaction with ligands with an 
already rather weak affinity (Insc and aPKC) 
for the PDZ3 domain was further reduced 
from 275 μM to 844 μM (3 fold decrease) in 
the case of Insc and from 101 μM to 663 μM 
(7-fold decrease) in the case of aPKC, 
respectively. Of note, no CSPs could be 
observed for the α-cat PBM ( 
Figure 36). Therefore, no interaction takes 
place between the PDZ3 domain and the α-cat 
PBM if the FID-motif is present with the PDZ3 
domain in cis. 
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Table 7: Differences in dissociation constants (in µM) between PDZ3 Δβ2-3loop and linkerΔII-PDZ3 Δβ2-3loop for 
different PBMs. 
PBM class sequence PDZ3 Δβ2-3loop linkerΔII-PDZ3 Δβ2-3loop fold difference 
dmPar6 II VKDGVLHL 54 ± 1 * 155 ± 10 2.9 
Insc I LTRQESFV 275 ± 8 844 ± 90 3.1 
Ed II RVIREIIV 19 ± 1 117 ± 5 6.1 
aPKC III LMSLEDCV 101 ± 3 663 ± 40 6.6 
Crb I KPPPERLI 16 ± 1 134 ± 7 8.2 
Stan I IDDDETTV 5.5 ± 0.3 73 ± 3 13.1 
Shg II DDDQGWRI 0.6 ± 0.1 * 11 ± 1 18.3 
α-cat III FQSPADAV 663 ± 40 n.d. - 
Kd values were determined by 2D line shape fitting of NMR CSP experiments with TITAN (Waudby et al. 2016). Errors were 
estimated with bootstrapping statistics on 100 replicates. The number of titration points and cross peaks analyzed for each 
interaction as well contributions from others are summarized in Table A 1 and Table A 2. n.d. refers to not detectable and 
means no detectable CSPs in NMR CSPs experiments. Asterisks indicate Kd values already published in Renschler et al. 
(Renschler et al. 2018) and reprinted with permission from AAAS. 
 
Taking together, these results demonstrate that the FID-motif is decreasing the affinities of the 
dmPar3 PDZ3 domain. Thereby the FID-motif counters the promiscuity of the Par3 PDZ3 domain to 
some extent.  
 
4.3.6 Discussion 
The FID-motif enables the dmPar3 PDZ3 domain to discriminate between different PBMs 
My binding analyses of the PDZ3 domain in presence of the FID-motif showed that the FID-motif 
weakens the affinities of the PDZ domain towards PBMs (Figure 36, Table 7). Besides, the FID-motif 
seems to level out the huge affinity differences between the highest affinity PBM tested in this 
study, Shg, and intermediate affinity PBMs such as dmPar6. The affinity of the dmPar3 PDZ3 domain 
decreases from 90-fold (Kd(dmPar3 PDZ3 Δβ2-3loop) vs Shg of 0.6 µM or dmPar6 of 54 µM) to 14-
fold (Kd(dmPar3 linkerΔII-PDZ3 Δβ2-3loop) vs Shg of 11 µM or dmPar6 of 155 µM) thereby reducing 
the affinity difference by a factor of more than 6 (Table 7, Figure 37A, B).  
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Figure 37: The selectivity of the dmPar3 PDZ3 domain is influenced by the FID-motif. (A) PBMs interacting with the 
dmPar3 PDZ3 Δβ2-3loop domain, otherwise as in Figure 31A. (B) PBMs interacting with the dmPar3 linkerΔII-PDZ3 Δβ2-
3loop domain, otherwise as in Figure 31A. (C) The FID-motif might modulate the dmPar3 PDZ3 domain affinities and switch 
the PDZ3 domain from an low affinity state (top) to a high affinity state (bottom). 
Based on the comparison of the binding affinities of the strongest interaction partners of the dmPar3 
PDZ domain in absence and presence of the FID-motif (Table 7, Figure 37A, B) it seems that the FID-
motif transforms the PDZ3 domain into a low affinity state (Figure 37C, top). Interestingly, sequence 
comparison of the highest affinity PBMs of both states (Figure 37A, B) reveals that apparently 
position -5 becomes much more conserved as three out of five high affinity PBMs of the dmPar3 
linkerΔII-PDZ3 domain contain a aspartate at this position. Interestingly, this position is far-off from 
the FID-interaction surface (Figure 35D).  
Several models could explain the reduced affinity of the dmPar3 PDZ domain in presence of the FID-
motif. In a competitive model, the residues of the FID-motif would bind the same residues within the 
PDZ3 domain involved in the interaction with a PBM. Thereby the FID-motif would sterically block 
the access of the PBM to the PBM binding groove of the PDZ3 domain. Alternatively, the FID-motif 
could allosterically influence residues inside the PBM binding groove thus altering its binding 
properties. However, based on the data of my CSPs experiments (Figure 35D), the close vicinity of 
the FID-motif interaction surface and the PBM binding groove would favor the first model in which 
the FID-motif sterically interferes with PBM binding especially of residues at the very C-terminus of 
the PBM. Thereby contributions in regard of selectivity of residues outside the core PBM become 
more critical as reflected in the fact that almost all PBMs interacting with the PDZ3 domain in 
presence of the FID-motif contain an aspartate residue at position -5. Non-surprising, the residues of 
the dmPar3 PDZ3 domain interacting with the FID-motif (Figure 35C, D) are also important for PBM 
recognition (Figure 27) further strengthening the first model.  
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Extensions at the C- and N-termini of PDZ domains have been described previously and can form a 
variety of different interactions with their PDZ domains (Ivarsson 2012; Luck et al. 2012; Ye & Zhang 
2013). PDZ extensions can occur as additional α-helices or β-strands on both termini.  In general, 
those extensions are directly adjacent to the respective PDZ domain or in very close vicinity. 
However, an element which is present more than ten amino acids upstream of the N-terminus of a 
PDZ domain has to my knowledge not been described previously. However, there are elements 
present extending more than ten amino acids from the respective PDZ domain termini such as the 
Crib motif N-terminal of the Par6 PDZ domain (Peterson et al. 2004; Whitney et al. 2011; Whitney et 
al. 2013; Whitney et al. 2016). The Par6 Crib motif forms two additional β-strands in the presence of 
GTP-bound Cdc42 and enhances the affinity of the Par6 PDZ domain for C-terminal ligands such as 
the Crb PBM. However, the FID-motif represents an extension with an inverse effect on the PDZ 
domain affinities compared to the Par6 Crib domain. 
 
The FID-motif is only conserved in fruit flies 
The FID-motif N-terminal of the dmPar3 PDZ3 domain enables the PDZ3 domain to discriminate 
PBMs within its otherwise promiscuous interaction space (Figure 37). Since the interactions of the 
Par3 PDZ3 domain are conserved to some extent between human and Drosophila (Figure 25, Figure 
26) (Renschler et al. 2018) the question arose whether the dmPar3 FID-motif is conserved in 
humans. However, sequence alignments of the linker region between the PDZ2 and PDZ3 domain of 
the vertebrate and invertebrate proteins were not feasible since the linker sequence is not 
conserved. Of note, alignment of several invertebrate Par3 proteins was much more successful 
(Figure 38). However, the dmPar3 FID-motif is only conserved in Drosophila and related species 
whereas the FID-interaction surface is much more conserved on the PDZ3 domain. Interestingly, 
bees and ants possess a very similar motif as fruit flies at the same location inside the Par3 PDZ2-
PDZ3 linker sequence (Figure 38). Therefore, the FID-motif might be a feature the Par3 PDZ3 domain 
acquired late and convergent in the evolution of fruit flies, ants and bees which is consistent with 
the observation of rapid evolution of short linear motifs (Davey et al. 2015). In addition, other Par3 
PDZ3 domains might have similar features which are not visible in sequence alignments due to their 
low conservation. Hence, detailed structural and biophysical analysis of the Par3 PDZ1-3 module is 
crucial to discover these short motifs. 
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Figure 38: Sequence alignment of the Par3 FID-motif. Sequences of invertebrate Par3 proteins were aligned using clustalΩ 
(Sievers et al. 2011) and color coded according to conservation with clustalX (Larkin et al. 2007). The FID-motif (boxed in 
red) is only conserved in a subset of invertebrates closely related to Drosophila melanogaster. Of note, bees and ants 
contain a similar motif N-terminal of the Par3 PDZ3 domain. The secondary structure elements of the N-terminal part of 
the dmPar3 PDZ3 domain are indicated as in Figure 27. The residues interacting with the FID-motif (Figure 35C, D) are 
indicated by purple spheres. 
 
The FID-motif might act as a modulator of the Par3 PDZ3 domain specificity 
Moreover, the dmPar3 FID motif might have a regulatory function similar to known PDZ extensions 
(Ivarsson 2012; Luck et al. 2012; Ye & Zhang 2013). Since the binding of the FID-motif to the PDZ3 
domain of dmPar3 reflects an auto-inhibited state with lowered affinities (Table 7, Figure 37), 
regulation of this inhibited state by post-translational modifications may be a mechanism to release 
auto-inhibition and enable a high affinity state. For example, phosphorylation of adjacent sequences 
may represent such a release mechanism since S612 and S621 are located at both sides of the 
dmPar3 FID-motif (Figure 37C) as well as six serine residues are present between the FID-motif and 
the N-terminus of the PDZ3 domain (Figure 34A). However, further studies have to be performed to 
investigate such regulatory mechanisms as well as the function of the FID-motif in vivo. Interestingly, 
the influence of the dmPar3 FID-motif on the dmPar3 PDZ3 domain specificity seems to almost 
exclusively exclude proteins involved in asymmetric cell division such as Insc or with catalytic activity 
such as aPKC (Figure 37). In contrast, the FID-motif still allows interactions with PBMs involved in 
apical localization such as Shg, Stan, Ed and Crb as well as dmPar6. Thereby, the FID-motif allows to 
fine tune the specificities of the dmPar3 PDZ3 domain. 
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In sum, I have identified here a non-conserved, N-terminal extension of the dmPar3 PDZ3 domain, 
called the FID-motif, which weakens the affinities of the dmPar3 PDZ3 domain for a subset of 
ligands. The FID-motif might be a modulator of the Par3 PDZ domain specificity. However, in depth 
analysis is necessary to investigate the influence of the FID-motif in vivo. 
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5. General Discussion 
The main challenges in characterizing the individual functions of cell polarity proteins and especially 
their individual domains and motifs are functional coupling, redundant interactions, functional 
differences in organism strains, protein constructs (different alleles, isoforms, tags etc.) and paralogs 
used in different studies (Nagai-Tamai et al. 2002; Fievet et al. 2013). Moreover, the developmental 
context as well as the cell type have a severe impact on the composition of cell polarity complexes 
(Henrique & Schweisguth 2003). Lastly, polarity proteins can be part of different complexes within a 
single cell at the same time (Goehring et al. 2011; Rodriguez et al. 2017). Taken together, all these 
points are enormous obstacles for the analysis of protein functions in mutational studies as each 
single point may obscure phenotypes. Therefore, detailed structural studies are essential to 
elucidate the molecular basis of complex formation in cell polarity. Additionally, PDZ domains 
require a free C-terminus to recognize canonical PBMs. Therefore, C-terminal tagging as used in 
some cases for fluorescence microscopy or immunoblotting may abolish PDZ:PBM association and 
thus interfere with discovering other, hitherto unidentified PDZ:PBM interactions. In sum, this may 
be the reason of some of the controversies not only associated with the Par3:Par6 interaction. 
Nevertheless, my coauthors and I have been able to dissect the Par3:Par6 interaction in atomic 
detail and investigate its function in vivo (Renschler et al. 2018). We were able to show that the 
Par3:Par6 interaction relies on the Par6 PBM interacting with the Par3 PDZ1 and PDZ3 domain in 
vitro and that these interactions are conserved between human and fly (Figure 19, Figure 20-Figure 
23, Figure 25). Furthermore we could show that the Par6 PBM can compete with the Par3 PDZ 
domain ligand Shg in vitro (Figure 24). In addition, my coauthors could show that the dmPar6 PBM 
seems to be functional redundant in terms of Par6 localization in vivo (Renschler et al. 2018). Hence, 
out study was able to solve the ambiguities about the details of the Par3:Par6 interaction and show 
the importance of the Par6 PBM in Par6 localization in vivo. 
Interestingly, almost all polarity and cell adhesion proteins contain a PBM or at least one PDZ 
domain. This highlights the importance of PDZ:PBM interactions in cell polarity and cell adhesion 
networks. My work demonstrates the necessity of investigating PDZ domain specificities since 
distinct specificity profiles of the Par3 PDZ1 and PDZ2 domains as well as the promiscuity of PDZ3 
and the influence of the FID-motif were impossible to infer on the sequence level (Figure 27, Figure 
28, Figure 31, Figure 37, Table 5 and Table 7). Hence a thorough investigation of function, specificity 
and redundancy of PDZ domains, as presented here, is essential to dissect their roles in polarity 
protein function and localization.  
Of note, it is worth mentioning that not all interaction partners of the dmPar3 PDZ domains are 
present in the same cellular environment at the same time due to difference in their expression 
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patterns as well as due to their regulation. Therefore, the Par3 PDZ domains have to maintain their 
specificities to multiple PBMs in order to fulfill all functions of Par3 in different developmental and 
cellular contexts (Figure 39). Hence Par3 has to be able to participate in different complexes. 
Nevertheless it is a recurring theme of the Par3 PDZ module to have multivalent interactions with its 
ligands (Figure 39) thereby enabling Par3 to form network-like structures. 
 
Figure 39: Interaction network of the dmPar3 PDZ domains. Approximate subcellular localizations of the Par3 PDZ domain 
interaction partners are shown. The interactions of the Par3 PDZ domains with different PBMs are color according to the 
localization of the binding partners with yellow indicating the Crumbs complex, orange members of the PAR complex, 
green-blue adherens junctions, merlot zonula adherens and green asymmetric cell division. Abbreviations according to 
Figure 2, Figure 3 and Figure 5. 
In addition, recent investigations of the N-terminal oligomerization domain of Par3 highlight the 
importance of Par3 clustering for proper establishment of cell polarity (Harris 2017). Moreover, Par3 
clusters have distinct activities depending on whether they dock to centrosomes or whether they are 
located  at the cell cortex or in assembly scaffolds of adherens junctions, or as part of the PAR 
complex (Harris 2017). Since the Par3 OD mediates Par3 oligomerization, but no other protein-
protein interactions, the recruitment of Par3 interaction partners is mediated by the PDZ domains of 
Par3. My analyses have shown that each individual Par3 PDZ domain possesses its unique but 
redundant binding profile (Figure 28, Figure 31, Table 5) determined by their structures (Figure 29 
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and Figure 30). Of note, the dmPar3 PDZ3 domain possesses overlapping PBM binding specificities 
(Figure 29, Figure 30, Figure 39) and conserved specificity determining residues of PDZ1 and PDZ2 
(Figure 33). Hence the Par3 PDZ domain can be seen as a chimera in regard of PDZ:PBM interactions 
between the PDZ1 and PDZ2 domains. Worth mentioning is the fact that not all tested PBMs are 
present at the same subcellular localization at the same time in every cell type. For example, during 
gastrulation in Drosophila embryos Crb is expressed in late stages (Krahn, Bückers, et al. 2010; Sen et 
al. 2015). However, epitheliogenesis also takes place in the embryo before Crb is expressed. In line 
with that observation, it is known for Par3 and Crb to function redundantly in polarity maintenance 
in mature follicular epithelia cells (Shahab et al. 2015). In contrast, Par3 knockouts have a server 
effect on epithelial morphology during Drosophila development (Shahab et al. 2015). Another 
example is the interaction between Par3 and Insc which takes place during asymmetric cell division 
but not during epitheliogenesis (Lu & Johnston 2013; Culurgioni & Mapelli 2013). Besides different 
expression patterns, post-translational modifications influence the function and localization of 
proteins. As such, the aPKC mediated phosphorylation of Par3 is a well-studied process by which 
Par3 is excluded from the PAR complex at the most apical domain of epithelia cells and enriched on 
adherens junctions (Tepass 2012; Lang & Munro 2017). Hence, the ability of the Par3 PDZ domains 
to interact with different ligands would be necessary to ensure correct Par3 localization and function 
in different complexes in a huge variety of developmental and cellular processes. Therefore, my 
analyses contribute to a better understanding of the function of the Par3 PDZ3 module as a whole 
and of the individual Par3 PDZ domains. Clustering increases the valency of Par3 assemblies as well 
as the ability of Par3 to recruit multiple interaction partners via the individual PDZ domains 
simultaneously. This enables the assembly of Par3 and its interaction partners into cluster with 
liquid-like properties and may enhance the segregation and thereby the polarization process 
(Recouvreux & Lenne 2016; Banani et al. 2017). Furthermore, I could show that the FID-motif folds 
back onto the dmPar3 PDZ3 domain (Figure 35) and enables the PDZ3 domain to discriminate 
between different PBMs ( 
Figure 36 and Table 7). Moreover fine tuning of the Par3 PDZ3 domain affinities as well as the PDZ3 
domain specificities by post-translational modifications of the FID-motif might pose an way to 
carefully adjust these large assemblies (Banani et al. 2017) (Figure 37 and Figure 39). Nevertheless, 
in vivo investigations addressing this hypothesis are necessary to fully understand the function of the 
Par3 FID-motif. 
Finally, this study will help to understand the underlying principles of the Par3 interaction networks 
that establish, maintain and disrupt cell polarity and therefore are essential for development and 
carcinogenic processes.  
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6. Materials 
6.1 Equipment 
Table 8: Equipment 
Instrument Manufacturer 
37 °C plate incubator Hereaus 
37 °C shaker incubator, HT Multitron Standard and HT Ecotron Infors 
Acculab-balance Sartorius 
Advanced Primus 25 Thermocycler Peqlab 
Advanced Primus 96 Thermocycler Peqlab 
Agarose gel chamber, HE 99X Amersham Biosciences 
Avance AVIII (600 MHz) spectrometer Bruker 
Avance AVIII (800 MHz) spectrometer Bruker 
Avanti J-26 XP centrifuge Beckmann Coulter 
Bio-5000 Scanner Microtek 
Centrifuge 5424 + 5417C Eppendorf 
Centrifuge bucket, 1 L Beckmann Coulter 
Centrifuge bucket, 50 mL Beckmann Coulter 
Digital Sonifier 450 Branson 
DNA sequencer (3730XL) Applied Biosystems 
dragonfly ttp labtech 
E-Box 1000/26M system Vilbert Lormat 
Electrophoresis power supply, EP 301 GE Healthcare 
EmulsiFlex-C3 AVESTIN, Inc. 
FPLC Äkta prime plus GE Healthcare 
FPLC NGC BioRad 
freezer (-20 °C) Liebherr 
freezer (-80 °C) Liebherr 
French press Emulsiflex-C3 Avestin 
Gyro-Rocker SSL3 Stuart 
Heating block VWR 
HERAEUS multifuge 3SRü centrifuge Thermo Scientific 
Hi Load 16/600, Superdex 75, preg grade (120 ml) GE Healthcare 
Hi Load 26/600, Superdex 75, preg grade (320 ml) GE Healthcare 
HisTrap HP, 1 x 1 ml GE Healthcare 
HisTrap HP, 1 x 5 ml GE Healthcare 
HiTrap Q HP GE Healthcare 
HiTrap SP HP GE Healthcare 
JA-25.50 rotor Beckmann Coulter 
JLA-8.100 rotor Beckmann Coulter 
Light box prolite Basic 2 Kaiser 
Magnetic stirrer, MR hei-Mix L and MR Hei-Mix S Heidolph 
Microwave Bosch 
Mighty small II gel caster GE Healthcare 
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NanodropTM 100 spectrometer Thermo Scientific 
PD-10 Desalting Columns GE Healthcare 
Peristaltic Pump P1 GE Healthcare 
pH meter HI 2221 HANNA Industries 
Photometer, bio photometer plus Eppendorf 
Pipetman neo P1000, P200, P100, P20, P10, P2 Gilson 
Precision balance 440-47N Kern 
SDS-PAGE unit, SE 250 Amersham Biosciences 
Sonoplus sonifier Bandelin 
Thermomixer comfort Eppendorf 
Vortex Genie 2 Scientific Industries 
 
6.2 Chemicals and consumables 
Table 9: Chemicals 
Chemical Supplier 
13C-D-Glucose (99%) Sigma-Aldrich 
2H,12C-D-Glucose (99%) Sigma-Aldrich 
Acrylamide-bis solution (29:1), 40 % (w/v) Roth 
Agarose Sigma-Aldrich 
Ammonium chloride Alfa Aesar 
Ammonium chloride (15NH4Cl) Sigma-Aldrich 
Ammonium persulfate (APS) AppliChem 
Ampicillin sodium salt Roth 
BigDye Terminator v3.1 Sequencing reagents ABI 
Biotin Roth 
Boric acid Sigma-Aldrich 
Bradford protein assay reagent (5x) Serva 
Bromophenol blue 0.04 % (w/v) Alfa-Aesar 
Calcium chloride (CaCl2 x 2 H2O) Merck 
Chloramphenicol Sigma-Aldrich 
Cobalt chloride (CoCl2 x 6 H2O) Sigma-Aldrich 
Coomassie Brilliant Blue G250 Fisher Scientific 
Copper (II) chloride Alfa Aesar 
Copper (II) sulfate (CuSO4 x 5 H2O) VWR 
D2O Sigma-Aldrich 
D-Glucose Baker 
Disodium  hydrogen phosphae (Na2HPO4) Merck 
Dithiothreitol (DTT) Enzo Life Science 
DNA loading dye (6x) Thermo Scientific 
dNTPs Thermo Scientific 
EDTA disodium salt Promega 
Ethanol Sigma-Aldrich 
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Gene ruler 100bp DNA ladder Fermentas 
Gene ruler 1kbp DNA ladder Fermentas 
Glycerol Roth 
GSH (reduced) Sigma-Aldrich 
HEPES Roth 
Hydrochloric acid (HCl), 6M Roth 
Imidazole Roth 
IPTG (Isopropyl β-D-1-thiogalactopyranoside) Roth 
Iron (III) chloride (FeCl3 x 6 H2O) Alfa Aesar 
Kanamycin sulfate Roth 
L-Arginine SAFC 
L-Methionine (methyl-labeled) CIL 
Magnesium chloride Acros Organics 
Manganese (II) sulfate (MnSO4 x 4 H2O) VWR 
MOPS Sigma-Aldrich 
N,N,N‘,N‘,-tetramethylethylenediamine (TEMED) Sigma-Aldrich 
Ni2+-NTA-agarose beads Quiagen 
PageRuler prestained protein ladder Thermo Scientific 
Potassium phosphate, monobasic (KH2PO4) CalBiochem 
Protino® Glutathione Agarose 4B Macherey-Nagel 
Rotiphorese® 50x TAE buffer Roth 
SafeView nucleic acid stain Applied biological materials Inc. 
SDS, 20 % (w/v) solution AppliChem 
SDS-PAGE buffer 10x (Tris, glycine, SDS) National Diagnostics 
Sodium azide (NaN3) Sigma-Aldrich 
Sodium chloride (NaCl) Merck 
Sodium dihydrogen phosphate monohydrate Merck 
Sodium hydroxide 10N (NaOH) Alfa-Aesar 
Sodium L-glutamate monohydrate Merck 
TEMED (N,N,N',N'-tetramethylethylene diammine) Sigma-Aldrich 
Thiamine hydrochloride Sigma-Aldrich 
Tris-HCl Roth 
Triton X-100 Sigma-Aldrich 
Zinc sulfate (ZnSO4 x 7 H2O) VWR 
 
Table 10: Enzymes 
Enzyme Vendor 
DNaseI Appli Chem 
DpnI NEB 
Kapa Polymerase Roche 
Lysozyme (fromm henn egg white) Fluka 
Tobacco etch virus (TEV) protease own production 
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Table 11: Consumables 
Product Manufacturer 
5 mm NMR tubes Norell 
96 well plate Greiner 
96-3 low profile INTELLI-PLATE® Art Robbins Instruments 
Concentrator Vivaspin 20 Sartorius 
Cuvettes (plastic) Roth 
Dialysis membrane, MWCO 3500 Spectrum Laboratories 
Falcon tubes (14 mL and 50 mL) Greiner 
Inoculation loop Greiner 
Inoculation spreader Sarstedt 
Membrane filters Millipore 
NucleoSpin® Gel and PCR Clean-up Machery-Nagel 
NucleoSpin® Plasmid EasyPure Machery-Nagel 
Parafilm Pechney 
Pasteur piptes Willmad Lab Glass 
PCR plastic tubes Greiner 
Pipet tips Greiner 
Pipets (single use, sterile) Simport 
Plastic cups (1.5 mL and 2 mL) Eppendorf 
Plastic cups (1.5 mL capless) Fisher Scientific 
Snap cap inoculation tubes Simport 
Syringe filter (0.22 µm, 0.45 µm) Millex 
Syringes (6, 20 and 60 mL) Fisher Scientific 
UV cuvettes (plastic) Eppendorf 
Vacuum sterile filter Millipore 
 
6.3 Buffers and media 
Table 12: Buffer and media composition 
Buffer Ingredients 
Agarose (1 %) stock 
solution 
5 g of agarose is dissolved in 500 mL heated 1x Rotiphorese TAE-
buffer and stored at 65 °C 
Ampicillin (1,000x) 2.5 g / 25 mL H2O (100 mg/mL) 
APS (10 %) 1 g / 10 mL (0.1 g/mL) 
Biotin (1,000x) 20 mg / 20 mL H2O (1 mg/mL; add some 1M NaOH to dissolve) 
Chloramphenicol (1,000x) 0.85 g / 25 mL pure EtOH (34 mg/mL) 
Coomassie stain solution 0.5 g Coomassie Brilliant Blue G250 (0.025%) in 30 mM HCl, 10% 
EtOH 
crystallization buffer 20 mM HEPES pH 7.5, 150 mM NaCl, 1 mM DTT 
DTT (1 M) 3.1 g DTT / 20 mL (155 mg/mL) 
DTT (5 M) 7.7 g DTT / 10 mL (770 mg/mL) 
EDTA pH 8.0 (100 mM) 37.22 g/L, pH 8,0 
elution buffer lysis buffer with 333 mM Imidazol 
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HEPES pH 8.0 (1 M) 238.3 g HEPES in 1L H2O, adjust pH 
Imidazole (1 M) 68.08 g Imidazole / 1000 mL 
IPTG (1 M) 4.8 g / 20 mL (240 mg/mL) 
Kanamycin (1,000x) 1.25 g / 25 mL H2O (50 mg/mL) 
LB 10 g bactotryptone, 5 g yeast extract, 10 g NaCl in 1 l of H2O, pH 
7.4, autoclaved 
LB-Agar 5 g bactotryptione, 2.5 g yeast extract, 5 g NaCl, 7.5 g agar (1.5 
%) in 500 ml H2O, pH 7.4, autoclaved 
lysis buffer NaP buffer with 10 mM Imidazol, 1 mM DTT, pH 7.5 
lysis buffer + lysis buffer with Lysozyme, RNAse, Triton X-100 
lysis buffer EDTA NaP buffer with 10 mM Imidazol, 1 mM DTT, 0.5 mM EDTA, pH 
7.5 
M9 (10x) 60 g Na2HPO4, 28.6 g KH2PO4, 5g NaCl dissolved in 1 L H2O, pH 
7.4 
M9 (1x, D2O) 1 L D2O, 6 g Na2HPO4, 2.86 g KH2PO4, 0.5 g NH4CL (unlabelled or 
15N), pH 7.4, 4 g glucose unlabelled or 2 g glucose labelled (1H,13C 
or 2H,13C or 2H,12C), 1 mL trace elements (1,000x), 0.1 mL trace 
elements (10,000x), 1 mL MgSO4 (1M), 1 mL biotin (1000x), 1 mL 
thiamine (1000x), 1 mL of each antibiotic (1000x), 0.3 mL CaCl2 
(1M) 
M9 (1x, H2O) 100 mL M9 (10x) in 1 L of H2O, pH 7.4, 0.5 g NH4CL (unlabelled or 
15N), 4 g glucose unlabelled or 2 g glucose labelled (1H,13C or 
2H,13C or 2H,12C), 1 mL trace elements (1,000x), 0.1 mL trace 
elements (10,000x), 1 mL MgSO4 (1M), 1 mL biotin (1000x), 1 mL 
thiamine (1000x), 1 mL of each antibiotic (1000x), 0.3 mL CaCl2 
(1M) 
MOPS pH 7.5 (1 M) 209.26 g MOPS in 1 L H2O, adjust pH 
NaP (10x) 87.6 g/L NaCl, 71 g/L Na2HPO4, pH 7.1 
NaP (1x) 50 mM NaP, 150 mM NaCl, pH 7.5 
NMR 20 mM NaP, 150 mM NaCl, pH 7.5 or 6.5, 1-2 mM DTT, (0.5 mM 
EDTA), (0.02 % NaN3) 
nonreducing SDS loading 
buffer (5x) 
3 mL Tris-HCl (1 M, pH 6.8), 2.5 mL glyercol (25 % final), 4.5 mL 
20% SDS, 1 mg bromophenol blue (0,01% final) 
PD 50 mM NaP pH 7.5, 150 mM NaCl, 10% glycerol, 2 mM DTT 
Q high salt 20 mM bis-Tris pH 7, 1000 mM NaCl, 1 mM DTT 
Q low salt 20 mM bis-Tris pH 7, 10 mM NaCl, 1 mM DTT 
reducing SDS loading 
buffer (5x) 
3 mL Tris-HCl (1 M, pH 6.8), 2.5 mL glyercol (25 % final), 4.5 mL 
20% SDS, 1 mg bromophenol blue (0,01% final), 1 mL of DTT (5 
M final) 
SP high salt 20 mM HEPES pH 7.5, 1000 mM NaCl, 1 mM DTT 
SP low salt 20 mM HEPES pH 7.5, 10 mM NaCl, 1 mM DTT 
Thiamine (1000x) 20 mg / 20 mL H2O (1 mg/mL) 
Trace elements (1,000x) 5 g EDTA in 100 mL H2O (adjust to pH 7.5); 0.833 g FeCl3 x 6 H2O, 
84 mg ZnCl2, 13 mg CuCl2 x 2 H2O, 10 mg CoCl2 x 6 H2O, 10 mg 
H3BO3 
Trace elements (10,000x) 3.37 g CuSO4 x 5 H2O, 3.0 g MnCl2 x 4 H2O, 0.43 g ZnSO4 x 7 H2O, 
0.5 CoCl2 x 6 H2O in 100 mL H2O 
Tris-HCl pH 6.8 (1 M) 60.5 g Tris-HCl in 500 mL H2O, pH 6.8 
Tris-HCl pH 8.0 (1 M) 121 g Tris-HCl in 1 L H2O, pH 8 
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Tris-HCl pH 8.8 (1.5 M) 90.75 g Tris-HCl in 500 mL H2O, pH 8.8 
XTAL 20 mM HEPES pH 7.5, 150 mM NaCl, 1 mM DTT 
 
6.4 Protein expression constructs 
Table 13: Protein expression constructs 
protein domain # aa # aa NMR/  
X-ray construct 
expression tag  
(cleavage) 
vector 
Chlamydia trachomatis 
GST  
(A0A0E9AVJ1) 
N-terminal domain 1-217  His6 (no) … HA 
(no) 
pET M30-HA 
D. melanogaster 
aPKC  
(FBgn0261854) 
PBM 599-606 -7 - 0 His6-GB1 (no) pRT Duet 
Crb  
(FBgn0259685) 
PBM 2246-2253 -7 - 0 His6-GB1 (no) pRT Duet 
Ed  
(FBgn0000547) 
PBM 1315-1322 -7 - 0 His6-GB1 (no) pRT Duet 
Insc  
(FBgn0011674) 
PBM 852-859 -7 - 0 His6-GB1 (no) pRT Duet 
Par3  
(FBpp0110299) 
FID-motif 610-620  His6-GB1 (no) pRT Duet 
PDZ1 330-419 5-94 His6-MBP (yes) pET M41 
PDZ2 459-553 5-99 His6-MBP (yes) pET M41 
PDZ3 634-760   His6-MBP (yes) pET M41 
PDZ3  Δβ2-3loop 634-666, 686-760 2-109 His6-MBP (yes) pET M41 
linker-PDZ3  Δβ2-3loop 554-666, 686-760  His6-GST (yes) pET M30 
linkerΔI-PDZ3  Δβ2-3loop 590-666, 686-760  His6-GST (yes) pET M30 
linkerΔII-PDZ3  Δβ2-3loop 610-666, 686-760  His6-GST (yes) pET M30 
linkerΔIII-PDZ3  Δβ2-3loop 618-666, 686-760  His6-GST (yes) pET M30 
linkerΔFID-PDZ3  Δβ2-3loop 554-609,634-666, 686-760  His6-GST (yes) pET M30 
PDZ1-3 330-760  His6-GST-HA (no) pET M30-HA 
PDZ1-3  Δβ2-3loop 330-666, 686-760  His6-GST (yes) pET M30 
Par3-Par6 PDZ1:PBM fusion 330-419, 344-351 5-94, -7 - 0 His6-MBP (yes) pET M41 
Par3-Shg PDZ1:PBM fusion 330-419,  5-94, -7 - 0 His6-MBP (yes) pET M41 
Par3-Insc PDZ2:PBM fusion 459-553 5-99, -7 - 0 His6-MBP (yes) pET M41 
Par6  
(FBpp0074229) 
Full length 1-351  His6-Sumo (no) pET M11 Sumo 
ΔPBM 1-343  His6-Sumo (no) pET M11 Sumo 
PB1-Crib 1-255  His6-Sumo (no) pET M11 Sumo 
PB1-CribPDZ 1-155  His6-Sumo (no) pET M11 Sumo 
PBM 344-351 -7 - 0 His6-GB1 (no) pRT Duet 
PBM L349A 344-351 -7 - 0 His6-GB1 (no) pRT Duet 
PBM H350A 344-351 -7 - 0 His6-GB1 (no) pRT Duet 
PBM L351A 344-351 -7 - 0 His6-GB1 (no) pRT Duet 
PDZ 155-255  His6-MBP (yes) pET M41 
Crib-PDZ 139-255  His6-MBP (yes) pET M41 
Shg  
(FBgn0003391) 
PBM 1500-1507 -7 - 0 His6-GB1 (no) pRT Duet 
Smash  
(Dmel_CG43427) 
PBM 1526-1533 -7 - 0 His6-GB1 (no) pRT Duet 
Std  
(FBgn0261873) 
PBM 13-23 -8 - 1 His6-GB1 (no) pRT Duet 
Stan  
(FBgn0024836) 
PBM 3542-3549 -7 - 0 His6-GB1 (no) pRT Duet 
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α-cat  
(FBgn0010215) 
PBM 900-907 -7 - 0 His6-GB1 (no) pRT Duet 
H. sapiens 
Par3  
(NP_001171714) 
PDZ1 246-364 4-122 His6-GST (yes) pET M30 
PDZ2 457-549 4-96 His6-GST (yes) pET M30 
PDZ3 583-685 5-107 His6-GST (yes) pET M30 
Par3-Par6a PDZ1:PBM fusion 246-364, 339-346 4-122, -7 - 0 His6-GST (yes) pET M30 
Par6a  
(NP_058644) 
PBM 339-346 -7 - 0 His6-GB1 (no) pRT Duet 
S. cerevisiae 
Sumo  
(Q12306) 
FL 1-105  His6 (no) pET M11 Sumo 
Streptococcus sp. group G 
protein G  
(P19909) 
B1 F353Y K358E 304-358  His6 (no) pRT Duet 
 
6.5 Primers 
Table 14: Primers 
construct primer name sequence 
dmPar3 linkerΔFID-
PDZ3 Δβ2-3loop 
FR98_Baz_linker-NII_fw CTCATCAGCAGCAATCGCAGCTCAACAGTTGGCACTCCCGCGAG 
FR98_Baz_linker-NII_rv CGCGGGAGTGCCAACTGTTGAGCTGCGATTGCTGCTGATG 
dmPar3 linkerΔIII-
PDZ3 Δβ2-3loop 
FR99_Baz_delNII_1_fw CTTTATTTTCAGGGCGCCATGGGCGCGGGCAGCGAGTCGGC 
FR99_Baz_delNII_1_rv GCCGACTCGCTGCCCGCGCCCATGGCGCCCTGAAAATAAAG 
dmPar3 linkerΔII-
PDZ3 Δβ2-3loop 
FR88_Baz_PDZ3+N_I_fw CTTTATTTTCAGGGCGCCATGGGCAACGAATCTCAGCACTTTATTGATGCGG 
FR88_Baz_PDZ3+N_I_rv CCGCATCAATAAAGTGCTGAGATTCGTTGCCCATGGCGCCCTGAAAATAAAG 
dmPar3 linkerΔI-
PDZ3 Δβ2-3loop 
FR89_Baz_PDZ3+N_II_fw CTTTATTTTCAGGGCGCCATGGGCCCGGTACAAAAATCCAGCAGCGC 
FR89_Baz_PDZ3+N_II_rv GCGCTGCTGGATTTTTGTACCGGGCCCATGGCGCCCTGAAAATAAAG 
GB1-Crb PBM FR93_GB1-Crb_fw GAAGAAAACCTGTATTTTCAGGGAAAACCGCCTCCGGAAGAACGCCTGATTTA
AACCGGCTTTCTGACCGAATAT 
FR93_GB1-Crb_fv ATATTCGGTCAGAAAGCCGGTTTAAATCAGGCGTTCTTCCGGAGGCGGTTTTC
CCTGAAAATACAGGTTTTCTTC 
GB1-dmPar3 FID-
motif 
FR120_GB1-dmPar3_linker_fw CAGAAGAAAACCTGTATTTTCAGGGAAGCGGCAACGAATCTCAGCACTTTATT
GATGCGGGCAGCTAAGATCCGGATCATGATCATACCG 
FR120_GB1-dmPar3_linker_rc CGGTATGATCATGATCCGGATCTTAGCTGCCCGCATCAATAAAGTGCTGAGAT
TCGTTGCCGCTTCCCTGAAAATACAGGTTTTCTTCTG 
GB1-hsPar6α PBM FR32_GB1-hPar6a_fw GAAAACCTGTATTTTCAGGGAGGCGATGGCAGCGGCTTTAGCCTGTAACGGTA
AAACCCTGAAAGG 
FR32_GB1-hPar6a_rv CCTTTCAGGGTTTTACCGTTACAGGCTAAAGCCGCTGCCATCGCCTCCCTGAA
AATACAGGTTTTC 
GB1-Smash PBM FR65_GB1-unchar_fw GAAGAAAACCTGTATTTTCAGGGAGATGGCATTAAATTTAGCTGCGTGTAACG
GTAAAACCCTGAAAGGTG 
FR65_GB1-unchar_rv CACCTTTCAGGGTTTTACCGTTACACGCAGCTAAATTTAATGCCATCTCCCTG
AAAATACAGGTTTTCTTC 
GB1-Stan PBM FR95_GB1-Stan_fw GAAGAAAACCTGTATTTTCAGGGAATTGATGATGACGAAACCACGGTGTAAAC
CGGCTTTCTGACCGAATAT 
FR95_GB1-Stan_rv ATATTCGGTCAGAAAGCCGGTTTACACCGTGGTTTCGTCATCATCAATTCCCT
GAAAATACAGGTTTTCTTC 
GB1-Std PBM FR94_GB1-Std_fw GAAGAAAACCTGTATTTTCAGGGACCACACCGTGAGATGGCCGTCGATTGTCC
GGACAGTGGATCTGGTTAAACCGGCTTTCTGACCGAATAT 
FR94_GB1-Std_rv ATATTCGGTCAGAAAGCCGGTTTAACCAGATCCACTGTCCGGACAATCGACGG
CCATCTCACGGTGTGGTCCCTGAAAATACAGGTTTTCTTC 
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7. Methods 
7.1 Molecular biology 
7.1.1 Agarose gel electrophoresis 
Deoxyribonucleic nucleic acid polymers can be easily separated by their length by agarose gel 
electrophoresis no matter whether they are linear fragments such as PCR products or circular such 
as plasmids. Since their intrinsic negative charge of the phosphate deoxyribose backbone, they move 
towards the cathode in an electric field. Within a mesh like environment of agarose gels, this fact can 
be employed to separate different sized molecules due to the faster migration of smaller fragments. 
A 1% (w/v) Agarose solution is pepared with 1x TAE Buffer (Table 12) and 50 mL are mixed with 2 μL 
of SyberGreen™ dye and cast. Agarose gels are run at 175 V for 14-18 min in 1x TAE buffer. 
 
7.1.2 Heat shock transformation of chemical competent E.coli cells 
Transformation describes the process by which bacteria take up foreign DNA either spontaneously 
or enhanced via certain methods. Any method is based on the perforation of the bacterial 
membrane by liposomes or by mechanical forces generated by an electric discharge, ultrasonic 
sound, or a short heat shock. The perforated membrane allows DNA to diffuse into the cells. The 
affinity of bacterial membranes for DNA can be enhanced by chemicals i.e. Ca2+-ions and by 
incubation of the bacteria with DNA prior to transformation. 
1 μL of purified plasmid DNA (~ 100 ng/ μL) or 5 μL of a ligation reaction, QC PCR or RF cloning PCR 
are added to 50 μL chemical competent cells and incubated 5 min on ice. Cells are heat shocked for 
1 min at 42°C. Cells are transferred immediately afterwards on ice and 500 μL LB medium (Table 12) 
are added. Cells are incubated for recovery for 30 min (purified plasmid DNA) or 90 min (ligation, QC, 
RF) at 37°C shaking at low rpm in order to allow expression of antibiotic resistance genes. After 
recovery, cells are plated on LB agar plates with the respective selection markers (Table 12) and 
incubated o/n at 37°C. 
 
7.1.3 PCR based methods 
The polymerase chain reaction (PCR) is used to amplify DNA fragments. To this end, a heat stable 
DNA polymerase, short DNA primers complementary to sequences at both ends of the DNA 
fragment and deoxy nucleotides (dNTPs) are added to a DNA template. By cycling the temperature, a 
series of steps are permutated which lead to an amplification of the template DNA. First, the DNA 
double helix is denatured with high temperatures around 95-98°C. Next, the temperature is 
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decreased to the annealing temperature of the primer (Table 14). The annealing temperature Tm is 
the temperature at which the primer binds specifically to is complementary sequence and can be 
calculated e.g. according to (Wallace et al. 1979; Green & Sambrook 2012): 
Equation 13: 
𝑇𝑚 = 64.9 +
41 × (𝑦𝐺 + 𝑧𝐶 − 16.4)
(𝑤𝐴 + 𝑥𝑇 + 𝑦𝐺 + 𝑧𝐶)
 
Where wA, xT, yG and zC are the number of bases of A, T, G anc C, respectively. Last, the 
temperature is increased to 72°C to allow the polymerase to elongate the primer at its temperature 
optimum. Finally, the cycle is repeated again. Since the product of the previous cycle is another 
template for the subsequent cycle, in general an exponential amplification of DNA is achieved. 
 
7.1.3.1 QuickChange™ mutagenesis 
The QuickChange (QC) Kit developed by Stratagene is a technique to introduce site specific 
mutations into a DNA sequence. QC reaction parameters are given in Table 15 and Table 16. 
 
Table 15: QC reaction 
Amount/ Volume  
25 ng target vector 
2.5 μL 10 μM Mix of fwd and rev Primers 
5 μL 5x High GC Kapa Buffer 
1 μL Kapa dNTP Mix 
0.5 μL Kapa HiFi Polymerase 
Adjust volume to 25 μL with sterile H2O 
 
Table 16: QC and RF reaction parameters 
Temperature Duration Step No of cycles 
98°C 3 min initialization  
98°C 30 sec denaturing 
20-25 X* °C 15 sec annealing 
72°C ** elongation 
72°C 10 min final elongation  
4°C forever storage  
* calculated according to Equation 13, ** calculated according to an extension rate of 2kb/ min 
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7.1.3.2 Restriction free cloning 
Cloning without the need of restriction sites and restriction enzymes is possible with restriction free 
(RF) cloning (van den Ent & Löwe 2006). RF cloning is a PCR based cloning approach. In short, a PCR 
product or any other linear double stranded DNA fragment encoding the gene of interest and 
flanked by priming regions complementary to the target vector insertion site is inserted into the 
target vector. In a linear amplification reaction, the DNA fragment acts as a primer for the 
amplification of the target vector. This leads to a nicked product with the gene of interest 
incorporated site specific into the target vector. Since the parental target vector is methylated, 
digestion with DpnI, a DNase specific for methylated DNA, degrades the parental target vector. 
Subsequently, the nicked product is transformed into a suitable host and can be used further. 
Inserts larger than 120 nt have to be PCR amplified. The primers used (Table 12) are designed 
according to the following specifications. The 5’ (forward) primer included ~25 bp overlapping with 
the sequence upstream of the target vector insertion site followed by ~25 bp of the gene of interest 
whereas the 3’ (reverse) primer was designed in a reversed order having ~25 bp of the antisense 
strand of the gene of interest at its 5’ end followed by ~25 bp of the antisense strand of the target 
vector insertion site. It is advisable to have some nucleotides in between the two insertion site of the 
target vector to reduce sterical hindrance. Additionally, care of reading frames present in the target 
sequence has to be taken in order to avoid frame shift mutations. Insert DNA was amplified by a PCR 
with a proofreading polymerase, analyzed by agarose gel electrophoresis, purified and served as 
“primers” for the subsequent RF cloning reaction. Inserts smaller than 120 nt can be synthesized by 
solid phase synthesis. However, the annealing sequences were designed according to the annealing 
sequences of longer inserts. 
The final RF cloning reaction is described in Table 17 with the reaction parameters in Table 16. After 
addition of 0.5 μL DpnI and incubation for 30 min at 37°C, RF cloning products are analyzed by 
agarose gel electrophoresis. Successful reactions are transformed into DH5α cells and plated on LB-
agar plates with appropriate antibiotics for selection. 
Table 17: RF cloning reaction 
Amount/ Volume  
25 ng target vector 
150 ng forward primer (alternatively, double-stranded PCR product for large inserts) 
150 ng reverse primer (not necessary if working with large inserts) 
5 μL 5x High GC Kapa Buffer 
1 μL Kapa dNTP Mix 
0.5 μL Kapa HiFi Polymerase 
Adjust volume to 25 μL with sterile H2O 
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7.1.4 DNA purification 
DNA is purified with the NucleoSpin® Gel and PCR Clean-up Kit (Machery-Nagel) according to the 
manufacturer’s instructions. 
 
7.1.5 Isolation of plasmid DNA 
Plasmids are small circular DNA fragments encoding genes outside the bacterial genome. In nature, 
they usually contain resistance genes and can be transferred between different bacterial cells. These 
attributes make them a great tool for genetic manipulation of bacteria cells since plasmids can be 
modified according to the needs of the experimenter by molecular methods. 
E.coli DH5α cells transformed with the desired plasmid were grown o/n at 37°C in 8 ml of LB medium 
(Table 12) supplemented with the respective selection marker. Cells were harvested at 4000 rpm 
(HERAEUS Multifuge 3SR+) at room temperature for 10 min and the supernatant was discarded. DNA 
was purified with the NucleoSpin® Plasmid EasyPure PCR Kit (Machery-Nagel) according to the 
manufacturer’s instructions. 
 
7.1.6 DNA sequencing 
The dideoxy method for DNA sequencing was invented by Sanger (Sanger et al. 1977). In short, 
dideoxy nucleotides (ddNTPs) fluorescently labeled according to their base as well as deoxy 
nucleotides (dNTPs) are added to a PCR mix. If a labeled ddNTP is incorporated by the polymerase 
instead of a dNTP, chain elongation is terminated and results in a fluorescently labeled DNA strand 
according to the last base incorporated at the 3’-end. The resulting mixture of differently sized and 
labeled DNA strands can be separated by HPLC and the 3’-base can be analyzed by fluorescent read 
out giving a chromatogram which represents the sequence of the template DNA. 
Standard sequencing primers can be found in Table 18 and reaction set up in Table 19 and Table 20. 
 
Table 18: Standard sequencing primer 
Primer Sequence annealing region direction Plasmid 
T7 terminator GCTAGTTATTGCTCAGCGG T7 terminator 3' to 5' pET M30, pET M30 HA pET 
M41, pRT Duet 
T7 promotor TAATACGACTCACTATAGGG T7 promotor 5' to 3' pET M30, pET M41 
GST fw GGGCTGGCAAGCCACGTTTGGTG C-terminus of GST 5' to 3' pET M30, pET M30 HA 
MBP fw CGTCAGACTGTCGATGAAG C-terminus of MBP 5' to 3' pET M41 
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Table 19: Sequencing PCR 
Amount/ Volume  
100 - 200 ng plasmid DNA 
1 μL 10 μM sequencing primer 
0.5 μL BDT mix 
2 μL 5x sequencing buffer 
Adjust volume to 10 μL with sterile H2O 
 
Table 20: Sequencing PCR parameters 
Temperature Duration Step No of cycles 
96°C 20 sec initialization  
96°C 20 sec denaturing 
30 50°C 10 sec annealing 
60°C 4 min elongation 
60°C 10 min final elongation  
4°C forever storage  
 
7.2 Protein biochemistry 
7.2.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
Each protein has its unique sequence and all physical properties can be derived from this sequence. 
One of those properties is the molecular weight (MW) which can be calculated as the sum of all 
MWs of all amino acids in the sequence of a protein. SDS-PAGE is one method to separate proteins 
according to their MW. To this end, the proteins are denatured by SDS in the loading buffer which 
forms a negatively charged complex with the proteins. Next, the sample is loaded on a 
polyacrylamide gel and a current is applied across the gel. The negative charged protein-SDS 
complexes will move towards the cathode of the electric field. During this movement, large protein-
SDS complexes will move slower than small ones since large protein-SDS complexes are retained 
more by the polyacrylamide gel. Thus, differently sized proteins are separated. If marker proteins 
with known MW are run on the same gel, the MW of the proteins inside the sample can be 
estimated. 
SDS-polyacrylamide gels are cast according to Table 12, Table 21 and Table 22 and run at 180 – 220 
V. Gels are stained with Coomassie for protein detection. 
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Table 21: Gel recipe for polyacrylamide separating gels. 
Gel percentage (separation range) 8% (30 - 250 kD) 12% (14 - 150 kD) 16% (5 - 70 kD) 
40% acrylamide (29:1) 14 mL 21 mL 28 mL 
H2O 37.5 mL 30.5 mL 23.5 mL 
1.5M Tris-HCl pH 8.8 (0.375 M) 17.5 mL 
20% SDS (0.1%) 0.35 mL 
10% APS (0.1%) 0.35 mL 
TEMED (0.5 uL / mL) 35 µL 
 
Table 22: Gel reipe for polyacrylamide stacking gel. 
 4% 
40% acrylamide (29:1) 3.5 mL 
H2O 26.5 mL 
1.0M Tris-HCl pH 6.8 (0.125M) 4.35 mL 
20% SDS (0.1%) 0.175 mL 
10% APS (0.1%) 0.175 mL 
 
7.2.2 Coomassie staining 
Coomassie Brilliant Blue G250 is a bright blue dye which interacts with proteins in a nonspecific 
manner via hydrophobic interactions. Therefore, Commassie can be used to detect proteins which 
have been separated by SDS-PAGE. 
Rinse gel three times in water and boil it in the microwave. Rinse again with water and cover the gel 
with Coomassie staining solution (Table 12 and Table 23). Boil gel in staining solution and incubate 5 
min shaking. Replace staining solution with water for destaining. 
Table 23: Coomassie staining solution 
Amount/ Volume  
Coomassie Brilliant Blue G250 0.8g 
Ethanol 100 mL 
H2O 900 mL 
6 M HCl 5 mL 
stir o/n  
 
7.2.3 Pull down assays 
The interactions of two different proteins can be probed via pull down assays. To this end, one 
binding partner is immobilized via an affinity tag at Sepharose beads. The other binding partner is 
then incubated with those beads. If both proteins interact, the binding partner not immobilized 
should be detectable after several washing steps in the eluted fraction. 
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First, a 1:1 slurry of glutathione beads (Macherey-Nagel) in PD buffer (Table 12) is prepared. Next, 
0.27 nmol of N-terminal His6-GST-HA-tagged dmPar3 PDZ1-3 or His6-GST-HA in PD buffer as well as 
16.2 nmol of His6-GST-SUMO-dmPar6 variants (see Figure 20A for details) are added and the volume 
is adjusted to 250 μL. After incubation for 60 minutes at 4°C, unbound proteins are removed by four 
washing steps. Each washing steps consists of centrifugation of the beads for 90 sec at 1500 g at 4°C 
and subsequent buffer exchange to 200 μL fresh PD buffer. Finally, bound proteins are eluted with 
PD buffer supplemented with 25 mM reduced GSH for 60 minutes at 4°C and precipitated with 10% 
(w/v) TCA for 30 minutes on ice. Precipitated proteins are pelleted by centrifugation (20 min, 20000 
g, 4°C) and resuspended in 20 μL SDS loading buffer, resolved by SDS-PAGE and detected by 
Coomassie staining for analysis. 
 
7.2.4 Recombinant protein expression 
Structural biology methods such as X-ray crystallography and NMR spectroscopy usually require vast 
amounts of pure protein. The method of choice to produce those high amounts is the 
overexpression of proteins recombinant in bacteria cells such as E.coli with subsequent purification 
steps. 
 
7.2.4.1 Unlabeled protein expression 
50 ml LB supplemented with the respective antibiotics (Table 12) are inoculated with E.coli BL21-
CodonPlus (DE3)-RIL cells carrying the desired protein expression construct (Table 13) and incubate 
o/n at 37 °C. The next morning, 500 mL LB supplemented with the respective antibiotics are 
inoculated with the o/n preculture at an OD600 of 0.2 – 0.3. The suspension culture is expanded at 
37 °C until the desired volume (usually 2 L for GB1-fusion constructs) is reached with an OD600 of 
0.8 – 0.9. At this point, the culture is shifted to 20 °C. After temperature equilibration (30 – 60 min) 
protein expression is induced by the addition of IPTG (0.5 – 1 mM final concentration) for 16 h. Cells 
are harvested by centrifugation (6000 g, 10 min, 4°C) and cell pellets are stored at -20°C until use. 
 
7.2.4.2 Isotope labeling 
NMR studies require the labeling of the protein to be investigated with specific isotopes such as 15N 
and 13C (Table 3). To this end, recombinant proteins are expressed in minimal media containing 
bioavailable forms of the isotopes such as 15NH4Cl as sole nitrogen source or 
13C-Glucose as sole 
carbon source. Furthermore, for NMR studies of larger proteins (≥ 25 kDa) it is desirable to enrich 
Deuterium in order to minimize Hydrogen mediated T2-relaxation. 
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50 ml LB supplemented with the respective antibiotics (Table 12) are inoculated with E.coli BL21-
CodonPlus (DE3)-RIL cells carrying the desired protein expression construct (Table 13) and incubate 
o/n at 37 °C. The next morning, 500 mL M9 minimal media containing the appropriate isotopes and 
supplemented with the respective antibiotics (Table 12) are inoculated with the o/n preculture at an 
OD600 of 0.15 – 0.3. To this end, a sufficient amount of the preculture is pelleted by centrifugation 
and resuspended in M9 minimal media. The suspension culture is expanded at 37 °C until the 
desired volume (usually 1 L 15N M9 (H2O) for 
15N-labeled PDZ domains constructs) is reached with an 
OD600 of 0.8 – 0.9. At this point, the culture is shifted to 20 °C. After temperature equilibration (30 – 
60 min) protein expression is induced by the addition of IPTG (0.5 – 1 mM final concentration) for 16 
h. Cells are harvested by centrifugation (6000 g, 10 min, 4°C) and cell pellets are stored at -20°C until 
use. 
 
7.2.5 Protein purification 
All methods in structural biology require sufficient amounts of pure protein. The following section 
covers several methods for protein purification. Depending on the needs of the methods used, 
different purification strategies combining different purification steps were chosen to fulfill these 
needs. Protein purification strategies are summarized in Table 24. 
Table 24: Protein purification strategies used for the studies of the dmPar3 PDZ domains. 
method proteins purification steps 
CSPs analysis/ 
NMR titrations 
GB1-fusion constructs Ni-NTA, GF 
15N-labeled PDZ domain Ni-NTA, TEV, GF 
15N-labeled dmPar3 
linkerPDZ3 Δβ2-3 loop constructs 
Ni-NTA, TEV, reverse Ni-NTA, (GF) 
backbone assignment 13C,15N-labeled 
linkerΔNII-PDZ3 Δβ2-3 loop 
Ni-NTA, TEV, reverse Ni-NTA, GF 
crystallization trials PDZ-ligand fusion Ni-NTA, TEV, IEX, GF 
Abbreviations as follows: Ni-NTA: Ni
2+
-NTA-affinity chromatography, GF: gel filtration, TEV: TEV protease cleavage, reverse 
Ni-NTA: Reverse Ni
2+
-NTA-affinity chromatography, IEX: Ion exchange chromatography. 
 
7.2.5.1 Ni2+-NTA-affinity chromatography 
Ni2+-Ions can form complexes with Imidazole and Imidazole ring containing molecules. Since histidine 
contains an Imidazole ring in its side chain, proteins can form complexes with Ni2+-Ions. This can be 
exploited to affinity purify proteins containing an appropriate number of histidine residues in an 
appropriate conformation. Therefore, an N-terminal histidine tag consisting of six histidines can be 
integrated into protein expression constructs. Those fusion proteins are able to bind to Ni2+-Ions 
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immobilized on Nitrilotriacetic acid agarose beads and can be separated from a protein mixture such 
as cell lysates. 
35 ml lysis buffer + (Table 12) per 1 L medium is used to resuspend cell pellets by vortexing for 10 
min at 4°C. Large lysis volumes (≥ 1 L culture volume) are lysed with an EmulsiFlex for 2-3 rounds at 
4°C, small lysis volumes are sonicated (KE 76 tip, 2 sec pulse, 1 sec pause, 20 % amplitude, total time 
1 min) on ice two times. Cell debris are removed by centrifugation (40 000 g, 4°C, 30 min). After 
filtration, the supernatant is mixed with Ni2+-NTA beads (5 mL per 1 L of culture) and incubated at 
4°C for 10 min. Next, the mixture is poured into a column and washed with lysis buffer until no 
protein is detected with a Bradford assay in the wash fraction. Bound proteins are eluted with 
elution buffer. Fractions are analyzed by SDS-PAGE and Coomassie staining. 
 
7.2.5.2 Dialysis and TEV protease cleavage 
Various protein purification steps require specific buffer conditions to ensure proper separation. For 
example, reverse Ni2+-NTA-affinity chromatography requires a Imidazole concentration below 5 mM 
and ion exchange chromatography require a low buffer conductivity (< 5 mS/cm). Simultaneously, 
the expression tag can be cut off by TEV protease since all protein expression constructs used in this 
thesis harbor a TEV protease recognition site (ENLYFQG) between the C-terminus of the expression 
tag and the N-terminus of the protein of interest. 
To this end, the protein solution is mixed with 1 aliquot of TEV protease (1 mL, 0.5 mg/mL), packed 
into a 5 kDa cut-off dialysis tube and dialyzed against an appropriate volume of the buffer (Table 12) 
with the desired characteristics for downstream applications (Table 24) o/n at 4°C. 
 
7.2.5.3 Reverse Ni2+-NTA-affinity chromatography 
After TEV protease cleavage, the cut off expression tag can be removed by a second Ni2+-affinity 
column. 
Beforehand, the Imidazole concentration has to be reduced at least below 5 mM preferably by a 
combined dialysis and TEV protease cleavage step. The protein mixture is batch incubated with an 
appropriate amount of Ni2+-NTA beads equilibrated with dialysis buffer, beads are washed with 
dialysis buffer until no protein is detected with a Bradford assay and eluted with dialysis buffer 
supplemented with 300 mM Imidazol. Fractions are analyzed by SDS-PAGE and Coomassie staining. 
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7.2.5.4 Ion exchange chromatography 
Each protein has charged residues. The sum of these charged residues define the overall charge of a 
protein which is reflected by its pI. In turn, this charge can be used to separate proteins from each 
other. In addition, those charges are influenced via protonation and deprotonation or simplified by 
the pH of the buffer. Moreover, charged particles interact with each other. These interactions can be 
used to immobilize proteins on charged beads such as sulphonated Sepharose (HiTrap SP) or 
quaternary amide Sepharose (HiTrap Q) at low ionic buffer strengths. Upon an increase of the ionic 
buffer strengths, proteins can be eluted again. 
Before running an ion exchange chromatography (IEX), the ionic strength of the protein solution has 
to be adjusted below 5 mS/cm which usually corresponds to a NaCl concentration about 10 mM. In 
addition, the buffer ion and buffer pH should not interfere with the binding of the protein of interest 
to the IEX matrix used. In general, if the pH is 1 unit below the pI of the protein of interest, it will 
bind to a cation exchanger such as a SP column, if the pH is 1 unit above the pI of the protein of 
interest, it will bind to an anion exchanger such as a Q column. The buffer should not bear the 
opposite charge of the exchange column since it would otherwise occupy the charged surface of the 
column matrix and would compete with the protein of interest for binding. Therefore, before 
running HiTrap SP column, buffer is exchanged to SP low salt buffer (Table 12) or Q low salt buffer 
(Table 12) before running a HiTrap Q column. 5 mL IEX columns are run at 2.5 mL/min on a NGC 
system (BioRad) and absorptions at 280 nm and 215 nm are monitored to identify protein containing 
fractions. Bound proteins are eluted by a gradient ranging from 0 – 40 % high salt buffer containing 
1000 mM NaCl. Protein containing fractions are analyzed by SDS-PAGE and Coomassie staining. 
 
7.2.5.5 Gel filtration chromatography 
Another method for protein separation is gel filtration (GF) or size exclusion chromatography. 
Hereby, the different sizes of proteins are used for separation. The matrix of GF columns is porous. 
Since smaller molecules therefore have a larger volume to diffuse through when passed over a GF 
column, they need longer to transverse the column than bigger molecules. Hence, small and large 
molecules are separated. 
S75 16/600 or S75 26/600 columns (GE Healthcare) are equilibrated with an appropriate buffer (e.g. 
NMR buffer for subsequent NMR measurements (Table 12)) and run on a NGC system (BioRad). 
Absorptions at 280 nm and 215 nm are monitored to identify protein containing fraction. Protein 
containing fractions are analyzed by SDS-PAGE and Coomassie staining. 
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7.3 Structural biology and biophysics 
7.3.1 NMR spectroscopy 
7.3.1.1 Data acquisition 
5 mm NMR tubes (Norell) were used to record all NMR experiments and NMR data was acquired 
with a 600 MHz Bruker Advance III spectrometer equipped with a TXIz probe head. All experiments 
were set up with Bruker Topspin 2.1 software. Furthermore, the standard set up used by laboratory 
coworkers was used for excitation pulses, decoupling sequences and gradient pulses. A summary of 
temperatures and spectra recorded can be found in Table 25. 
Table 25: Overview of NMR experiments conducted during my thesis. 
constructs/ experiments spectra temperature 
individual dmPar3 PDZ domains / titrations 1H,15N-HSQC 293 K 
dmPar3 linker-PDZ3 Δβ2-3 loop / titrations 1H,15N-HSQC 293 K 
dmPar3 linker-PDZ3 Δβ2-3 loop / constructs 1H,15N-HSQC 303 K 
dmPar3 PDZ1-3 module 1H,15N-TROSY 303 K 
individual hsPar3 domains 1H,15N-HSQC 303 K 
GB1-dmPar3 FID-motif / assignment 1H,15N-HSQC, -HNHA, 
-HNHB, -HNH-NOESY 
293 K 
GB1-dmPar3 FID-motif / titration 1H,15N-HSQC 293 K 
 
7.3.1.1.1 1H,15N-HSQC experiments 
2D 1H,15N-HSQC experiments were recorded with 1024 complex points for a sweep width of 13 ppm 
in the 1H dimension, and 128 complex points for a sweep width of 26 ppm in the 15N dimension. 
 
7.3.1.1.2 1H,15N-TROSY experiments 
2D 1H,15N-TROSY experiments were recorded with 768 complex points for a sweep width of 13 ppm 
in the 1H dimension, and 128 complex points for a sweep width of 26 ppm in the 15N dimension. 
 
7.3.1.1.3 Assignment of the dmPar3 FID-motif 
In order to assign the residues of the dmPar3 FID motif (NESQHFIDAGS) in context of the GB1-fusion 
construct, an unusual assignment strategy was chosen. Excellent technical support and advice was 
provided by Dr. Vincent Truffault. 
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Figure 40: Assignment strategy of the dmPar3 FID-motif. (A) J-couplings used for 3D 
1
H,
15
N-HNHA spectra are shown as 
solid green line (
1
JHN) and as dashed green line (
3
JHN-Hαi). (B) J-couplings used for 3D 
1
H,
15
N-HNHB spectra are shown as solid 
green line (
1
JHN) and as dashed green line (
3
JHN-Hαi-1 and 
3
JHN-Hβi). (C) A hypothetical stripe of a 
1
H,
15
N-HNH-NOESY spectrum 
is shown highlighting the information content of a 
1
H,
15
N-HNH-NOESY spectrum. Characteristic positions of Hβ-, Hβ/γ-, Hα-, 
HNi-1-, HNi+1- and H2O- cross peaks are indicated at the right and at the left. 
 
A highly concentrated sample of the 15N-labeled GB1-dmPar3 FID motif fusion construct (1.7 mM) in 
NMR buffer (Table 12) was available. In addition, only eleven cross peaks originating from the FID-
motif in the spectrum of the GB1 fusion had to be assigned (Figure 35A, Figure A 2). Hence, 2D 
1H,15N-HSQC as well as 3D 1H,15N-HNHA, 1H,15N-HNHB and 1H,15N-HNH-NOESY spectra were 
recorded. The 3D 1H,15N-HNHA spectrum contains HN cross peaks of the backbone and the Cα-proton 
of the same residue (Hαi) (Figure 40A). The 3D 
1H,15N-HNHB spectrum contains HN cross peaks of the 
backbone and the Cβ-protons of the same residue (Hβi) (Figure 40B). However, at high concentrations 
(> 0.5 mM), the 3D 1H,15N-HNHB spectrum also contains cross peaks of the Cα-proton of the previous 
residue (Hαi-1). Therefore, sequential information can be extracted from this spectrum. Additionally, 
the 3D 1H,15N-HNH-NOESY spectrum contains cross peaks of protons in the vicinity of HN pairs 
(usually around 5 Å) at characteristic positions (Figure 40C) further enriching the available 
information. All of these information combined enabled Dr. Truffault and me to assign the residues 
of the FID-motif inside the GB1-dmPar3 FID-motif fusion protein (Figure 35A). The assignment was 
carried out at 20°C, spectra were analyzed with TopSpin 2.1 (Bruker) and Sparky (Lee et al. 2015). 
Table 26 summarizes the acquisition parameters used. In order to identify peaks originating from the 
dmPar3 FID-motif, the 1H,15N-HSQC spectrum of the 15N-labeled GB1-dmPar3 FID-motif fusion was 
compared with a 1H,15N-HSQC spectrum of 15N-labeled GB1 without the FID-motif. Cross peaks only 
present in the 1H,15N-HSQC spectrum of the 15N-labeled GB1-dmPar3 FID-motif (Figure A 2) were 
selected for subsequent assignment of the 1H,15N-resonaces of the dmPar3 FID-motif. 
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Table 26: Acquisition parameters for dmPar3 FID-motif backbone assignment. 
 
 
 
spectra 
dimension  
1H 15N 1H 
complex 
points 
sw 
[ppm] 
complex 
points 
sw 
[ppm] 
complex 
points 
sw 
[ppm] 
1H,15N-HSQC 1024 13 128 26 - - 
1H,15N-HNHA 1024 13 58 26 72 13 
1H,15N-HNHB 1024 13 58 26 72 13 
1H,15N-HNH-NOESY 1024 13 64 26 112 13 
 
7.3.1.2 Data processing and visualization 
All NMR spectra were processed with the NMRPipe/NMRDraw package (Delaglio et al. 1995) and 
visualized with NMRview (Johnson & Blevins 1994). 
 
7.3.1.3 Chemical shift perturbation experiments 
Chemical shift perturbation (CSP) experiments of NMR titrations are a powerful tool to study protein 
interactions. Since the position of a cross peak in a NMR spectrum depends on the local magnetic 
field and thus on the chemical environment, changes in this environment can be observed by NMR 
spectroscopy. 
Since proton based NMR experiments are very sensitive towards changes in buffer composition such 
as pH (Hayes et al. 1975; Patel et al. 1975) and ionic strength (Mildvan & Cohn 1963), variations in 
buffer composition of the 15N-labeled protein and its unlabeled ligand have to be avoided. To this 
end, all 15N-labeled proteins with their respective ligands are dialyzed against a large volume of NMR 
buffer (Table 12) o/n at 4°C or exchanged into the same buffer by gel filtration. 15N-labeled protein 
concentration was adjusted to 67-113 µM (Table 27) with NMR buffer containing 5-10% D2O. After 
recording the reference spectra, highly concentrated unlabeled ligand was added at defined molar 
ratios. During the course of the titrations, the number of scans was increased to compensate for 15N-
labeled protein dilution due to volume increase. 
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Table 27: Concentration of 
15
N-labeled dmPar3 PDZ domains used for CSP experiments 
 
15
N-labeled     
PBM dmPar3 PDZ1 dmPar3 PDZ2 dmPar3 PDZ3 dmPar3 linkerΔII-
PDZ3 Δβ2-3 loop 
dmPar3 PDZ1-3 
Δβ2-3 loop 
Smash 67 100 100 - - 
Insc 75 100 100 113 - 
Crb 83 80 105 105 - 
Stan 70 82 100 105 - 
Ed 75 100 100 105 - 
Shg 75 100 100 107 - 
dmPar6 75 100 100 109 74 
a-cat 100 100 108 110 - 
aPKC 75 108 75 95 - 
Std 100 100 104 - - 
dmPar6 L0A 75 - - - - 
dmPar6 H-1A 75 - - - - 
dmPar6 L-2A 80 - - - - 
Shg vs dmPar6 104 - 103 - - 
 
7.3.1.4 Chemical shift perturbation analysis 
Chemical shift perturbations can be used to semi-quantify the interaction of two binding partners 
and to map the interacting regions if resonance assignments are available. To this end, the average 
CSPs are used and are calculated in ppm: 
Equation 14: 
𝐶𝑆𝑃 = √∆𝛿1𝐻
2 + (
∆𝛿15𝑁
4
)
2
 
where Δδ1H is the difference in proton chemical shift and Δδ15N is the difference in nitrogen chemical 
shift at a 30-fold stoichiometric excess of dmPar3 PDZ3 Δβ2-3loop domain compared to the 
respective reference in the absence of ligand in chase of 15N-labeled dmPar3 FID-motif titration with 
unlabeled dmPar3 PDZ3 Δβ2-3loop domain (Figure 35B), 24-fold stoichiometric excess of dmPar3 
FID-motif compared to the respective reference in the absence of ligand in chase of 15N-labeled 
dmPar3 PDZ3 Δβ2-3loop titration with unlabeled dmPar3 FID-motif (Figure 35D) or at a nine-fold 
stoichiometric excess of PBM compared to the respective reference in the absence of ligand in the 
case of dmPar3 PDZ domain titrations with PBMs (Renschler et al. 2018). Chemical shifts were 
extracted using Sparky (Lee et al. 2015), CSPs were quantified using Equation 14 and mapped and 
color coded onto a suitable protein structures (x-ray, NMR or homology model) via pymol or are 
mapped onto the protein sequence. 
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7.3.1.5 Two dimensional line shape analysis 
Each NMR spectra contains a vast amount of data about the local chemical environments of the 
observed nuclei as well as the change of that environment over time. In order to extract this data, 
line shape fitting analysis is performed. During two dimensional line shape analysis performed with 
TITAN (Waudby et al. 2016), each spectrum is simulated and the parameters used for simulation are 
fitted against the experimental data. 
1H,15N-CSP studies for the dmPar3 PDZ domains were quantified using TITAN according to 
instructions and online documentation (http://www.nmr-titan.com and 
https://bitbucket.org/cwaudby/titan/wiki/Home). Spectra were acquired with 1024 and 128 points 
in the 1H and 15N dimensions, respectively, and processed with the NMRPipe/NMRDraw package 
(Delaglio et al. 1995) with exponential window functions with a line broadening of 4 Hz in the proton 
dimension and 8 Hz in the nitrogen dimension. Spectra were zero-filled to 4096 and 1024 points in 
the 1H and 15N dimensions, respectively. In order to obtain comparable results for different ligands, 
the same cross peaks were used for the analysis of each PDZ domain (Table A 1). Errors were 
estimated with bootstrapping statistics on 100 replicates. Figures for line shape analyses were 
prepared with TITAN. 
 
7.3.1.6 Secondary structure determination 
The 3J-coupling constants are directly linked with the stereochemistry of the atoms between which J-
coupling occurs and can be used to extract information about the angles between them (Bystrov 
1976). In addition, it is possible to directly correlate 3JHN-Hαi-coupling constants with secondary 
structure elements which are defined by the torsion angle φ of the peptide backbone. 
3JHN-Hαi-coupling constants in Hz were determined according to Equation 15 from 3D 
1H,15N-HNHA 
spectra: 
Equation 15: 
𝐽𝐻𝑁−𝐻𝛼𝑖 =
3
𝑎𝑟𝑐𝑡𝑎𝑛 √
𝐼𝐻𝛼𝑖
𝐼𝐻𝑁
⁄
2𝜋 ∙ 𝐷3 ∙ 𝑓
  
with 𝐼𝐻𝛼𝑖 being the intensity of the Hαi cross peak, 𝐼𝐻𝑁 being the intensity of the HNi diagonal peak, 
𝐷3 being the evolution time of the 3JHN-Hαi-coupling (here 14 ms) and 𝑓 being an empirical 
determined relaxation factor. 𝑓 accounts for the loss of magnetization during 𝐷3 and was 
determined to be 0.9 (V. Truffault, personal communication). Characteristic 3JHN-Hαi-coupling 
constants found in secondary structure elements are summarized in Table 28.  
 
114 
 
Table 28: Characteristic 
3
JHN-Hαi-coupling constants in secondary structure elements 
Secondary structure element 3JHN-Hαi-coupling constant (Hz) 
α-helix < 6 
random coil/ ambiguous 6 – 8 
β-strand > 8 
 
In order to assign secondary structure elements, the intensifies of the Hαi cross peak and HHN 
diagonal peak in the 3D 1H,15N-HNHA spectra of 15N-labeled GB1-dmPar3 FID-motif were quantified 
using Sparky (Lee et al. 2015). 3JHN-Hαi-coupling constants were calculated using Equation 15. 
Secondary structure elements were subsequently assigned by comparison with characteristic 3JHN-Hαi-
coupling constants in secondary structure elements (Table 28). Additionally, qualitative analysis of 
3D 1H,15N-HNH-NOESY strips was performed to resolve amgibuities. In 3D 1H,15N-HNH-NOESY 
spectra, spacial distances correlate with the peak intensities. Therefore, it is possible to gain 
information of the secondary structure since in α-helices the Hαi-3 is in close proximity of the HNi 
giving rise to a detectable cross peak in the corresponding 1H,15N-HNH-NOESY strip of residue i. 
Furthermore, in elongated conformations of the protein chain such as β-strands and random coils, 
the intensities of HNi-1 cross peaks are significant less intense compared to HNi-1 cross peaks found in 
α-helices. Hence, qualitative analysis of 1H,15N-HNH-NOESY spectra aids in resolving ambiguous 3JHN-
Hαi-coupling constants. 
 
7.3.2 X-ray crystallography 
7.3.2.1 Crystallization condition screening 
In order to grow protein crystals, the proteins in solution has to pass the phase barrier between a 
under saturated solution and a supersaturated solution (Blow 2010; Rupp 2009). However, if 
proteins are concentrated in concentrators above their saturation point, they usually tend to 
aggregate and do not form crystals. In order to prevent this aggregation, the transition has to be 
smooth to allow crystal nucleus formation. In addition, other variables influencing the crystal growth 
such as salt concentration, pH and additives favoring crystal contacts should be adjusted. One gentle 
way to increase the protein concentration is the extraction of water from the protein solution via 
vapor diffusion. In sitting drop vapor diffusion, a mixed drop of protein solution and reservoir 
solution is sitting above a well filled with reservoir solution inside an air-tight chamber. The reservoir 
solution consists of various ingredients such as buffers, additives, salts and hygroscopic crystallizing 
agents. Since the concentration of the crystallizing agent is higher in the reservoir, water diffuses 
from the drop into the reservoir. This diffusion leads to an increase of the protein concentration in 
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the drop. Finally, the protein concentration reaches supersaturation and hopefully crystal growth 
starts. The exact crystallization conditions for each protein differ. Therefore the crystallization 
conditions have to be determined empirically by screening the crystallization space by varying pH, 
crystallization agent, crystallization agent concentration, temperature, protein concentration as well 
as other parameters such as additives (salts, volatile agents, etc.) and their concentrations. To this 
end, commercially available screens have been developed. 
The Insc PBM was fused with a seven amino acid long GS-linker to the C-terminus of the dmPar3 
PDZ2 domain, expressed in LB and purified by Ni-NTA affinity chromatography, SP ion exchange 
chromatography and gel filtration. The dmPar3 PDZ2-Insc fusion was concentrated to 25 mg/mL in 
XTAL buffer (Table 12) and initial crystallization screening was performed with the commercially 
available screens listed in Table 29. Initial crystallization screening was performed in sitting drop 96-
well plates (96-3 low profile INTELLI-PLATE®, Art Robbins Instruments) with drops consisting of 0.3 
µL protein solution and 0.3 µL reservoir solution. Crystal growth was observed in various wells after 
seven to 14 days at 20°C. Next, crystals obtained were tested by mechanical stability or by 
synchrotron irradiation whether or not they were protein crystals. Therefore, crystals were cryo-
protected, flash frozen in liquid nitrogen and diffraction quality was measured at the Swiss Light 
Source (SLS, Villingen, Switzerland). Although some crystals diffracted well showing diffraction spots 
at 2 Å, the overall quality of the datasets was low since the completeness was low. 
Table 29: Initial crystallization screens 
Screen Manufacturer 
Classics QIAGEN 
Classics II QIAGEN 
PEGs QIAGEN 
PEGs II QIAGEN 
Protein Complex QIAGEN 
JCSG+ QIAGEN 
AmSO4 QIAGEN 
 
Consequently, the most promising conditions in terms of resolution were chosen to improve the 
crystallization conditions (Table 30). Crystal improvement screens were set up with a dragonfly 
pipetting robot (ttp labtech) and screening was performed in sitting drop 96-well plates (96-3 low 
profile INTELLI-PLATE®, Art Robbins Instruments) with drops consisting of 0.3 µL protein solution and 
0.3 µL reservoir solution. Protein solution contained the dmPar3 PDZ2-Insc fusion protein at 
concentrations of 25.8 mg/mL or 13.2 mg/mL. Crystal growth was observed in various wells within 
12 h to seven days at 20°C. Crystals were cryo-protected and diffraction data was recorded at the 
SLS. The highest quality crystal used for structure determination of the dmPar3 PDZ2 : Insc PBM 
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complex was grown in 63.64 mM MES pH 6, 36.36 mM HEPES pH 7, 0.1 M NH4SO4, 30 % (w/v) PEG 
5000 MME. 
Table 30: Crystal improvement screens 
initial condition screen 
from to 
Classics II/ D3 0.1 M HEPES pH 7 0.1 M MES pH 6.5 0.1 M HEPES pH 7.5 
30 % (w/v) Jeffamine ED 2001 pH 7 20 % (w/v) 40 % (w/v) 
PEGs II/ G2 0.1 M MES pH 6.5 0.1 M MES pH 6 0.1 M HEPES pH 7 
0.2 M NH4SO4 0 M NH4SO4 0.7 M NH4SO4 
30 % (w/v) PEG 5000 MME constant  
 
In addition to the dmPar3 PDZ2:Insc PBM construct mentioned above, several other constructs have 
been generated to solve crystal structures of dmPar3 PDZ domains in complex with various PBMs 
(Table 31). Although all constructs were expressed in sufficient amounts and soluble and pure 
protein could be obtained, none of the constructs tested yielded high-quality diffraction data (Table 
31).  
Table 31: Crystallization construct of dmPar3 PDZ domains not yielding high-quality diffracting crystals 
dmPar3  
PDZ domain 
PBM linker length 
(position) 
expression solubility final 
purity 
crystals 
grown 
crystal quality 
PDZ2 Insc 15 GS  
(PDZ-PBM) 
ok ok ok no  
PDZ3 Δβ2-3 
loop 
dmPar6 5 GS  
(PDZ-PBM) 
ok ok ok ok no diffraction 
15 GS  
(PDZ-PBM) 
ok ok ok ok diffraction to 12 Å after 
crystal improvement  
Shg 7 GS  
(PDZ-PBM) 
ok ok ok ok diffraction to 4 Å after 
crystal improvement  
15 GS  
(PDZ-PBM) 
ok ok ok ok no diffraction 
Ed 7 GS  
(PDZ-PBM) 
ok ok ok ok no diffraction 
linker-PDZ3 
Δβ2-3 loop 
- - ok ok ok no  
Shg 7 GS  
(PDZ-PBM) 
ok ok ok no  
dmPar6 7 GS  
(PDZ-PBM) 
ok ok ok no  
Ed 7 GS  
(PDZ-PBM) 
ok ok ok no  
MBP-linker- 
PDZ3 Δβ2-3 
loop 
- - ok ok ok no  
- 4 A  
(MBP-linker) 
ok ok ok no  
 
7.3.2.2 Cryogenic protection of protein crystals 
Protein crystals consist of huge amounts of water. In contrast, x-ray diffraction data is usually 
acquired at temperatures of 100-120 K in order to reduce radiation damage to the protein molecules 
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inside the crystal. At these low temperatures the water would freeze and the water molecules would 
form crystal lattices. Hence, the frozen water would also cause a diffraction pattern. Therefore, x-ray 
diffraction of the water molecules inside the protein crystals has to be avoided. In order to avoid 
water crystallization, the protein crystals are incubated with cryo-protectants such as glycerol, PEG-
400, salts etc. which lead to the formation of amorphous ice with no defined crystal lattice. Since 
amorphous ice has no lattice, diffraction from water molecules of amorphous is always destructive 
and thus leads to no observable diffraction spots on the detector. 
In order to cryo-protect protein crystals, suitable cryo-protectant solutions have to be found. To this 
end, reservoir solution is mixed with glycerol or PEG-400 at 30 % (v/v) and flash frozen in liquid N2. If 
the frozen solution stays transparent, a suitable cryo-protectant solution is found. However, if the 
frozen solution is opaque or cracks and/or other forms of deformation, phase separation etc. are 
observed the cryo-protectant has to be changed or the cryo-protectant concentration has to be 
adjusted. After establishing a suitable cryo-protectant solution, protein crystals are transferred into 
the cryo-protectant solution, shortly incubated, flash frozen in liquid N2 and stored in liquid N2 until 
recording diffraction data at the synchrotron. DmPar3 PDZ2-Insc fusion crystals used for dmPar3 
PDZ2 : Insc PBM complex diffraction data collection were cryo-protected in reservoir solution 
supplemented with 30 % (v/v) PEG-400. 
 
7.3.2.3 Data acquisition 
The dmPar3 PDZ2 : Insc PBM complex diffraction data was collected at the SLS at the PXII beamline 
with a PILATUS 6M pixel detector with 0.5° oscillation per image, a filter transmission of 0.1, a 
detector distance of 0.295 m, and λ = 1 Å in a cryostream. 
 
7.3.2.4 Data processing 
During data processing, each spot recorded in the diffraction data set is indexed, i.e. the Miller 
indices h, k and l are assigned. Therefore, during indexing, the diffraction spots are assigned to their 
coordinates in the reciprocal space. Next, the space group is assigned. To this end, all possible space 
groups are scored according to their probability to produce the diffraction pattern and the highest 
scoring one is chosen. Subsequently, the intensity of each spot is determined by integration. Finally, 
scaling takes place. During scaling, all data is merged into one file and partial reflections from several 
frames are added up. To this end, intensities obtained from partial reflections in different 
orientations on each of the frames are variably scaled together. In addition, during scaling, the Rfree-
set of reflections (Brünger 1992) is generated. 
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The dmPar3 PDZ2 : Insc PBM complex X-ray diffraction data was processed using images from 0°-
360° in XDS (Kabsch 2010), no anomalous signal was observed. The space group was determined by 
pointless (Evans 2006). Data set statistics are provided in Table 32. 
 
Table 32: Statistics of X-ray data collection and refinement of the dmPar3 PDZ2 : Insc PBM complex 
Data collection  
Wavelength (Å) 1.0 
Resolution range (Å) 41.49  - 1.767 (1.83  - 1.767) 
Total reflections 104544 (9415) 
Unique reflections 8254 (803) 
Multiplicity 12.7 (11.7) 
Completeness (%) 99.60 (98.04) 
I / σI 28.04 (3.74) 
Wilson B-factor (Å
2
) 29.42 
CC1/2 1 (0.92) 
Crystal properties  
Space group I 2 2 2 
Unit cell dimensions  
a, b, c (Å) 42.203, 48.851, 78.576 
α, β, γ (°) 90, 90, 90 
Refinement  
Resolution range (Å) 41.49 - 1.767 (1.83 - 1.767) 
Reflections used in refinement 8252 (802) 
Reflections used for Rfree 413 (40) 
Rwork / Rfree (%) 0.1763 (0.2222) / 0.2059 (0.2910) 
CCwork / CCfree (%) 0.947 (0.920) / 0.952 (0.832) 
RMS(bonds) 0.006 
RMS(angles) 0.77 
Ramachandran favored / allowed / outliers (%) 98.78 / 1.22 / 0 
Rotamer outliers (%) 0 
Clashscore 2.23 
Number of non-hydrogen atoms 691 
macromolecules 653 
ligands 5 
solvent 33 
Average B-factor (Å
2
) 36.64 
macromolecules (overall) (Å
2
) 36.06 
PDZ domain (Å
2
) 36.05 
Insc PBM (Å
2
) 33.91 
solvent (Å
2
) 43.06 
Sulfate (Å
2
) 69.99 
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7.3.2.5 Phase determination by molecular replacement 
During X-ray data acquisition, only intensities are recorded. However, phase information is needed 
in order to transform the reciprocal space into real space. Therefore, the phases have to be 
determined. If homologous structures are available, it is feasible to use these structures for phasing 
(Rossmann & Blow 1961). PHASER uses log-likelihood methods to place the search model in order to 
obtain phase information (McCoy et al. 2007). 
Phases of the dmPar3 PDZ2 : Insc PBM complex X-ray diffraction data were obtained by PHASER 
(McCoy et al. 2007). The second PDZ domain of hsDlg3 (2fe5, 37 % identity) as well as the PDZ 
domain variant C378S of the rat homolog of Dlg (2awx, 34 % identity) were used as search models. 
The search modes were trimmed by chainsaw (Stein 2008) to the last common atom with dmPar3 
PDZ2. Additionally, loops were removed from the models manually and both models were used in an 
ensemble search. PHASER found a single solution with a LLG of 269 and a TFZ of 15.7. Inspection in 
coot did not reveal any clashes. Furthermore, no density was present in solvent channels and the 
crystal packing seemed to be reasonable. Initial refinement with Phenix (Adams et al. 2010) 
including simulated annealing resulted in Rwork / Rfree of 36.96 / 37.26. Therefore, phase 
determination by molecular replacement was successful. 
 
7.3.2.6 Structure refinement 
During refinement, the model and the phases are improved. Successive rounds of model building 
and subsequent refinement lead to improved phases which in turn lead to better maps to build in. 
Therefore, the model explains the experimental data better after refinement since it represents the 
data better. This progress can be monitored by the crystallographic R-factor: 
Equation 16: 
𝑅 =
∑ ||𝐹𝑜𝑏𝑠| − |𝐹𝑐𝑎𝑙𝑐||
∑|𝐹𝑜𝑏𝑠|
 
The crystallographic R-factor compares the observed structure factors Fobs with the back calculated 
structure factors Fcalc derived from the model. If the R-factor lowers during refinement, the model 
explains the data better. However, the R-factor has to be cross validated in order to avoid over 
fitting. To this end, approximately 5 % of the observed reflexes are not included into refinement. 
Similar to the R-factor, a Rfree-factor is calculated (Brünger 1992). If both R (also called Rwork) and Rfree 
decrease during refinement, the refinement is valid and the resulting model explains the 
experimental data better than the previous model. 
The initial model obtained from PHASER was refined successively using alternating rounds of 
refinement in Phenix (Adams et al. 2010) using anisotropic B-factors and model building in Coot 
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(Emsley et al. 2010). Figures displaying structures were prepared using PyMOL (www.pymol.org). 
Final refinement statistics are provided in Table 32. 
 
7.3.2.7 Iterative-build OMIT map 
During refinement, the previously build model is used to calculate the crystallographic phases for the 
next refinement cycle. However, this model is biased e.g. by wrongly placed atoms. Since the 
refinement of the model adjusts the parameters describing the correctly placed atoms (e.g. position, 
B-factors), these parameters are also adjusted to compensate for errors in the model. Therefore, the 
improved phases contain reminiscences of the errors even though if they are corrected at a later 
stage during refinement. Consequently, memories of their positions are present as model bias and 
validation of such bias is necessary. 
One effective way to remove or to check for model bias was introduced by T. Terwiliger et al. as 
iterative-build OMIT maps (Terwilliger et al. 2008). To this end, parts of the model are iteratively 
omitted and with these OMIT models, model building, density modification and refinement is carried 
out. Since the resulting map has never been affected by a model in the OMIT region, this map is bias 
free inside the OMIT region. As a result, OMIT maps for each OMIT region are generated and can be 
combined to an iterative-build composite OMIT map without any model bias. The iterative-build 
OMIT map routine has been implemented in phenix (Adams et al. 2010) and was applied for OMIT 
map generation of the Insc PBM of the dmPar3 PDZ2:Insc complex (Figure 29D). 
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8. Appendix 
8.1 1H,15N-HSQC spectra of dmPar3 linker-PDZ3 Δβ2-3loop constructs and 
dmPar3 PDZ3 Δβ2-3loop CSPs experiments with the dmPar3 FID-motif 
 
Figure A 1: 
1
H,
15
N-HSQC spectra of dmPar3 PDZ3Δβ2-3loop constructs and dmPar3 PDZ3Δβ2-3loop CSPs experiments 
with the dmPar3 FID-motif. (A) Overlay of 
1
H,
15
N-HSQC spectra of dmPar3 PDZ3 Δβ2-3loop constructs described in Figure 
34A. dmPar3 PDZ3 Δβ2-3loop is shown in black, dmPar3 linker-PDZ3 Δβ2-3loop in purple, dmPar3 linkerΔI-PDZ3 Δβ2-3loop 
in light blue, dmPar3 linkerΔII-PDZ3 Δβ2-3loop in green, dmPar3 linkerΔIII-PDZ3 Δβ2-3loop in orange, dmPar3 linkerΔFID-
PDZ3 Δβ2-3loop in red. The magenta box indicates the region of the spectra displayed in Figure 34A. (B) Overlay of the 
1
H,
15
N-HSQC spectra of the dmPar3 PDZ3 Δβ2-3loop domain in the absence (black) and presence of increasing 
stoichiometric amounts of the FID-motif containing linker of dmPar3 fused to GB1 as indicated. Data are shown for three 
out of eight titration points (Table A 2). The magenta box indicates the region of the spectra displayed in Figure 34. 
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8.2 Assignment of the 1H,15N-resonances of the dmPar3 FID-motif 
 
Figure A 2: Assignment of the 
1
H,
15
N-resonances of the dmPar3 FID-motif in context of the GB1-dmPar3 FID construct. 
Overlay of the 
1
H,
15
N-HSQC spectra of GB1-dmPar3 FID-motif (black) and GB1 (red). Peaks originating from the GB1 domain 
display no CSPs in presence of the dmPar3 FID-motif. Cross peaks originating from the dmPar3 FID-motif are labeled. In 
addition to cross peaks originating from the dmPar3 FID-motif, two additional peaks not present in the GB1 spectrum are 
present and could be assigned to serine (S*) and glycine (G*) residues introduced as a linker between the GB1 and the 
dmPar3 FID-motif. 
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8.3 NMR line shape fitting analysis of the dmPar3 PDZ domains 
8.3.1 Cross peaks and number of titration steps used for line shape fitting analysis 
Table A 1: Cross peaks used for line shape analysis of the individual dmPar3 PDZ domains 
PDZ1 PDZ2 PDZ3 linker-PDZ3 
I11 G17 T19 G23 
Y15 F23 G23 N67 
L34 27T V26*** Q74 
Q36 41K K43 E81 
N59 46R I46 V102 
E73 51E A50  
L79* 61L N67****  
E80 80I Q74  
L84 82R** E81  
L89 92I V88*****  
 96R V102  
*not Ed; **just Insc, Shg; *** not aPKC, Crb, Ed; **** not dmPar6; ***** just dmPar6 
 
Table A 2: Number of titration steps used for line shape fitting analysis 
PDZ1 PDZ2 PDZ3 linker-PDZ3 
5 (Ed)SB 4 (Smash) 4 (Smash) 7 (Insc) 
8 (Shg)SRB,SW, MCS, FAR 5 (Insc)SRB 5 (Insc)SRB 7 (Crb) 
10 (dmPar6)SRB,SW,MCS, FAR 5 (Stan) 5 (Crb) 7 (Stan) 
6 (dmPar6 L0A) 5 (Ed)SRB 5 (Stan) 7 (Ed) 
5 (dmPar6 H-1A) 5 (Shg)SB 5 (Ed)SRB 7 (Shg) 
5 (dmPar6 L-2A) 5 (α-cat)BS 8 (Shg)SRB,SW, MCS, FAR 7 (dmPar6) 
 5 (aPKC)BS 13 (dmPar6)SRB,SW, MCS, FAR 7 (aPKC) 
 5 (Std) 5 (α-cat)BS  
  5 (aPKC)BS  
The following abbreviations indicate persons who acquired NMR titration data used for line shape fitting analysis: SRB 
(Susanne R. Bruekner), PLS (Paulin L. Salomon), BS (Benjamin Schroeder), SW (Silke Wiesner) and FAR (Fabian A. 
Renschler). 
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8.3.2 Line shape fitting analysis of dmPar3 PDZ1 
 
Figure A 3: Line shape fitting analysis of the dmPar3 PDZ1 interaction with the Ed PBM. Contour plots of 
1
H,
15
N-HSQC 
spectra of each cross peak used in TITAN line shape fitting analysis (Waudby et al. 2016) at each titration point are shown. 
Observed cross peaks are shown in blue whereas fits are shown in red. Black lines indicate the course of the titration 
between the reference point and an estimated saturation point of the fit CSPs. The grey area around the cross peaks 
indicates the region of interest selected to fit the data in TITAN. Titration points are indicated above each column. Plots 
were generated by TITAN. NMR titration data was provided by Susanne Bruekner. 
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Figure A 4: Line shape fitting analysis of the dmPar3 PDZ1 interaction with the dmPar6 PBM. NMR titration data was 
provided by Susanne Bruekner, Silke Wiesner, Mira C. Schütz-Stoffregen and me. Otherwise as in Figure A 3. 
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Figure A 5: Line shape fitting analysis of the dmPar3 PDZ1 interaction with the dmPar6 L0A PBM. Otherwise as in Figure A 
3. 
 
Figure A 6: Line shape fitting analysis of the dmPar3 PDZ1 interaction with the dmPar6 H-1A PBM. Otherwise as in Figure 
A 3. 
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Figure A 7: Line shape fitting analysis of the dmPar3 PDZ1 interaction with the dmPar6 L-2A PBM. Otherwise as in Figure 
A 3. 
 
Figure A 8: Line shape fitting analysis of the dmPar3 PDZ1 interaction with the Shg PBM. NMR titration data was provided 
by Susanne Bruekner, Silke Wiesner, Mira C. Schütz-Stoffregen and me. Otherwise as in Figure A 3. 
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8.3.3 Line shape fitting analysis of dmPar3 PDZ2 
 
Figure A 9: Line shape fitting analysis of the dmPar3 PDZ2 interaction with the α-cat PBM. NMR titration data was 
provided by Benjamin Schroeder. Otherwise as in Figure A 3. 
 
Figure A 10: Line shape fitting analysis of the dmPar3 PDZ2 interaction with the aPKC PBM. NMR titration data was 
provided by Benjamin Schroeder. Otherwise as in Figure A 3. 
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Figure A 11: Line shape fitting analysis of the dmPar3 PDZ2 interaction with the Ed PBM. NMR titration data was provided 
by Susanne Bruekner. Otherwise as in Figure A 3. 
 
Figure A 12: Line shape fitting analysis of the dmPar3 PDZ2 interaction with the Insc PBM. NMR titration data was 
provided by Susanne Bruekner. Otherwise as in Figure A 3. 
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Figure A 13: Line shape fitting analysis of the dmPar3 PDZ2 interaction with the Shg PBM. NMR titration data was 
provided by Susanne Bruekner. Otherwise as in Figure A 3. 
 
Figure A 14: Line shape fitting analysis of the dmPar3 PDZ2 interaction with the Smash PBM. Otherwise as in Figure A 3. 
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Figure A 15: Line shape fitting analysis of the dmPar3 PDZ2 interaction with the Stan PBM. Otherwise as in Figure A 3. 
 
Figure A 16: Line shape fitting analysis of the dmPar3 PDZ2 interaction with the Std PBM. Otherwise as in Figure A 3. 
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8.3.4 Line shape fitting analysis of dmPar3 PDZ3 Δβ2-3loop 
 
Figure A 17: Line shape fitting analysis of the dmPar3 PDZ3 Δβ2-3loop interaction with the α-cat PBM. NMR titration data 
was provided by Benjamin Schroeder. Otherwise as in Figure A 3. 
 
Figure A 18: Line shape fitting analysis of the dmPar3 PDZ3 Δβ2-3 loop interaction with the aPKC PBM. NMR titration 
data was provided by Benjamin Schroeder. Otherwise as in Figure A 3. 
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Figure A 19: Line shape fitting analysis of the dmPar3 PDZ3 Δβ2-3 loop interaction with the Crb PBM. Otherwise as in 
Figure A 3. 
 
Figure A 20: Line shape fitting analysis of the dmPar3 PDZ3 Δβ2-3 loop interaction with the Ed PBM. NMR titration data 
was provided by Susanne Bruekner. Otherwise as in Figure A 3. 
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Figure A 21: Line shape fitting analysis of the dmPar3 PDZ3 Δβ2-3loop interaction with the Insc PBM. NMR titration data 
was provided by Susanne Bruekner. Otherwise as in Figure A 3. 
 
Figure A 22: Line shape fitting analysis of the dmPar3 PDZ3 Δβ2-3loop interaction with the Shg PBM. NMR titration data 
was provided by by Susanne Bruekner, Silke Wiesner Mira C. Schütz-Stoffregen and myself. Otherwise as in Figure A 3. 
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Figure A 23: Line shape fitting analysis of the dmPar3 PDZ3 Δβ2-3loop interaction with the dmPar6 PBM. NMR titration 
data was provided by Susanne Bruekner, Silke Wiesner, Mira C. Schütz-Stoffregen and myself. Otherwise as in Figure A 3. 
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Figure A 24: Line shape fitting analysis of the dmPar3 PDZ3 Δβ2-3loop interaction with the Smash PBM. Otherwise as in 
Figure A 3. 
 
Figure A 25: Line shape fitting analysis of the dmPar3 PDZ3 Δβ2-3loop interaction with the Stan PBM. Otherwise as in 
Figure A 3. 
 
137 
 
8.3.5 Line shape fitting analysis of dmPar3 linkerΔII-PDZ3 Δβ2-3loop 
 
Figure A 26: Line shape fitting analysis of the dmPar3 linkerΔII-PDZ3 Δβ2-3loop interaction with the aPKC PBM. 
Otherwise as in Figure A 3. 
 
Figure A 27: Line shape fitting analysis of the dmPar3 linkerΔII-PDZ3 Δβ2-3 loop interaction with the Crb PBM. Otherwise 
as in Figure A 3. 
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Figure A 28: Line shape fitting analysis of the dmPar3 linkerΔII-PDZ3 Δβ2-3loop interaction with the Ed PBM. Otherwise 
as in Figure A 3. 
 
Figure A 29: Line shape fitting analysis of the dmPar3 linkerΔII-PDZ3 Δβ2-3loop interaction with the Insc PBM. Otherwise 
as in Figure A 3. 
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Figure A 30: Line shape fitting analysis of the dmPar3 linkerΔII-PDZ3 Δβ2-3loop interaction with the dmPar6 PBM. 
Otherwise as in Figure A 3. 
 
Figure A 31: Line shape fitting analysis of the dmPar3 linkerΔII-PDZ3 Δβ2-3loop interaction with the Shg PBM. Otherwise 
as in Figure A 3. 
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Figure A 32: Line shape fitting analysis of the dmPar3 linkerΔII-PDZ3 Δβ2-3loop interaction with the Stan PBM. Otherwise 
as in Figure A 3. 
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